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Agnes Binagwaho, Gian Luca Burci, Luisa Cabal, Katherine DeLand, Timothy Grant Evans, Eric Goosby, Sara Hossain, Howard Koh, Gorik Ooms, 
Mirta Roses Periago, Rodrigo Uprimny, Alicia Ely Yamin
Executive summary
Health risks in the 21st century are beyond the control of 
any government in any country. In an era of globalisation, 
promoting public health and equity requires cooperation 
and coordination both within and among states. Law can 
be a powerful tool for advancing global health, yet it 
remains substantially underutilised and poorly understood. 
Working in partnership, public health lawyers and health 
professionals can become champions for evidence-based 
laws to ensure the public’s health and safety.
This Lancet Commission articulates the crucial role of 
law in achieving global health with justice, through legal 
instruments, legal capacities, and institutional reforms, 
as well as a firm commitment to the rule of law. The 
Commission’s aim is to enhance the global health 
community’s understanding of law, regulation, and the 
rule of law as effective tools to advance population health 
and equity.
The term law throughout is used to mean legal 
instruments such as statutes, treaties, and regulations 
that express public policy, as well as the public institutions 
(eg, courts, legislatures, and agencies) responsible for 
creating, implementing, and interpreting the law. By 
establishing the rules and frameworks that shape social 
and economic interactions, laws exert a powerful force 
on all the social determinants of health. Well designed 
laws can help build strong health systems, ensure safe 
and nutritious foods, evaluate and approve safe and 
effective drugs and vaccines, create healthier and safer 
workplaces, and improve the built and natural environ-
ments. However, laws that are poorly designed, imple-
mented, or enforced can harm marginalised populations 
and entrench stigma and discrimination.
This Commission brings together global leaders in the 
fields of health, law, and governance. We make the case 
for better, more strategic linkages between health and law, 
and the professionals who work in both fields. We begin 
by providing a short explanation of legal terms and 
concepts, and the actors and institutions that govern 
health. Our report is structured around four legal 
determinants of health, each of which powerfully affects 
health outcomes. We use the term legal determinants of 
health because it demonstrates the power of law to address 
the underlying social and economic causes of injury and 
disease. These four legal determinants show how law can 
substantially influence health and equity. We do not 
endeavour a systematic review of law in global health, but 
rather to advocate for, and demonstrate, the crucial value 
of law in advancing global health with justice. Finally, 
drawing on identified areas for reform, as well as 
principles of good governance and the right to health, we 
offer seven concrete recommendations for action.
Legal determinant 1 states that law can translate 
vision into action on sustainable development. The UN 
Sustainable Development Goals (SDGs) present a bold 
and unifying vision for global health and development. 
Law offers the mechanisms, frameworks, and account-
ability measures to achieve this vision. In particular, 
law can be used to lay the foundations for Universal 
Health Coverage (UHC), which is a crucial element of 
sustainable development. We show how the power of law 
can be used to achieve health with justice through a case 
study of how law can build and implement UHC. We 
make two recommendations for action.
Recommendation 1 suggests that the UN, WHO, and 
international partners should set standards to support 
the implementation of, and objectively evaluate com-
pliance with SDG 3·8 (UHC), as well as the upcoming 
UN political declaration on UHC in 2019.
Key messages
1 Law affects global health in multiple ways, by structuring, perpetuating, and 
mediating the social determinants of health.
2 Although law has been central to major public health achievements in the past, 
its capacity to advance global health with justice remains substantially underutilised, 
particularly among professionals in the fields of health and science.
3 The right to health, a legally binding norm, provides a foundation for advancing 
global health with justice and should underpin health-related legal reforms.
4 Every human being has a right to affordable, high quality health services. 
By embedding equity and accountability in all health systems, the law and the rule of 
law can achieve health coverage that is truly universal—delivering the Sustainable 
Development Goals’ promise to leave no one behind.
5 Although the ability to enforce compliance with international legal obligations is 
generally limited, and largely dependent on power dynamics and political will, creative 
mechanisms can foster compliance and help establish impetus for action.
6 Law can address the pressing health concerns of the 21st century, across diverse areas. 
From tobacco control, non-communicable diseases, and road safety, to health 
emergencies, law can implement fair, evidence-based interventions to save lives. 
The global health community should champion evidence-based legal interventions 
and build the research case for legal action.
7 Laws that stigmatise or discriminate against marginalised populations are especially 
harmful and exacerbate health disparities. The global health community must oppose 
laws that undermine the right to health and to equity.
8 To realise the full potential of law to advance global health with justice, the global 
health community should build legal capacity and establish a sustained dialogue with 
legislators, regulators, judges, civil society, and researchers.
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Recommendation 2 advises that governments should 
strengthen or create a legal framework, such as a 
constitutional or statutory right to health, to ensure 
rights-based UHC on the basis of principles of equity 
and non-discrimination, including affordability, financial 
protection, transparency, accountability, participation, 
privacy, and sustainable financing.
Legal determinant 2 states that law can strengthen the 
governance of national and global health institutions. 
Law can be used to structure and clarify the complex web 
of institutions, norms, and processes that govern global 
health. We identify three key governance challenges that 
undermine coordinated action for health, as well as ways 
in which law can ensure good governance for health. 
First, where the mandates of global health actors overlap, 
conflict, or leave gaps, law can harmonise mandates and 
provide mechanisms to promote cooperation. Second, 
innovative legal and governance strategies can foster 
state compliance and strengthen existing international 
rules. Third, law can increase transparency, openness, 
inclusiveness, and accountability. We make two recom-
mendations for action.
Recommendation 3 suggests that the UN, WHO, and 
international partners should use their respective powers 
and influence to safeguard the public’s health and safety 
through the creation or adoption of good governance 
standards, embracing the highest principles of equity, 
inclusive participation, transparency, and accountability.
Recommendation 4 advises that governments should 
develop legal frameworks that establish principles of 
good governance throughout national health systems 
and policy making, form a country-appropriate mech-
anism to advise on legal interventions with high health 
impact, and adopt legislation requiring health impact 
assessments for policies, programmes, and projects that 
might seriously affect health.
Legal determinant 3 states that law can implement fair, 
evidence-based health interventions. Evidence-based laws, 
effectively implemented and fairly enforced, can create the 
conditions for good health. We provide a framework for 
evaluating health laws and identifying those laws that 
advance health with justice. We offer concrete examples of 
such laws, across three domains of health: infectious 
diseases, non-communicable diseases, and injuries. In 
each domain, we discuss the ways in which international 
and domestic laws interrelate and inform one another. We 
also show how laws that are not informed by evidence and 
human rights could instead undermine health and justice, 
entrenching inequality and discrimination. We make one 
recommendation for action.
Recommendation 5 suggests that WHO should increase 
its legal capacity to enable it to spearhead development of a 
global evidence-base for public health laws and to support 
the enactment and implementation of national and global 
health laws that are effective and sustainable.
Legal determinant 4 emphasises the importance of 
building legal capacities for health. Strong legal capacities 
are a key determinant of progress towards global health 
and sustainable development. Yet, too often, countries 
lack either the basic legal infrastructure or the capacity to 
build it. We make the case for productive, mutually 
reinforcing linkages between law and health, and identify 
three aspects of legal capacity-building for health: 
improving legal environments, growing the evidence-
base with high quality effectiveness research, and training 
key actors in law-making and law-implementing skills. 
We make two recommendations for action.
Recommendation 6 suggests that governments should 
build national capacities to enact and effectively 
implement public health laws.
Recommendation 7 suggests that WHO and The Lancet 
should partner with legal and health experts to create 
an independent standing commission on global health 
and the law that would advance the health-related SDGs 
by proposing evidence-based legal interventions for 
addressing major global health challenges, reforms of 
the global health architecture and international law, and 
strategies to build and strengthen global and national 
health law capacities.
In making these recommendations, we acknowledge 
that law reform is a complex and drawn-out process, 
presenting both technical and political challenges. 
Achieving global health with justice will require 
international and interdisciplinary cooperation, as well 
as leadership at all levels. However, as we underline in 
this report, law reform holds enormous promise. With 
the ability to effect real change at the population level, we 
argue, law should be considered among the key tools of 
the global health community. By providing insight on the 
legal determinants of health, our aim is to empower the 
global health community to strengthen its legal capacity, 
and to use law more strategically in the pursuit of health 
and equity. Globalisation has heightened risks to our 
health, but it also presents unprecedented opportunities 
to confront global health threats collaboratively, drawing 
on expertise and lessons learned within and among 
nation states. No government acting alone can achieve 
health with justice. Instead, we need laws and policies at 
every level—local, national, and global—to achieve a 
world that is healthier and safer.
Introduction
Health with justice
Health in the 21st century is being shaped by rapid 
globalisation. The unprecedented movement of people, 
money, technology, and ideas around the world is changing 
the profile of health and disease. Although previous 
decades have seen substantial reductions in major global 
risk factors such as unsafe sanitation, and malnutrition, 
new threats have emerged.1 Global health hazards 
nowadays share four important features: (i) health hazards 
are not bound by borders, ranging from infectious 
diseases, to non-communicable diseases, and injuries; 
(ii) they have common underlying causes, such as 
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dangerous pathogens, unhealthy behaviours, or unsafe 
environments; (iii) they are exacerbated by inequities 
linked to the socio-economic determinants of health; and 
(iv) they require a coordinated, multi-sectoral global 
response.2–4 A crucial element of that response will be the 
strategic use of law at all levels—local, national, and 
international—resting on stronger cooperation between 
the legal and health professions. Just as the interdependence 
of states and people heightens health risks, it also presents 
unprecedented opportunities to confront global health 
threats collaboratively, drawing on expertise and lessons 
learned within and among nation states.
The mission of the Lancet-O’Neill Institute of 
Georgetown University Commission on Global Health 
and Law (the Commission) is to articulate a compelling 
vision of the role of law in global health. In this report, 
we explain key legal concepts, offering important ways in 
which law can be wielded to advance health and equity—
not for an audience of legal scholars, but for the global 
health community. Although many global health 
professionals will be familiar with legal measures as an 
emergency response to health crises, this is only one 
facet of law.5 Less well understood is the role of law in 
governing global health institutions, in resolving 
disputes, and in health promotion and protection. Even 
less visible are those uses of law that, while not 
necessarily designed to affect health, have a profound 
impact upon it. Understanding these forces, and how to 
harness them, will be vital to improving population 
health in the 21st century.
Law and global health
We define global health as: study, research, and practice 
with the objective of preventing injuries and diseases 
and promoting the public’s health, while achieving 
equity in health for all people worldwide—both within 
and among states.6 In adopting this definition, our 
report builds on the 2014 Lancet-University of Oslo 
Commission on Global Governance for Health 
(Lancet-Oslo Commission), which concluded that “we 
must no longer regard health only as a technical, 
biomedical issue, but acknowledge the need for global 
cross-sectoral action and justice in our efforts to address 
health inequality.”4 Global health is infused by the value 
of social justice, aiming to address gaping health 
disparities within and among countries.7 It strives to 
realise the universal right to health, grounded in 
international human rights.8
Law is a key determinant of health. By law, we mean the 
statutes, regulations, and rules that express public policy. 
We also include the public institutions such as legislatures, 
agencies, and courts in our definition, which are 
responsible for creating, implementing, and interpreting 
the law.9 Law exerts a powerful influence on health by 
structuring, perpetuating, and mediating the risk 
factors and underlying conditions known as the social 
determinants of health:10 education, food, housing, 
income, employment, sanitation, and health care. The 
impact of law is felt not only in individual decisions 
(eg, of courts and tribunals) but also in statutes and reg-
ulations that operate at the population level (eg, agricultural 
subsidies, Universal Health Coverage [UHC], or man-
datory seat belt usage). As such, law can be a powerful 
tool for securing and advancing health and equity. It can 
be used to set and defend the norms and standards of 
good health, to establish and strengthen resilient health 
systems, and to hold actors and institutions accountable.
However, law can also be a formidable barrier to 
achieving global health and equity. Throughout history, 
misguided, out-dated, arbitrary, or discriminatory laws 
have caused great harm. Punitive laws, for example, can 
discourage marginalised individuals from accessing care, 
restrict reproductive rights, and enable discrimination in 
employment or insurance. Whether driven by animus or 
unsupported by scientific evidence, bad laws can under-
mine individual and population health, while entrenching 
inequalities. They can exclude, stigmatise, and inappro-
priately punish individuals. Furthermore, they can 
constrict the space for dissent and debate, for an 
independent press, and for social action. In such cases, 
law reform is crucial—but often difficult. The process of 
overturning old national legislation or adopting revised or 
new treaties often involves bitter and drawn-out struggles. 
New or better health laws can threaten the interests 
of powerful actors, including states, businesses, and 
lobbyists, who will vigorously oppose reform. Even if law 
reform is possible, once in force, new laws face challenges 
of moni toring and enforcement, in arenas often 
characterised by fragmentation and contestation.
Approach and aims
The Commission views law and health as mutually 
reinforcing, and urges the legal and health communities 
to work cooperatively toward a common goal of “global 
health with justice”.8 Working together, law reform should 
afford people “a fair and just opportunity to be as 
healthy as possible”.11 Law reform should also seek 
to eliminate the “systematic and potentially remediable 
differences in one or more aspects of health across socially, 
demographically, or geographically defined popu lations 
or population subgroups,”12 as well as inequalities or 
differences in health that are “avoidable, unfair or [which 
stem] from some form of injustice”.13 This vision is 
expressed in the United Nations Sustainable Development 
Goals (SDGs), which view health as a key component of a 
comprehensive, universal development agenda. The 
SDGs envision “justice for all”, resting on “transparent, 
effective, and accountable institutions”.14
The multiple actors, institutions, and sectors in global 
health offer great promise to achieve health with justice, 
but also face steep challenges. Governments and inter-
national institutions do not harness the full power of law 
to improve health and save lives—whether by dismantling 
barriers or by enacting affirmative reforms to safeguard 
The Lancet Commissions
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population health. Therefore, ensuring that the global 
health community clearly understands the role of the law, 
and how best to use it, is imperative. This report makes 
the case for the power of law to improve health, by 
informing the global health community about the effects 
of law on health (through what we describe as the legal 
determinants of health); exploring real-world case studies, 
opportunities and challenges; linking the health and legal 
communities, while building shared capacity (ie, infra -
structure and resources); and empowering com munities, 
countries, and global health institutions to use law to 
advance global health with justice.9
The Commission assembled a multidisciplinary team of 
experts from diverse backgrounds, including law, health, 
policy, economics, and governance. While reflecting this 
richness of expertise, our Report sits within the disciplinary 
tradition of public health law scholarship,15 and the 
emerging field of global health law scholarship.7 Public 
health law is “the study of the legal powers and duties of 
the state to ensure the conditions for people to be healthy 
… and the limitations on the power of the state to constrain 
the…legally protected interests of individuals for the 
common good.”15 Global health law, as a related field of 
study, uses a similar analytical orientation, but focuses on 
the relationship between international law and health.
Law is the primary topic of analysis in our report. Public 
health law predominantly uses legal doctrinal methods, 
informed by analytical frameworks from epidemiology 
and population health. Public health law is beginning to 
incorporate empirical methods, designed to evaluate the 
effects of law on public health,16 and has a strong normative 
dimension: the view presented in this Commission is that 
not only is law a powerful tool for achieving global health 
with justice, but also that law should be used for this 
purpose. The universal right to health is a core standard 
against which legal interventions should be assessed.
As the Lancet-Oslo Commission powerfully emphasises, 
issues far removed from the traditional public health 
context—for example, market forces, income inequality, 
and global governance structures—have a substantial 
effect on health. Law stands to influence almost every one 
of these, meaning that the subject of global health and the 
law is potentially vast. Therefore, the Commission has had 
to be selective, and, for this reason, is necessarily limited 
in scope. Our concept of legal determinants is not the only 
way to frame the topic. Rather, it reflects the Commission’s 
views of what constitute the major dimensions of law in 
global health, in the present era. The Commission has 
identified areas of law that most directly affect population 
health, and which lie within the remit of public health 
authorities. We do not purport to offer a systematic review, 
but rather to enunciate core legal concepts, building the 
case for the value of law in global health.
The legal determinants of health
Our Report begins with a short explanation of relevant 
legal terms and concepts: discussing where and how 
law works locally, nationally, and internationally, and 
why the rule of law is essential for health, development, 
and justice. We also describe the main actors in global 
health. This provides a foundation for our four key legal 
determinants of health: the areas identified in which 
stronger, more strategic linkages between health and 
law could substantially strengthen the overall global 
health agenda.
The first legal determinant is that law can translate 
vision into action regarding sustainable development. Law 
can help to achieve the SDGs’ unifying vision for global 
health and development. We illustrate the potential of law 
in advancing the SDGs through a case study on UHC. The 
second legal determinant is that law can strengthen the 
governance of national and global health institutions. The 
field of global health is complex, comprising a web of 
instit utions, norms, and processes at the global, national, 
and subnational levels. Weak gover nance undermines 
leadership and coordinated action for health. Law can 
strengthen health governance, including transparency, 
benchmarks, and monitoring, with ongoing evaluation, 
civil society engagement, and accountability. The third 
legal determinant is that law can implement fair, evidence-
based health interventions. Evidence-based public health 
laws—effectively imple mented and enforced—can create 
the conditions for healthy populations. We offer key 
examples of effective laws across three health domains: 
infectious diseases, non-communicable dis eases, and 
injuries. We also show how law can undermine health and 
justice. The final legal determinant is that law can be used 
to build legal capacities and reinforce all the legal 
determinants of health. All the aforementioned deter-
minants require stronger, mutually reinforcing link ages 
between law and health. Effective health laws are guided 
by science and translate the best available evidence on 
health improve ment. Legal capacity building includes 
stronger legal institutions (legislatures, agencies, and 
courts), expanding the evidence-base with research 
evaluating the effectiveness of laws, and training key 
actors in law-making and law-implementing skills.
In section 6, we offer seven recommendations, drawing 
on the major concepts identified throughout the report. 
The recommendations encompass these four legal 
determinants of health, covering rights-based UHC, 
good governance standards, fair and evidence-based 
interventions, and building legal capacity.
Section 1: the legal system for global health
The concept of law has long been debated among legal 
scholars, as have modes of interpretation. For the purposes 
of this report, the Commission proposes a “Primer on 
Law” intended to be understandable to a public health 
audience. In this section, we define law and explain how it 
is created, implemented, and enforced at the domestic 
and international levels; describe the essential idea of the 
“rule of law”; articulate the obligations of the state to 
ensure the conditions for health; and explain how law 
The Lancet Commissions
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functions as a tool to shape health outcomes. Finally, we 
identify the key actors and institutions in global health.
What is law? How is it created, implemented, and 
enforced?
Although not always perceptible, law is all around us. 
The most common definition of law is a body of norms 
(or rules of conduct) of binding force and effect, specified 
and enforced by a recognised authority. Law is used to 
create rights and duties, which should be applied fairly 
and consistently throughout society. Once implemented, 
people experience the effects of law every day, as it shapes 
their lives through the enforcement of legal standards 
and accompanying policies. This understanding of law is 
best illustrated at the domestic level, where the 
recognised authority is the sovereign state—the supreme 
authority within that territory. Because nation states have 
sovereign authority, they can enact and enforce laws. 
However, no sovereign authority exists at the international 
level, and the law requires states to agree to the terms of 
the legal instrument. Even when governments do assent 
to international agreements, these can be hard to enforce. 
Nevertheless, international legal norms remain essential 
for advancing health rights.
Domestic and international law are interrelated and bi-
directional in their impact on health and justice. 
Innovations in domestic law and policy can offer a model 
for other cities, countries, or regions to follow, or have a 
global effect; high-impact litigation in one jurisdiction 
can empower advocates in other jurisdictions to 
undertake similar action. International law, in turn, 
influences domestic law and policy by creating widely 
accepted standards. Domestic legal norms diffuse to 
other jurisdictions and up to international institutions, 
while international norms diffuse down to influence local 
and national laws, regulations, and policies.
Domestic law
Law is used to establish norms, rules, and systems. In the 
health context, these rules should seek to reduce or prevent 
risks of injury and disease equitably across populations.17 
In addition to imposing obligations on individuals and 
businesses in a society, law also confers rights; for example, 
in many countries, every inhabitant has the right to health 
care and public health services, and to equal justice 
under the law. The state holds the primary obligation to 
fulfil these entitlements. Domestic law encompasses the 
following sectors, each derived from different sources. 
Constitutions are the highest law of the land. Statutes, 
regulations, and case law must conform to constitutional 
norms and principles. Statutes (also called legislation, acts, 
laws) enacted by legislatures such as Parliament or the 
Congress express public policy. Regulations, also termed 
delegated legislation, from executive or administrative 
agencies safeguard the public’s health and safety 
(legislative bodies typically empower agencies to act). Case 
law, from courts and other tribunals, interprets and applies 
the constitution, statutes, and regulations to specific cases 
and sets judicial precedent. Beyond individual cases, the 
effect of case law differs from country to country, 
depending on its constitutional and legal traditions.
Constitutional law is widely regarded as the supreme 
law of the land. For the other three sources of law, different 
jurisdictions might accord them different importance 
or priority. We use the term “law” to encompass all 
four sources—each of which can substantially affect 
health—as well as their interactions.
International law
International law does not take the same form as domestic 
law. The simplest definition of international law is a set of 
norms or rules generally regarded and accepted as 
binding, in relations between states and other groups 
such as international organisations. International law 
primarily governs the conduct of states but can also 
substantially affect private parties such as corporations 
(eg, in relation to trade law) and individuals (eg, in relation 
to human rights law). Article 38 of the Statute of the 
International Court of Justice offers the most authoritative 
statement of the sources of international law, listing three 
primary sources: treaties, customary international law, 
and general principles.18 (panel 1).
Unlike in domestic law, there is no distinct international 
sovereign authority, and no global government steers 
international relations and transnational cooperation. 
Instead, various international institutions such as the 
UN, WHO, and the World Trade Organization (WTO) 
have law-making powers or act as forums to facilitate 
negotiation of treaties by member states. Additionally, 
states themselves might negotiate bilateral or multilateral 
treaties or other transnational agreements.
Trade is an example within which various forms of 
international law are evident. The WTO oversees several 
multilateral treaties, to which its member states adhere. 
Panel 1: Sources of international law: treaties, custom, and general principles
Treaties are international agreements (which might also be referred to as conventions or 
covenants), concluded between states in written form, and governed by international law. 
However, States must give their consent to be bound—and even if they do so, they might 
express reservations to exclude or to modify their legal obligations. A country that has 
ratified or acceded to a particular treaty, and is therefore legally bound by its provisions, is 
described as a state party. Certain international institutions have law-making power. WHO 
has adopted two major treaties under its Constitution: the Framework Convention on 
Tobacco Control (adopted under Article 19) and the International Health Regulations 
treaty (adopted under Article 21).18
Customary international law refers to legal norms that have emerged from general and 
consistent state practice. Customary law is binding on all states, except those that 
persistently object.
General principles of law refer to an amorphous body of law that emphasises broad 
principles recognised in national legal systems such as common law, civil law, or Islamic 
law (Sharia). Given the proliferation of treaty law, modern tribunals rely less on general 
principles and consider them to be a secondary source of law.
The Lancet Commissions
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States are also free to negotiate their own trade 
agreements (FTAs), such as regional compacts (eg, the 
United States–Mexico–Canada Agreement) or bilateral 
agreements, which might create additional norms to 
those found in WTO treaties. Even though these 
agreements are usually outside the sphere of the WTO, 
they must be consistent with WTO rules.
In the absence of a sovereign authority and a clear 
hierarchy of norms and rules, international law faces 
multiple governance challenges, including ensuring 
efficient implementation and compliance (see section 3). 
For example, international human rights are a central 
goal of many global health organisations and an important 
commitment for countries. However, states’ compliance 
with human rights has been highly variable, often 
undermined by powerful political and economic interests.
Across sectors, contemporary governance is characterised 
by the increasing use of non-binding instruments adopted 
with a normative intent. These instruments aim to guide, 
urge, or discourage particular behaviours. Soft legal 
instruments, covering a broad range of topics, are known 
by various terms,19 and we have chosen to use the term soft 
rules throughout this report.
The broad category of soft rules includes “any written 
international instrument, other than a treaty, containing 
non-binding principles, norms, standards, or other 
statements of expected behaviour.”20 Codes of practice, 
global strategies, declarations and resolutions can all be 
described as soft rules, as can recommendations, guide-
lines, and frameworks. UN and WHO resolutions, 
although agreed through a formal legal process, usually 
do not create binding legal obligations for member 
states. However, although not legally binding, these 
instruments can have practical effects comparable to 
those of binding law, and are especially important to 
bench marking, monitoring, and transparency.
Soft rules have several advantages over formal law. 
They are usually less costly (in both economic and 
political terms) and quicker to negotiate; they can be less 
rigid, and therefore easier to amend; and they can reflect 
more ambitious targets. Governments are often more 
willing to sign up to goals that are framed as targets 
or declarations rather than obligations.21 Furthermore, 
processes to develop soft rules can include a more diverse 
coalition of actors beyond nation states, including voices 
from civil society that are traditionally marginalised in 
treaty negotiations.22
The relationship between soft rules and hard law is 
fluid. Soft rules can form a basis for the development of 
formal international law, or international governments 
could adopt non-binding standards into their legal 
instruments. For example, WTO’s Agreement on 
Sanitary and Phytosanitary Measures incorporates the 
non-binding guidelines of the Codex Alimentarius 
Commission—a collection of internationally recognised 
standards, codes of practice, and guidelines that apply 
throughout the food supply chain.23 The United Nations 
Political Declaration on the Prevention and Control of 
Noncommunicable Diseases (September 2011) offers 
another example of soft rules. Negotiated through the 
General Assembly, the Declaration contains member 
states’ commitments to prevent and control non-
communicable diseases.
Perhaps most importantly, soft rules can be adopted 
into domestic law through a nationally sanctioned 
process (eg, through legislative or judicial decrees). 
Many soft rules aim for national-level implementation, 
including the Joint United Nations Programme on HIV 
and AIDS (UNAIDS) guidance on the prevention and 
treatment of HIV, and WHO’s guidelines on salt and 
sugar consumption. Countries have discretion to select 
which soft rules to adopt domestically. Figure 1 shows 
the relationship between international and domestic 
law, including the translation of soft rules into 
domestic law.
The rule of law
To earn and maintain the trust of the public, law 
makers—including legislatures, administrative agencies, 
courts, and international bodies—must create, enforce, 
and interpret the law impartially. These actions are the 
fundamental precept of the rule of law. Under the rule of 
law, no individual, business, institution, or government 
official is above the law: governments and public officials 
must be held legally accountable to act in the public 
interest (panel 2).
SDG 16 links the rule of law to development, as a 
crucial foundation for the creation and maintenance of 
“just, inclusive and peaceful societies”.25 In the absence 
of the rule of law, neither health nor development can be 
fully realised.
State obligations to support the right to health
Governments in virtually every legal system have both 
the authority and the duty to safeguard the health of the 
Figure 1: Relationship between domestic and international law
Can transition to binding through various 
mechanisms—eg, integration, customary international law, 
International Court of Justice decisions
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population.15 This authority derives from domestic 
and international norms. Nation states derive their 
authority through the concept of sovereignty: sovereign 
govern ments have sole authority to make laws and 
regulations regarding the public’s health. This principle 
recognises that certain risks—such as infectious 
diseases, natural disasters, industrial hazards, contam-
inated food and water—as well as the measures needed 
to prevent or reduce those risks, are outside the control 
of individuals or groups. No individual acting alone can 
assure the conditions for health and safety; only the State 
has the power necessary to intervene at the population 
level, through coordinated action.
Many international instruments, including WHO’s 
constitution and treaties, contain state obligations to 
safeguard health-related rights. Article 12 of the 
International Covenant on Economic, Social and Cultural 
Rights (ICESCR) from 1966 contains the foundational 
expression of the right to health.26 General Comment no. 
14 of the Committee on Economic, Social and Cultural 
Rights (a body comprising 18 independent experts that 
monitor state implementation of the ICESCR by states 
parties) interprets and elaborates on Article 12.27 General 
Comments offer guidance to states, clarifying treaty 
obligations and how they should be implemented.28
According to the ICESCR and General Comment no 14, 
the right to health is a “fundamental human right 
indispensable for the exercise of other human rights”, and 
“every human is entitled to the enjoyment of the highest 
attainable standard of health conducive to living a life in 
dignity”.29 States have an obligation to ensure available, 
accessible, affordable, and acceptable health facilities.
The state’s primary obligation is to protect the health 
and safety of its inhabitants, not only citizens and lawful 
residents, but also asylum seekers, refugees, and 
undocumented immigrants. Traditionally, states do not 
have duties toward individuals in other jurisdictions. 
However, humanitarian law, human rights law, and 
WHO treaties can imply or even explicitly prescribe 
transnational obligations. For example, states have a duty 
not to make, store, or deploy banned weapons (such as 
chemical weapons), and not to violate fundamental 
human rights. The International Health Regulations 
(IHR) contains non-binding language encouraging state 
parties to help build health system capacities in lower-
income states. Soft rules, such as the Pandemic Influenza 
Preparedness (PIP) Framework, require parties to share 
novel flu virus specimens and provide reciprocal benefits 
to other states.
When states act to ensure the public’s health and safety, 
they can impose restrictions on private interests.30 Public 
health interventions can constrain personal autonomy, 
privacy, or liberty, and can limit businesses’ economic 
freedom. Finding a balance between protecting liberties 
and securing population health is an enduring theme 
in public health law and ethics.31 Failing to strike an 
appropriate balance might result in disproportionate 
personal burdens, especially on marginalised populations. 
However, often, no conflict exists between individual and 
collective interests. For example, protecting the rights of 
individuals living with HIV or AIDS empowers them to 
access treatment, which both improves their health 
and reduces the likelihood of transmission. The role of 
the law, then, is to safeguard the health and safety 
of individuals and communities, while not restricting 
personal freedoms more than strictly necessary to fulfil 
health objectives.
The Siracusa Principles on the Limitation and 
Derogation Provisions in the International Covenant on 
Civil and Political Rights (ICCPR) 1985 guide states in 
striking the delicate balance between protecting liberties 
and securing population health.32 The Siracusa Principles 
were developed in response to concerns about govern-
ments illegally or unjustifiably declaring martial law or a 
state of emergency to deny fundamental rights and 
freedoms. The Principles were established to deter mine 
when such departures from the ICCPR might be 
permissible. Restrictions might be justifiable when they 
are in accordance with the law; based on a legitimate 
objective; strictly necessary in a democratic society; the 
least restrictive and intrusive means available; and not 
arbitrary, unreasonable, or discriminatory.33 Under 
international law, the Siracusa Principles are persuasive 
but non-binding, meaning that states should strongly 
consider but are not legally required to follow them.
Functions of law
Law has numerous functions, many of which directly or 
indirectly affect health. By “functions of law”, we mean 
how the law shapes societal interactions.34 The 
Commission chose to focus on three crucial functions. 
Law can be used to establish standards and norms that 
guide conduct, resolve disputes, and govern public and 
private institutions. Throughout this report, we draw on 
these three functions, explaining their relationship to 
global health.
Panel 2: The rule of law
We adopt the definition used by the UN in its 2004 report, 
The Rule of Law and Transitional Justice in Conflict and Post-
Conflict Societies:
“A principle of governance in which all persons, institutions 
and entities, public and private, including the State itself, are 
accountable to laws that are publicly promulgated, equally 
enforced and independently adjudicated, and which are 
consistent with international human rights norms and 
standards. It requires, as well, measures to ensure adherence 
to the principles of supremacy of law, equality before the law, 
accountability to the law, fairness in the application of the 
law, separation of powers, participation in decision making, 
legal certainty, avoidance of arbitrariness and procedural and 
legal transparency.”24
The Lancet Commissions
1864 www.thelancet.com   Vol 393   May 4, 2019
Establishing norms and standards in domestic and 
international law
In domestic law, the first duty of sovereign states is to 
protect the health, safety, and welfare of the population. 
Governments fulfil this duty principally by developing 
and enforcing rules and standards that structure the 
physical and social environment, guiding behaviour of 
individuals and the conduct of organisations. National 
constitutions typically empower governments to safe-
guard the public’s health and might also allocate 
responsibilities between states or provinces and the 
federal government, and between legislatures, agencies, 
and courts.
In the health context, states set norms and standards 
using the following powers.15 The power to tax and spend 
creates economic incentives (eg, agricultural subsidies) 
or disincentives (eg, tobacco taxes) for individual and 
corporate conduct that affects health. The power to alter the 
information environment and inform the public about the 
health effects of products (labelling, warnings, health 
education) or restrict deceptive marketing such as cigarette 
advertising. The power to alter the socio economic environ-
ment can create more equitable societies with fairer access 
to public goods (redistributive taxation, safety nets, and so-
cial welfare policies). The power to alter the physical and 
built environment can improve the quality of water and 
sani tation in communities, or can create liveable spaces 
and communities that are conducive to physical activity, 
including parks, play grounds, or bike paths. Governments 
use direct regulation of people, profes sionals, and 
businesses to set and enforce rules for numerous purposes 
—some of these include mandating childhood vaccinations 
or seatbelts, establishing systems for credentialing and 
licensing health professionals, or determining standards 
for motor vehicles or pharmaceuticals.
Indirect regulation through the tort system such as 
product liability and tobacco litigation creates disincentives 
for businesses that make and sell unsafe or hazardous 
consumer products. Finally, legal or regulatory reform 
provides substantive rights in relation to health and to 
justice (eg, informed consent, confidentiality, privacy, 
non-discrimination); or deregulation, in cases where 
existing laws or regulations impede public health (such as 
law banning distribution of sterile injection equipment) 
or stigmatise marginalised communities (such as criminal 
penalties for engaging in same-sex behaviour).
States could also use inward-facing regulation to 
improve the machinery of government.35 States should 
ensure the good governance rule of law, consisting of 
inclusive participation, honest stewardship of public 
resources, and accountability, in addition to strong 
regulatory capacities. For example, in 2011, the South 
African Constitutional Court held that the nation’s 
constitution contained an implied governmental 
obligation to establish an effective anticorruption unit.36 
Inward-facing regulation can also improve the delivery of 
health goods and services by ensuring a strong, 
well-funded health system. Inward-facing regulation is 
related to the third function of law (governing institutions).
International law also sets norms and standards that 
have a direct or indirect effect on health and safety, and 
with which states should, or must, comply. International 
health-related norms include protecting the child’s 
best interests and capacities,37 prevention and control of 
non-communicable diseases, and access to essential 
medicines.38 Standards that directly affect health include 
those for sanitary, which relate to animals; phytosanitary, 
which relate to plants; environmental pollution levels, and 
classification of diseases.23 WHO oversees three major 
international legal instruments,39 to which we refer 
throughout this report. The first is The Framework 
Convention on Tobacco Control (FCTC), an international 
treaty and thus legally binding; the IHR, another legally 
binding treaty; and The PIP Framework, which is not a 
formal treaty.
Many international rules were not created for a health 
purpose but have a profound impact on health. 
International trade rules (including intellectual property 
agreements), have far-reaching consequences for health. 
The relevant international regimes, their rules, and their 
intersection with health are described in the appendix.
Countries often have broad discretion as to how, and to 
what extent, they conform to international norms and 
standards. Full conformance often requires states to 
translate international norms and standards into national 
legislation. For example, WHO’s FCTC (2003) requires 
states parties to adopt and implement effective national 
measures to ensure that tobacco product packaging and 
labelling do not promote tobacco products by false, 
misleading, or deceptive means.40 States must act within 
their own legal systems to comply with international law. 
However, states retain sovereignty in deciding whether to 
ratify the treaty and in how they incorporate its 
requirements into their domestic law.
Domestic law can also provide greater precision than 
that which is expressed in expansive legal instruments. 
International health-related rights—such as the rights to 
health, privacy, and non-discrimination—are enshrined in 
many regional and domestic legal frameworks, including 
national constitutions.41,42 To fully realise the right to 
health, governments must implement measures through 
domestic law and regulation (panel 3). Broad international 
guidance requires detailed national policy making.
Resolving disputes at national and international levels
The second crucial function of law is as a tool to resolve 
disputes between individuals, organisations, and govern-
ments. This role of the law can occur in diverse venues, 
including traditional courts of law, and via alternative 
dispute resolution mechanisms, such as mediation or 
arbitration. Although dispute resolution typically involves 
specific parties, the outcomes can reach well beyond these 
parties. In the following sections, we examine how two 
important forms of dispute resolution—strategic national 
See Online for appendix
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litigation and international dispute resolution—have been 
used in the health context, and how their outcomes have 
been leveraged as broad public policy tools.
Strategic national litigation is the first important form of 
dispute resolution. Despite landmark public health 
litigation—on issues ranging from mental health and 
tobacco control, to access to medicines—the legal and 
public health communities continue to debate the 
strategic value of litigation in pursuit of public policy goals 
or other systemic change. Litigation is time-consuming, 
expensive, and technical, with unpredictable outcomes. 
Any individual or corporation can bring a court case, 
potentially furthering private interests inconsistent with 
the public’s health. Corporations can use the courts to 
overturn or diminish the effect of health and safety laws, 
or to defend marketing unsafe or unhealthy products.
Moreover, public policy requires balancing competing 
interests, and courts are generally not well suited to such 
determinations. In right-to-health litigation, courts are 
charged with deciding which individuals are eligible to 
receive a specific health service or product. However, 
judges have limited facts and perspective: they must 
Panel 3: Case study of legal responses to infectious disease (hepatitis C)
Despite enormous gains in the treatment of disease, the 
increasingly globalised nature of the world nowadays has made 
the spread of infectious diseases across borders a persistent, 
global public health challenge. In seeking to contain the spread 
of infectious disease, countries leverage a broad array of tools 
at their disposal. One important tool is the law, which poses 
unique challenges and opportunities in its role to help contain 
infectious disease. The global response to hepatitis C 
exemplifies some of these challenges and opportunities.
Worldwide, approximately 70 million people live with chronic 
hepatitis C virus infection.43 In the last decade, the development 
of direct-acting antivirals has provided an effective cure in the 
form of oral, well tolerated treatment regimens for people with 
chronic hepatitis C virus infection; cure rates of over 95% have 
been achieved with direct-acting antiviral regimens.44 Despite 
the existence of an effective cure, the number of people treated 
for hepatitis C still remains a relatively small fraction of those 
infected or diagnosed.45,46 Patent-related barriers that keep 
prices high substantially contribute to this problem.46
Direct-acting antivirals have a wide range of patents, covering 
the chemical molecules, manufacturing processes, methods of 
treatment, and formulations.47 Patents covering various 
aspects of direct-acting antivirals prevent the entry of 
competitors, allowing originator companies to select the price 
for the market.48 Although these patents cover a broad range 
of features, the reality of country-specific patent regimes 
means that a patent granted in one country might not be 
granted by, or even filed in another country. In countries where 
patents are not filed or granted, local production or 
importation of generics is possible, and the competition from 
these generics, in turn, drops the price and increases access to 
the drug. An example of this was observed in Georgia and 
Morocco;49 in both countries, primary patents for the direct-
acting antiviral sofosbuvir were not filed. As a result, generic 
companies could produce that drug, enter the market, and 
decrease the price of the drug.
In countries where patents are issued, another set of options 
have been utilised by groups and countries to mitigate 
patent-related barriers. For example, some non-governmental 
organisations have been attempting to systematically test or 
undermine patents issued in certain countries to facilitate 
competition and access.46 Many national patent regimes 
provide the opportunity for third party filings, which serve as a 
way to register concerns about whether the compound has 
sufficiently met the requirements of patentability. 
Non-governmental organisation attempts to undermine 
patents have led to the rejection of key patent applications for 
direct-acting antivirals in Brazil, China, Egypt, and Ukraine.46,50–58
Where patents exist and have been unsuccessfully challenged, 
another option available to groups and countries is voluntary 
licence agreements. These agreements formalise originator 
companies’ permission to manufacture and sell generic versions 
of their drug regimens in specific countries or regions. As a result, 
countries included in originator companies’ voluntary licensing 
agreements are able to access generic direct-acting antivirals 
from licencees at lower prices.53 For example, one manufacturer 
licenced its products to eleven generic manufacturers in India, 
facilitating the sale of generics in more than 100 countries.53
Countries not included in voluntary licence agreements can still 
increase competition and access by way of other strategies. 
The Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPS),54 an international legal agreement 
between all the member nations of the World Trade 
Organization, acts to constrain actions for countries with 
respect to patents. However, countries do have the right under 
TRIPS to grant government use or compulsory licences in certain 
circumstances.54,55 In September, 2017, Malaysia became the first 
country to issue a compulsory licence for a direct-acting 
antiviral.46,52 After issuing the licence, Malaysia was then included 
in the voluntary licence agreement of some manufacturers.56
The net effect of this global patchwork of patent laws and 
policies is, on the one hand, a steep price cut in low-income and 
middle-income countries, and, on the other hand, a slowly 
declining price trend in upper middle-income and high-income 
countries.46 The former is promising because more than 60% of 
people with hepatitis C nowadays live in a country that could 
access generic direct-acting antivirals.46 However, not all 
countries that can access more affordable generic treatments 
do, and, still more troubling, although some competition has 
altered prices in upper middle-income and high-income 
countries, high prices of direct-acting antivirals continues to 
impede access to an effective cure.46
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adjudicate according to the parties and evidence in front 
of them, rather than considering issues at the population 
level. Are judges better placed to decide on the allocation 
of scarce health resources than elected officials? When is 
it appropriate for a court to decide that an individual 
litigant is entitled to access pharmaceuticals not listed 
on the government’s or WHO’s essential medicines 
registries?
While acknowledging these weaknesses, and others, 
we believe that well targeted strategic litigation—eg, 
proceedings that seek systematic change and remedies 
that extend far beyond the individual litigants—can be 
effective in advancing public health, complementing 
other approaches.
Tobacco litigation is perhaps the most familiar example 
of successful strategic litigation to drive public policy.57 In 
the USA, advocates and state attorney generals brought 
class action litigation against tobacco companies after 
pursuing numerous other legal and policy avenues. 
Tobacco control litigation, still in process, has produced 
two well known outcomes. The first was the 1998 Master 
Settlement Agreement, which forced tobacco companies 
to curtail marketing and to make annual payments, in 
perpetuity, to US states, and the second was the “Tobacco 
Papers”, a vast cache of internal industry documents 
uncovered in 1994 that revealed duplicitous industry 
actions such as concealing the harms of tobacco use and 
the addictiveness of nicotine, and marketing directed 
toward children and adolescents.58
Tobacco litigation has had enduring effects on public 
health. The litigation exposed the unethical behaviour 
of industry executives, informed the public of the 
devastating dangers of tobacco smoke, and secured 
industry funds for health promotion. The Tobacco 
Papers are housed in a public repository, informing 
subsequent tobacco control measures throughout the 
world.59 The FCTC emphasises the value of domestic 
litigation, asking parties of states to share information 
and strategies.
Strategic litigation can also precisely interpret broad 
or abstract principles, such as the right to health, 
leading to improved health care. Litigation on access to 
anti-retroviral drugs is one area in which notable 
success has been achieved. In Minister of Health versus 
Treatment Action Campaign (2002), the Constitutional 
Court of South Africa held that government limits 
on the public sector provision of nevirapine were 
unreasonable and unconstitutional. Nevirapine halves 
perinatal HIV trans mission rates. The Court found that 
limiting access was a breach of the right to health care, 
which was not consistent with a positive state obligation 
to progressively realise the rights of mothers and infants 
to essential health services.60 Similarly, the Venezuelan 
Supreme Court (1999) required the State to provide HIV 
treatment and to develop social awareness campaigns.61 
In 2000, the Argentine Supreme Court found that the 
“right to health falls within the right to life…the first 
natural right of the individual”, and directed the 
government to provide HIV treatment.62 These cases, 
along with other right to health litigation, have 
contributed greatly to social movements.63
Controversies in public health litigation have also been 
reported. Modelled on the cases described above, 
individuals have increasingly launched health rights 
litigation around the world on issues including repro-
ductive rights, mental health, and smoking in public 
places.64 Notably, this litigation often occurs in the 
context of democratic failure: litigants turn to the courts 
because corruption, autocratic practices, and the 
dominance of powerful interests provide little 
opportunity for changing policies through the political 
system.65 Although gaining traction,66 the justiciability of 
the right to health (ie, the question whether or not a 
court can adjudicate a claim brought on the basis of the 
right to health) remains a contested issue in many 
jurisdictions.64 The long-term effects of litigation on 
equity and justice are not yet clear,64 and are dependent 
on context. For example, one study of litigation in a 
southern Brazilian state concluded that “judicialization 
largely serves the disadvantaged who turn to the courts 
to secure a wide range of medicines.”67 However, in other 
cases, courts have granted individuals access to 
expensive medications, some of which have little 
demonstrated value. When courts override careful policy 
assessments by the legislature, they might divert 
resources for health that could otherwise have been used 
for more cost-effective interventions. Consequently, 
scholars have noted: “Courts in adjudicating health 
human rights need to frame the right in the context of 
Panel 4: Litigation as a tool to define the right to health
In 1991, Colombia enacted a new Constitution followed by a series of reforms intended to 
extend health insurance to all citizens. The 1991 Constitution enshrined economic and 
social rights, establishing a Constitutional Court as a specialised tribunal to oversee the 
new constitutional jurisdiction. This gave individuals the right, when economic and civil 
rights were not being met, to take the government to court through a writ called a 
tutela.69 Tutelas give citizens an avenue to ensure that the government actively provides 
for their constitutional rights, including rights to health care.
However, health-related tutelas rapidly overwhelmed the tribunal. According to a report 
by the Human Rights Ombudsman’s Office, between 1999 and 2008 there were 
674 612 actions for protection of constitutional rights in relation to health issues.70,71 
Additionally, rather than creating a more equitable dispute resolution system for all 
Colombians, tutelas were often exploited by members of the wealthier class.72 
The Colombian Constitutional Court subsequently issued a sweeping decision to improve 
the equity and oversight of the health system and stem the tide of litigation.73
The decision provided necessary definition and limits to the right to health for Colombia. 
Moreover, the Colombian Court had to carefully assess the practical and financial burden its 
decision would have on the government. As scholars have noted, “if health-related rights are 
treated as unconditional and not limited by resource capacity, this can put an unsustainable 
burden on public insurers and undermine the ability to [act] as wise stewards of public 
resources through negotiating prices or resisting patent extensions and so forth”.68
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the larger equity and solidarity goals of a public health 
care system…one danger with a rights-based approach is 
that it can reinforce the individual demands for high-
priced treatments, thus exacerbating the difficulties 
governments have in running fair and efficient health 
care systems.”68
This danger was realised in Colombia, where 
individuals bringing legal actions known as tutelas 
overwhelmed the public health system in the 1990s and 
2000s, requiring a judicial ruling on the limits and 
definition of the right to health (panel 4).
However, individuals in many of these cases were 
simply seeking the treatments and other services to 
which they were already legally entitled.74 As scholars 
from multiple disciplines have recognised, there is no 
inherent conflict between right to health adjudication 
and efficient and equitable priority setting.75
Furthermore, litigation can be time-intensive, costly, 
and unpredictable, dampening its potential benefits. In 
the US tobacco litigation, industry defendants imposed 
enormous delays and high costs over the course of 
decades and multiple waves of litigation before health 
advocates eventually gained traction in the courts.76
Many industries, including the food, beverage, alcohol, 
and tobacco industries often use litigation to diminish 
innovative public health laws. In 2012, tobacco companies 
successfully halted US Food and Drug Administration 
(FDA) regulations to mandate graphic warnings. The US 
Supreme Court found that the FDA rule violated the 
companies’ constitutional commercial speech rights. 
Industries’ use of the commercial speech doctrine has 
also undermined public health regulations designed to 
prevent obesity and other non-communicable disease 
risk factors.
At the international level, multiple dispute resolution 
systems exist, with varying degrees of effectiveness. The 
WTO’s is among the most robust, with three main 
stages: first, consultations between the parties; second, 
adjudication by panels, followed by the Appellate Body; 
and finally, implementation of the ruling, including 
countermeasures if the losing party fails to comply. The 
World Bank’s International Centre for Settlement of 
Investment Disputes (ICSID) offers another venue for 
transnational litigation. The ICSID is charged with 
interpreting bilateral or multilateral investment treaties 
designed to protect industry investments in governments 
that are parties to those treaties.
The WTO and ICSID, as tribunals, must reach 
judgment on the individual cases before them and not on 
their possible implications for public policy. In some 
cases, they have protected industry interests over the 
public’s health. Tobacco companies have used both ICSID 
and WTO processes to challenge tobacco control laws in 
Uruguay (marketing restrictions) and Australia (plain 
packaging). The ICSID arbitration panel ruled decisively 
in Uruguay’s favour in July, 2016, requiring Philip Morris 
to pay the costs of the defendant and the court.
In contrast to certain well established dispute settlement 
systems, WHO’s treaty dispute mechanisms are weak. 
Under Article 27·1 of the FCTC, the parties must try to 
settle their disputes “through diplomatic channels”, using 
negotiation or mediation. If the parties cannot settle their 
dispute in this way, the FCTC envisages ad-hoc arbitration 
with the exclusive jurisdiction of an arbitration panel. 
However, only three countries have formally agreed to 
be bound by this arbitration, and the mechanism has 
never been used.
The IHR (2005), the WHO treaty aimed at global health 
security, include a dispute settlement process between 
state parties (Article 56), which is voluntary. State parties 
should first seek to resolve the dispute through negotiation 
or mediation, after which the matter might be referred to 
the Director-General. However, this voluntary dispute 
settlement system has never been used.
WHO’s PIP Framework uses a combination of non-
binding norms and legally binding contracts to achieve 
its aims. The PIP Framework was devised to forge a 
compromise among higher and lower-income countries 
on virus sharing and equity. The associated contracts, 
known as Standard Material Transfer Agreements 
(SMTAs), are used to bind non-state actors who would 
not usually be subjects of international law, such as 
pharmaceutical companies or academic institutions.39 
The SMTAs include a binding arbitration clause: “if a 
dispute cannot be resolved through negotiations or other 
non-binding means of the parties’ choice, disputes shall 
be subject to binding arbitration on conditions that are 
mutually agreed by the parties.”77–79
Other dispute resolution models beyond international 
legal instruments include public–private partnerships 
(PPPs), such as the Global Fund to Fight AIDS, 
Tuberculosis and Malaria; and Gavi, the Vaccine Alliance, 
as well as institutions such as the World Bank. These 
resolution models have rules and regulations related to 
how grant and loan resources can be used, and how they 
must be accounted for.
Furthermore, regional and international human rights 
treaties often have quasi-judicial dispute settlement 
systems for states that accept to be bound by them, which 
are available once domestic avenues have been exhausted 
—for example, the Committee on the Elimination of 
Discrimination Against Women (CEDAW), a treaty body 
tasked with monitoring state party compliance with 
the international Convention on the Elimination of 
All Forms of Discrimination against Women.80 Unlike a 
court, a treaty body does not pass judgments, but 
monitors compliance and issues recommendations. In 
2011, CEDAW heard the matter of Alyne da Silva Pimental 
Teixeira versus Brazil, which concerned human rights 
violations in the context of maternal mortality. CEDAW 
recommended reparations for the individual harmed, 
also recommending that Brazil reduce maternal mortality 
risks and discrimination against pregnant women. Brazil 
complied with both aspects of the decision.81
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Governing public and private institutions
Finally, law can be used to establish, structure, and 
oversee public and private institutions. This function 
overlaps with the first two functions (establishing norms 
and resolving disputes) primarily with respect to scope 
and process. Law governs the operations of government 
institutions that are involved in setting standards 
(eg, parliaments, administrative agencies, and courts), as 
well as corporations and non-governmental organ-
isations. We briefly explain how law works to establish, 
structure, and oversee the key players and organisations 
in global health.
Laws can establish institutions and define the reach of 
their activities by setting out institutional mandates. A 
mandate refers to the explicit, implied, and customary 
powers and responsibilities of an organisation.82 
A state’s constitution defines the government’s obli-
gations to safeguard the public’s health and to protect 
personal freedoms and rights. Constitutions often 
establish branches of government, allocating power 
among them (and setting limits on those powers), and 
delineating responsibilities. Statutes establish a country’s 
key agencies, such as the Ministry of Health, defining its 
mandate and powers, while allocating funds for its 
operations. Treaties establish and govern inter national 
institutions, such as WHO. The WHO constitution is a 
legally binding treaty that defines the organisation’s 
mission, scope of its organisational activities, and 
the responsibilities of its organs (assembly, executive 
board, regional and country offices, and secretariat). A 
corporation’s mandate—that is, the purpose for which 
the corporation has been established—is set out in its 
charter or founding documents, such as a Memorandum 
of Association. Corporations are formed under provincial 
or federal laws that specify their fiduciary duties, duties 
to report and pay tax, and other responsibilities. Statutes 
and regulations can define the activities, structure, and 
limitations of a not-for-profit organisation with a global 
health mission. Non-governmental organisations must 
abide by the legal parameters set for their operation. The 
proliferation of institutions working in global health has 
added a new level of complexity, which includes the 
overlapping mandates of public, private, and non-
governmental organisations, and public–private partner-
ships. We elaborate on these issues in section 3.
Law also governs processes and institutions by 
providing systems of checks and balances. The classic 
example is the checks and balances between the 
legislative, executive, and the judicial branches of 
government, which help prevent one branch from 
dominating. Under this principle of government, 
“separate branches are em powered to prevent actions by 
other branches and are induced to share power.”83 The 
law specifies the powers of each branch and the ways in 
which each branch can limit the powers of the others. 
The actions of legislatures and agencies are often 
subject to judicial review, but the legislature can override 
decisions of judges (other than with constitutional 
rulings). Checks and balances are crucial to the rule of 
law (panel 5).84
However, their robustness depends on institutional 
design, as well as the legal system and political culture 
within the jurisdiction.
Although governmental checks and balances provide 
the classic example, a similar framework can operate 
within and between public and private institutions, 
and between institutions making decisions at different 
levels—eg, national governments can modify the effect of 
decisions made at the international level. WTO members 
are required to implement the 1995 Agreement on Trade-
Related Aspects of Intellectual Property Rights (TRIPS) 
through national legislation recognising and enforcing 
pharmaceutical patents.54 However, in many jurisdictions, 
these intellectual property protections have limited 
individuals’ access to medicines. In response, 
governments have devised mechanisms to balance 
intellectual property protection with greater access to 
medicines.85 Therefore, national legislation on medicines 
procurement or patentability criteria, as well as TRIPS 
flexibilities, have sought to expand social goals, while 
recognising private rights.86 Yet further scope remains for 
countries to use the flexibilities that TRIPS provides to 
enable greater access to medicines.87
Non-state actors can also provide a check on 
unreasonable exercise of government power. Civil 
society organisations are instrumental in demanding 
transparency and account ability from governing 
institutions. Non-state actors have a powerful voice in 
pushing governments and international institutions to 
use their legal tools in a manner that promotes justice 
and human rights, such as by protecting marginalised or 
disadvantaged populations. For example, advocacy on 
HIV has spurred government action around the world, 
ranging from research funding through to expanded 
treatment access.88 Whether at the grassroots level or 
internationally, participation by non-state actors and civil 
society organisations in governing processes increases 
the legitimacy, transparency, justice, and democracy of 
such processes.
Panel 5: Checks and balances and the rule of law
The rule of law is central to achieving health with justice, 
and systems of checks and balances are central to the rule of 
law. Although checks and balances are often codified, this is 
not always the case. The World Justice Project notes: 
“governmental checks take many forms; they do not operate 
solely in systems marked by a formal separation of powers, 
nor are they necessarily codified in law. What is essential, 
however, is that authority is distributed, whether by formal 
rules or by convention, in a manner that ensures that no 
single organ of government has the practical ability to 
exercise unchecked power”.84
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Key players in global health
National public health agencies and intergovernmental 
institutions dominated the global health landscape for 
decades. Although these actors remain central, the 
landscape is changing rapidly: new institutions are 
proliferating, and traditional structures of power and 
control are evolving (see section 3). Many of these key 
players do not have the power to make law, but all are 
subjects of law. They are parties to contracts, disputes, or 
rules of various kinds, and they can use their influence to 
either encourage or impede legal reforms.
Nation states
Nation states remain the major force in the global 
governance system. The nation state is “the fundamental 
building block of the global polity … [and] the primary 
authority for the negotiation of global rules.”4 Compared 
with other actors, nation states have the broadest range of 
powers, with the sovereign power to directly govern and 
regulate health. While health ministries continue to 
oversee most public health policy making, laws made by 
multiple different agencies—across sectors such as 
agriculture, commerce, transport, and the environment—
can profoundly affect health outcomes.
Moreover, nation states make up the membership of 
intergovernmental organisations, with a seat at the 
decision-making table. The major intergovernmental 
institutions include UN agencies and programmes, 
regional organisations, and economic policy forums 
such as the G7 and G20. Nation states also have a high 
degree of influence through their overseas development 
aid programmes, and through bilateral or multilateral 
cooperation.
International organisations
The UN is the primary international organisation. The 
UN system is charged with ensuring international 
cooperation, including promotion of health and human 
rights. UN organs and agencies have historically engaged 
in global health work. The WHO, formed in 1948, was 
the first specialised UN agency, and, under its 
constitution, has the primary mandate for governing 
global public health. For many decades, WHO remained 
the preeminent, if not the sole, institution in the global 
health space. The WHO has robust legal powers to 
govern global health and to encourage action among 
countries, including powers to make international 
treaties in the form of conventions and health regulations. 
However, many other UN bodies operate in the arena of 
global health, including the Food and Agriculture 
Organization (FAO, which has treaty-making powers)89 
the UNDP, UNICEF, the UN Population Fund (UNFPA), 
and UNAIDS,90 all of which can influence both national 
and global health law.
Other multilateral organisations exert a substantial 
indirect influence on the legal and economic dimensions 
of global health. Of importance are the WTO and the 
Bretton Woods institutions. The WTO’s mission is to 
“open trade for the benefit of all”.91 WTO members must 
commit to certain legal obligations in fulfilling this 
mission, such as enacting strong protection for intellectual 
property. This may create access barriers for health 
services or impede public health policy by increasing the 
cost of essential medicines.92
Established in 1944 with an initial mission of post-
World War II reconstruction, the Bretton Woods 
institutions are the World Bank and the International 
Monetary Fund (IMF). They shape the global health 
landscape through their financial and economic support 
for global health and development. The World Bank 
provides financial and technical assistance to developing 
countries to foster income growth and end extreme 
poverty.93 Since the 1970s, its loans and grants have 
supported a range of development priorities, including 
health. During 2000–16, the World Bank invested 
US$35 billion in health, nutrition, and population.94 In 
the aftermath of the Ebola epidemic in west Africa, the 
Bank has focused on global health security.
The IMF is an intergovernmental institution 
comprising 189 member countries, with a mission “to 
ensure the stability of the international monetary 
system”.95 Their work includes lending and capacity 
development, and when providing support (or bail-outs) 
to countries in financial difficulties, the IMF’s assistance 
might be accompanied with conditions such as 
deregulation or reduced health spending.4,96
Non-state actors
Just as public health at the national level is no longer the 
sole purview of health ministries, WHO has now been 
joined by an “explosion of actors in the global health 
arena”.97 Non-state actors—notably philanthropies, 
hybrid PPPs, and civil society organisations—have 
become crucial to the development, influence, and 
funding of global health initiatives. Through financial 
resources as well as social mobilisation and advocacy, 
these organisations wield considerable influence and can 
use that influence to drive legal change. Corporations, 
including in the tobacco, alcohol, food, and beverages 
sectors, can have negative effects on health. The private 
sector also works to improve health outcomes, providing 
funds but also expertise and personnel in response 
to specific needs such as health emergencies. For 
example, during the 2013–14 Ebola outbreak, companies 
provided logistics, communications, and transportation, 
as well as operating treatment units.98,99
Private philanthropic organisations are non-state actors 
that have become major funders of global health. The 
Bill & Melinda Gates Foundation is the single largest 
donor of discretionary funds to WHO.100 This Foundation 
has a strong focus on technical solutions to global health 
challenges, investing in vaccines (eg, HIV, polio, and 
malaria) as well as family planning, nutrition, and 
maternal and child health.101 The Rockefeller Foundation 
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is an older, more established philanthropic foundation 
with a long history in public and global health, which 
champions UHC. Other examples of philanthropic 
foundations include the Clinton Foundation working on 
HIV and AIDS, Bloomberg Philanthropies working on 
tobacco control and liveable cities, Mundo Sano working 
on neglected tropical diseases, the Children’s Investment 
Fund Foundation working on child health and poverty, 
and the Fundación Carlos Slim, working for health, 
justice, and community development.7,102–104 Other 
prominent philanthropies include The Arab Gulf 
Programme for Development, working on poverty 
alleviation, human development, and human rights; the 
Aga Khan Foundation, addressing human development 
and strengthening civil society organisations; and the 
Sasakawa Memorial Health Foundation, working on 
leprosy, and rights of people with disabilities.
A defining feature of the global health governance 
landscape is the rise of PPPs: hybrid structures made up 
of non-state actors (eg, businesses, philanthropies, and 
civil society organisations) working jointly with govern-
ments and health agencies. These partnerships have 
both economic and legal dimensions. PPPs respond to 
the desire of funders to exercise greater control over the 
use of their resources, and to bypass bureaucratic and 
governance barriers in the UN system. Institutions 
established as PPPs often have a specific mandate, with 
control and influence shared by the public and private 
partners. They exist on a continuum, in which some are 
more public in nature (eg, largely financed funding 
agencies that include private actors on their boards), 
whereas others are closer to private institutions—
eg, entities working closely with the private sector to 
accelerate research and development (figure 2).105
The largest PPPs operating in global health include the 
Global Fund to Fight AIDS, Tuberculosis and Malaria; 
and Gavi, the Vaccine Alliance. Unitaid is a PPP that 
invests in innovations to prevent, diagnose, and treat HIV, 
tuberculosis, and malaria. The Coalition for Epidemic 
Preparedness Innovations is among the newer PPPs, 
working to galvanise the development of new vaccines 
against diseases with pandemic potential. In 2016, the US 
National Academy of Sciences found that PPPs could 
deliver “improved responsiveness and accountability to 
society and…better outcomes in shorter timeframes.”105
Civil society organisations—primarily non-govern-
mental organisations—have long been influential in 
global health as advocates for research and treatment, 
and for human rights. Among the most well known 
non-governmental organisations are Médecins Sans 
Frontières, CARE International, the International Red 
Cross and Red Crescent, Oxfam International, Save the 
Children, Rotary, and Caritas. Many of these civil society 
organisations work primarily in the humanitarian and 
development sectors, and as first responders to health 
emergencies (eg, in natural disasters, epidemics, and 
war zones).
Other civil society organisations, such as the Center for 
Reproductive Rights, focus their efforts (including 
leveraging the law) on advancing international health and 
human rights. There are also civil society organisations at 
the country level undertaking grassroots social mobilisation 
and advocacy, such as the Treatment Action Campaign 
(HIV) and Section 27 (the right to health) in South Africa, 
and the Center for Health, Human Rights and 
Development in Uganda. Patient rights groups have also 
been powerful advocates for government policy, legal 
change, and funding, including in relation to HIV, 
tuberculosis, and Alzheimer’s disease, as have professional 
and scientific associations and networks such as the 
American Heart Association and the International Council 
of Nurses. Although these rights groups are often left out 
of formal global diplomacy, civil society organisations can 
be an influential voice for human rights and the right to 
health, especially domestically, as well as in multi-partner 
alliances such as the Framework Convention Alliance on 
Tobacco Control.106
Section 1 provided an introduction to the legal system 
for global health, including explanations of three key 
functions of law and the key players. We now turn to the 
substantive ways in which law can affect health and 
justice, which we characterise as the legal determinants 
of health.
Section 2: legal determinant 1
The first legal determinant can be used to translate vision 
into action on sustainable development. This determinant 
relates to the power of law to channel the SDGs’ unifying 
vision for global health into concrete action. We first 
briefly describe the SDGs’ agenda for global health. 
Because UHC is so crucial to the future of global health, 
we present a case study showing how law can advance 
the SDGs’ bold vision of health and justice. We examine 
the legal foundations of UHC, as well as legal mechan-
isms for its implementation.
The SDGs and global health
Adopting the 2030 Agenda for Sustainable Development 
in September, 2015, the UN General Assembly articulated 
a transformational vision: ‘‘We envisage a world free of 
poverty, hunger, disease and want, where all life can 
thrive. We envisage a world free of fear and violence. A 
world with universal literacy. A world with equitable and 
universal access to quality education at all levels, to 
Figure 2: The public–private partnership continuum
Adapted from National Academy of Sciences, Engineering, and Medicine,105 by permission of The National 
Academies Press.
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health care and social protection, where physical, mental 
and social well-being are assured. A world where we 
reaffirm our commitments regarding the human right to 
safe drinking water and sanitation and where there is 
improved hygiene; and where food is sufficient, safe, 
affordable and nutritious.’’14
Member states promised to rigorously implement this 
agenda, which comprises 17 goals (the SDGs) and 
169 targets, by 2030. They replace the Millennium 
Development Goals (MDGs), while building on their 
success, expanding their scope, and highlighting 
unfinished business. Committing to “leave no one 
behind”, the SDGs articulate an equity agenda, developed 
through a crosscutting multisectoral strategy involving a 
consultative, grass-roots process.107
Health in the SDGs
Although the MDGs included several health-specific 
goals,108 the SDGs have a single unifying health goal. 
Goal 3, supported by 13 targets, aims to “ensure healthy 
lives and promote well-being for all at all ages”.109 
Referencing the millions of preventable deaths, including 
deaths of children and childbearing women, goal 3 states: 
‘‘these deaths can be avoided through prevention and 
treatment, education, immunization campaigns, and 
sexual and reproductive healthcare. The Sustainable 
Development Goals make a bold commitment to end the 
epidemics of AIDS, tuberculosis, malaria and other 
communicable diseases by 2030. The aim is to achieve 
UHC, and provide access to safe and affordable 
medicines and vaccines for all. Supporting research and 
development for vaccines is an essential part of this 
process as well’’.109
Several other SDGs directly relate to the conditions 
needed for healthy people and healthy communities. For 
example, goal 2: “end hunger, achieve food security and 
improved nutrition and promote sustainable agric-
ulture;”110 goal 5: “achieve gender equality and empower 
all women and girls”;111  and goal 6: “ensure access to 
water and sanitation for all”.112
Virtually all other goals include targets that relate directly 
or indirectly to health, such as: targets 4·2 (access to early 
childhood development and care); 7·1 (affordable modern 
energy services); 11·6 (adverse environmental impact of 
cities, with special emphasis on air pollution); 13·1 (climate 
related hazards and natural disasters, and related 
mortality); 16·1 (reducing violence-related deaths); 
16·9 (legal identity for all, including birth registration); and 
17·19 (measuring statistical capacity-building, including 
the registration of births and deaths).14
Justice in the SDGs
At the core of the SDGs’ vision is equal and universal 
access to health care and justice, with an emphasis on 
their interrelationship. For example, goal 3 aims to 
“ensure healthy lives and promote well-being for all at all 
ages”,109 and includes targets such as achieving UHC 
(target 3·8).109 Goal 3 also relies on the concept of justice 
in its targets. Target 3·b focuses on building support for 
“research and development of vaccines and medicines for 
the com municable and non-communicable diseases that 
primarily affect developing countries”.109 This goal relies 
in part on concepts of justice embodied in transnational 
legal agreements, such as the Doha Declaration and the 
Agreement on Trade Related Aspects of Intellectual 
Property Rights.113 Furthermore, goal 16 aims to “promote 
just, peaceful and inclusive societies”, and calls for “access 
to justice for all, and building effective, accountable 
institutions at all levels”.113 A goal 16 target promotes “the 
rule of law at the national and international levels”, 
ensuring “equal access to justice for all”.114 This formalises 
a longstanding understanding that the pursuit of justice 
is an essential ingredient of sustainable development.115
The role of law in realising the SDGs
With health linkages throughout the SDGs, the potential 
to advance health through realising the SDGs is vast. 
However, the ability of law to achieve this remains largely 
untapped and requires an enhanced understanding and 
recognition of how best to use law in different SDG 
areas. For example, climate change—which threatens the 
health SDGs and many others—is directly addressed in 
SDG 13, and is an area where the use of law is robust (eg, 
UN Framework Convention on Climate Change, the 
Paris Agreement, carbon taxes, and renewable energy 
incentives). However, the use of law specifically to 
address the interaction between health and climate 
change is less well developed and is an important agenda 
item for the future.
The SDGs and their targets give greater specificity to 
the broad principles expressed in the right to health. 
Going well beyond health-care services, they encompass 
the multiple conditions needed for health and safety 
throughout the lifespan. In turn, law can help give these 
goals tangible effect, moving the question from ‘‘what is 
sustainable development?’’ to ‘‘how can sustainable 
development be achieved?”116 Governments use all three 
functions of law to establish the frameworks of authority 
needed to move from principles to actions. In relation to 
the SDGs, laws are essential to enshrine the right to 
health in national policy and to oversee the quality of 
health professionals and hospitals through licensing and 
accreditation (eg, establishing norms and standards); to 
adjudicate disputes between individuals, health providers, 
and the State (eg, resolving disputes); and to establish 
new institutions with a specific or broad health mandate 
(eg, governing institutions).
Regarding a broad, aspirational statement like SDG 3 
(“ensure healthy lives and promote well-being for all at 
all ages”), law can provide detail and accountability. What 
does the concept of healthy lives mean? Who is obligated 
to ensure the conditions for health and safety? Through 
what mechanisms will they do so? To what standards will 
they be held? How will they be held accountable for good 
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performance? UHC offers a good illustration of the way 
in which law can translate vision into action on 
sustainable development. In the next section, we use 
UHC as a case study to identify the ways in which law 
functions both to lay the foundations for, and to 
implement, health for all.
Case study: law as a tool to achieve UHC
UHC as a crucial component of sustainable development
Nationally and globally, there exist profound differences 
in health outcomes, the socioeconomic determinants of 
health, and the availability and affordability of quality 
health services. The WHO and the World Bank both 
estimate that at least half of the world’s population cannot 
obtain essential health services.117 The most glaring 
inequities in health outcomes often correlate directly with 
unequal access to health services: service coverage is 
often poorest where needs are greatest.118 These inequities 
occur both between countries (healthy life expectancy is 
44·4 years in Sierra Leone, compared with 74·9 in Japan)119 
and within countries (ethnicity, geography, and socio-
economic status can greatly reduce the accessibility and 
quality of health care).120 For example, in Australia, life 
expectancy for Aboriginal and Torres Strait Islander men 
born from 2010 to 2012, was 10·6 years lower than that of 
non-Indigenous men. The discrepancy for women 
was nearly as wide at 9·5 years.121  The WHO views UHC 
as among its highest priorities.8,117,122–125 In 2005, the 
58th World Health Assembly  (WHA) adopted a resolution 
for sustainable health financing, universal coverage, and 
social health insurance, calling on countries to plan for 
the transition to UHC.126 Since then, UHC has become a 
global priority and a central element of WHO’s efforts to 
strengthen health systems and improve the quality and 
distribution of health and health services.127–129 With the 
UN General Assembly adopting the SDGs in September, 
2015, UHC became a global target, which will be 
reinforced by the UN high-level meeting on UHC in 
2019.130 SDG 3.8 views UHC as “financial risk protection, 
access to quality essential health care services and access 
to safe, effective, quality and affordable essential 
medicines and vaccines for all”.113 SDG 3.8, if fully 
implemented, would help realise the universal right 
to health.
Definition and basic principles
UHC does not have a uniform definition and its variable 
meanings have created uncertainty. The World Bank 
offers a broad, conceptual framing: “UHC is about 
people having access to the health care they need 
without suffering financial hardship.”131 WHO gives a 
more detailed definition, noting: ‘‘UHC means that all 
people can use the promotive, preventive, curative, 
rehabilitative and palliative health services they need, of 
sufficient quality to be effective, while also ensuring that 
the use of these services does not expose the user to 
financial hardship.’’132
WHO emphasises equity in access to health services 
(everyone who needs services should get them, not only 
those who can pay for them); the quality of health 
services; and protection against financial risk—ensuring 
that the cost of using services does not put people at risk 
of financial harm, so that people’s ability to pay is not 
linked to their ability to access health services.
UHC has been defined as a practical expression of the 
right to health,133 drawing together all the health-related 
SDGs. However, it focuses primarily on access to and 
provision of health care, whereas the right to health is 
considerably broader, embracing multiple conditions for 
healthy and safe lives, such as potable water, nutritious 
and safe food, adequate housing, and clean air.
Health systems range from national health systems 
with single or multiple payers, to government subsidised 
access, to public or private insurance; therefore, no single 
path exists to UHC.134 However, countries embracing 
UHC tend to consider health a basic human right, often 
enshrined in their national constitutions or laws. Since 
2010, over 100 countries have sought technical guidance 
from WHO and the World Bank to move towards UHC.135 
Countries representing half of the world’s population 
(Brazil, China, India, Russian Federation, and South 
Africa) are engaged in health system reforms to extend 
service coverage and increase financial protection.135
Although UHC often faces political resistance because 
of cost, the World Bank regards it as high value for 
money.134 UHC brings direct benefits such as improved 
population health and more productive societies.136 
Health coverage also contributes indirectly to develop-
ment, as healthy children learn better,137,138 and healthy 
populations facilitate economic growth.139,140 Furthermore, 
studies show that for every dollar spent on key health 
services, the direct and indirect benefits would exceed 
costs by a factor of between 9 and 20, further showing the 
benefits that arise from investing in health.3
Legal foundations of UHC
The duty to provide UHC derives from two sources of 
law: national and international.
Regardless of a government’s motivation for pursuing 
UHC, the legal foundations remain the same in that a 
state has the sovereign duty and authority to safeguard 
the public’s health and safety.15 The State’s duty and 
power to implement UHC derives from its constitution 
or legislation. For example, Thailand’s constitution, 
promises that “health is considered as an entitlement of 
Thai citizens and equal access to basic health services 
should be guaranteed.”141,142 Brazil’s Constitution likewise 
recognises health as a social right.86,143 In other 
jurisdictions, national public health legislation provides 
the mandate for UHC.
A legal right to health services is important but not 
sufficient. Governments must abide by the rule of law to 
develop, implement, and adjudicate a UHC framework. 
If the rule of law is weak, it will be difficult to engage 
The Lancet Commissions
www.thelancet.com   Vol 393   May 4, 2019 1873
other legal mechanisms to achieve not only UHC, but 
also more basic tasks of governance. If public officials or 
health professionals are corrupt, it will be difficult to 
garner the resources and ensure the equity and 
functionality of UHC.
International law creates robust obligations to 
safeguard the right to health, strengthening states’ 
domestic duty. The ICESCR (Article 2·1) requires states 
parties to: “take steps, individually and through inter-
national assistance and co-operation, especially economic 
and technical, to the maximum of its available resources, 
with a view to achieving progressively the full realization 
of the rights recognized in the present Covenant by all 
appropriate means, including particularly the adoption 
of legislative measures”.26,144
Specifically, under Article 12, states parties “recognize 
the right of everyone to the enjoyment of the highest 
attainable standard of physical and mental health”, and 
undertake to take steps on concrete health goals, 
including the “prevention, treatment and control of 
epidemic, endemic, occupational and other diseases”.26,144
As described above, the UN Committee on Economic, 
Social and Cultural Rights offered an authoritative 
interpretation of “the right to the highest attainable 
standard of health” in General Comment 14.29 Beyond the 
ICESCR, many treaties safeguard health rights, including 
non-discrimination in access—for example, the UN 
Convention on the Rights of the Child, the Convention on 
the Elimination of all Forms of Discrimination Against 
Women, and the Convention on the Rights of Persons 
with Disabilities. Even though states may be parties to 
different treaties, the overwhelming majority of countries 
are party to at least one treaty that embodies the right to 
health, making it a virtually universal standard.
Human rights treaties place the primary responsibility 
for ensuring the right to health on governments. Yet, 
governments are also obligated to provide international 
assistance to protect and promote the right to health, for 
example under article 2(1) of the ICESCR. The concept of 
shared responsibilities for health has a “solid textual 
foundation”.42 The Office of the UN High Commissioner 
for Human Rights (OHCHR) guidelines on maternal 
morbidity and mortality and human rights, the UNAIDS 
and OHCHR guidelines on HIV and AIDS and human 
rights, and the Maastricht Principles on Extraterritorial 
Obligations of States in the Area of Economic, Social and 
Cultural Rights all confirm the international obligation to 
provide assistance on UHC. Furthermore, the UN Special 
Rapporteurs on the Right to Health have been clear on the 
obligations of states in so-called hard law and soft rules.145
Because states hold the primary responsibility to create 
and maintain UHC, many argue that gaping inequalities 
between countries are beyond legal remedy. We reject 
this proposition. The international community holds a 
responsibility to reduce health disparities, and international 
health assistance will remain an important funding source. 
Low-income and middle-income countries do need to 
devote a higher percentage of their gross domestic product 
(GDP) into health systems, but still might be unable to 
afford the estimated US$86 per capita (2012) required for 
UHC, and $112 per capita (2014) to achieve the health 
SDG.146,147 The first Special Rapporteur on the Right to 
Health, Paul Hunt, observed that ‘‘if there is no legal 
obligation underpinning the human rights responsibility 
of international assistance and cooperation, inescapably 
all international assistance and cooperation is based 
fundamentally upon charity. While such a position might 
have been tenable 100 years ago, it is unacceptable in the 
twenty-first century.’’148
Although there is a strong ethos of charitable discretion 
in international health assistance, sustainable funding 
requires a mutual sense of responsibility between those 
providing and those receiving assistance.149 Otherwise, the 
international system creates a situation in which 
governments can blame each other for not doing enough.150 
Moreover, in low-income countries, or those with unstable 
governments, weak health systems can exacerbate 
vulnerabilities leading to extremism and violence.
Development assistance for UHC is essential to global 
security—both health security and human security. In 
this regard, countries have existing commitments: under 
the UN Charter (to cooperate in achieving the universal 
observance of human rights) and the ICESCR (to provide 
international assistance and cooperation). Therefore, 
establishing an international legal or regulatory frame-
work to clarify the obligations of international health 
assistance would be appropriate. Under such a frame-
work, countries could, for example, agree to devote a 
percentage of their GDP towards national UHC, while 
higher-income countries agree to fill financing gaps 
through international development assistance for health.
The role of law in achieving UHC
Law provides both the mandate for UHC and the tools to 
achieve it. However, although the mandate is universal 
(based on the right to health) the means of realising UHC 
differ from country to country, depending on the legislative 
and regulatory mechanisms available, as well as policy 
choices. These mechanisms and choices will affect each of 
the crucial measures of UHC: access, equity, quality, cost, 
and choice. All these measures are important, but they 
also entail subtle or overt political choices or trade-offs. 
For example, universal access to high quality services, 
equitably distributed, has substantial economic costs. If 
governments place a high value on individual choice in 
the private market, this will affect measures such as 
access, equity, quality, and cost.151 States, of course, are not 
entirely restricted in the ability to make trade-offs: their 
actions are constrained, at the very least, by their human 
rights obligations—especially the right to health.
In its report about health systems financing, WHO 
noted, “all countries must make choices and trade-offs, 
particularly in the way that pooled funds are used”.152 The 
trade-offs inherent in realising UHC are often depicted as 
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a cube (figure 3), in which the X-axis depicts the population 
(who is covered?), the Y-axis depicts the cost (the proportion 
of direct costs that are covered from pooled funds, that is, 
prepaid funds from different sources that are accumulated 
and used to cover everyone who is part of the pool, such 
as the entire population), and the Z-axis depicts the 
services covered. Moving closer to universal coverage 
means expanding the cube: extending coverage to more 
people, including the marginalised and vulnerable; 
offering more services to meet essential health needs; and 
paying a greater part of the cost, thereby protecting citizens 
from impoverishment.152
Increasing coverage also requires good governance, and 
an understanding of both the documented and practical 
gaps in UHC: the possible “bottlenecks and weaknesses 
that prevent health systems from serving the entire 
population and from providing the full suite of priority 
services at a cost that is affordable and sustainable.”86 
Crucially, UHC must be understood as effective, 
affordable access to quality health services (UHC in 
practice)—and not merely covering everyone with some 
form of insurance, regardless of whether they can in fact 
access quality health services (UHC on paper). Effective 
access, particularly for those with the least means, will 
not only depend on how health systems are designed 
(eg, strengthening primary health services), but also on 
how health insurance systems are designed. Legal 
strategies relating to each axis of the cube (figure 3), in 
addition to good governance, are further discussed.
The X-axis, or, the population axis, describes who is 
covered. The term “universal” in UHC relates to a state’s 
duty to provide health services to all people under its 
jurisdiction. Without adequate legal frameworks to 
support it, so-called universality might be no more than 
an aspiration, doing little to change “policies under 
which many governments either deliberately or passively 
refuse to grant access to health services to some people 
living within their national borders”.153
Governments often exclude a wide swath of vulnerable 
people from high quality services, including asylum 
seekers, refugees, undocumented immigrants, expatriate 
workers, indigenous peoples, nomadic people, or groups 
that are historically marginalised because of sexual 
orientation, gender identity, sex characteristics, disability, 
political beliefs, or religious affiliation.153,154 These popu-
lations are often already vulnerable, and least able to 
afford out-of-pocket health care expenditures; they are 
precisely the groups a UHC system should aim to cover. 
For example, in Rwanda, households are means-tested 
on their assets and revenue and stratified accordingly. 
The government then pays premiums for the 25% of the 
population who have been classified as the most 
vulnerable.155
The law should inclusively define the meaning of the 
term universal in a country’s UHC scheme, as well as 
providing redress in cases of discrimination or service 
denial. This can be achieved by enshrining the right to 
health in a country’s constitution or legislation;152 
establishing a patient charter of rights that defines the 
right of access to the scheme, along with a dispute 
resolution system to deal with complaints by those who 
are denied health services to which they are entitled;86 
empowering a health-care ombudsman or health-care 
commission with powers to investigate breaches of the 
State’s duty to provide health services; decentralising or 
devolving health systems management, so that people 
can access services (including dispute resolution) at the 
local level, without having to travel; regulating the way 
in which health insurance schemes (public and private) 
deal with membership and coverage, such as banning 
insurers from discriminating against individuals with 
pre-existing conditions and requiring coverage of 
essential services such as vaccines, primary care, 
nutrition services, and child and maternal health; and 
ensuring statutory protection for the security, privacy, 
and confidentiality of health information.86
The Y-axis, or, the cost axis, describes financing in 
UHC. Governments express genuine concerns about 
financing UHC.152 Full funding entails developing health 
systems that can deliver all required health services that 
are of good quality and readily accessible to the whole 
population. Sustainable financing can involve one of two 
strategies. Governments can allocate more of their 
overall budget to health—for example, at least 5% of 
GDP.156,157 Alternatively or in addition, they can find new 
ways to raise revenue, whether by improving general tax 
administration and collection, increasing existing taxes, 
or introducing new taxes.152
States can raise revenue for UHC in a variety of ways. 
In countries with a longer history of UHC, funds are 
Figure 3: Universal Health Coverage cube
Adapted from WHO,152 by permission of World Health Organization.
Cost axis: proportion of direct 
costs covered from
 pooled funds
Services axis:
which services 
are covered?
Include new 
services
Population axis: who is covered?
Extend coverage for health 
services to more people
Reduce out-of-pocket 
fees and cost sharing
Funding mechanism 
created from pooled funds
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traditionally raised through compulsory pre-payment 
schemes, such as taxation, compulsory insurance 
contributions, or a combination of both.86 Conversely, 
low-income and lower-middle-income countries that 
have moved towards UHC are using novel mixes of 
funding mechanisms for their national health insurance 
models.158 These include general taxes, earmarked taxes 
(eg, raised from taxing unhealthy products such as 
tobacco, alcohol, sugary beverages, or from airline 
taxes—a key source of financing for Unitaid), payroll 
deductions, household premium contributions, and in 
some cases, foreign assistance (eg, about half of the 
financing for South Africa’s UHC programme comes 
from the US President’s Emergency Plan for AIDS 
Relief).134,158,159 However, countries, should not overly rely 
on international health assistance because it can be 
inconsistent and unreliable, impeding the government’s 
ability to plan for and finance its health system over the 
long term. Additionally, donors often give preference to 
their own special areas of health need, which might not 
match what the host population needs.
Moreover, countries should generally avoid voluntary 
schemes (those in which people are not required to 
purchase insurance) as these schemes are not effective 
ways to achieve UHC. Increasing—or, particularly in the 
case of sugary beverages or other categories of unhealthy 
foods, initiating—taxes on unhealthy products is a 
particularly promising route, which creates a direct, 
positive health effect while also raising revenue (panel 6).
Each of these mechanisms can raise legal issues. For 
instance, donor funding is often underpinned by inter-
national agreements with donor countries or organi-
sations—eg, World Bank or Global Fund payments 
come with clear contractual conditions. Moreover, UHC 
programmes that combine public and private funding for 
health raise governance challenges, underlining the need 
for appropriate and robust oversight and regulation of 
coverage plans. For example, the Insurance Regulatory 
Authority in Kenya regulates insurers, including licensure, 
quality assurance, and consumer protection and edu-
cation.161 Earmarking (also known as hypothecation) can be 
a useful way to raise revenue and target behavioural health 
risks, as in the case of tobacco taxes that are earmarked for 
health spending. However, existing laws may prohibit the 
use of earmarking, and the practice is seen as contentious 
because it constrains fiscal policy making.
Furthermore, at each stage of the financing process 
(from revenue raising, to pooling, to the purchasing of 
services by providers and governments) regulation plays 
an important role in ensuring funds are allocated fairly 
and transparently.86 Regulatory agencies are often 
empowered to require full disclosure of finances, and 
can oversee the efficiency and honesty of funding flows.
The Z-axis, termed the services axis, determines which 
services are covered in UHC. Health financing also 
concerns “the efficiency, equity, and effectiveness of the 
ways in which resources are raised, pooled, allocated, and 
used to achieve desired health systems outcomes”.134 As 
WHO has warned, “pooled funds will never be able to 
cover 100% of the population for 100% of the costs and 
100% of needed services. Countries will still have to make 
hard choices about how best to use these funds”.152 This 
statement is in relation to the third axis of the UHC cube 
which describes the services that are covered. When 
Panel 6: Policy options that involve the use of law and regulation, from WHO’s menu 
of policy options on non-communicable diseases160
Tobacco use
•	 Increase	excise	taxes	and	prices	on	tobacco	products
•	 Implement	plain	or	standardised	packaging	and	large	graphic	health	warnings	on	all	
tobacco packages
•	 Enact	and	enforce	comprehensive	bans	on	tobacco	advertising,	promotion,	and	
sponsorship, including cross-border advertising and using modern means of 
communication
•	 Eliminate	exposure	to	second-hand	tobacco	smoke	in	all	indoor	workplaces,	public	
places, public transport, and in all outdoor mass-gathering areas
•	 Provide	cost-covered,	effective,	and	population-wide	support	(including	brief	advice,	
national toll-free quit line services, and treatment for addiction) for tobacco cessation 
to all those who want to quit smoking
•	 Implement	measures	to	minimise	illicit	trade	in	tobacco	products
Harmful use of alcohol
•	 Increase	excise	taxes	on	alcoholic	beverages
•	 Enact	and	enforce	bans	or	comprehensive	restrictions	on	exposure	to	alcohol	
advertising (across multiple types of media)
•	 Enact	and	enforce	restrictions	on	the	physical	availability	of	retailed	alcohol	
(via reduced density of retail outlets and reduced hours of sale)
•	 Enact	and	enforce	drink-driving	laws	and	blood	alcohol	concentration	limits	via	
sobriety checkpoints
•	 Establish	minimum	prices	for	alcohol	if	applicable
•	 Enact	and	enforce	an	appropriate	minimum	age	for	purchase	or	consumption	of	
alcoholic beverages
•	 Restrict	or	ban	promotions	of	alcoholic	beverages	in	connection	with	sponsorships	
and activities targeting young people
Unhealthy diet
•	 Reduce	salt	intake	through	the	implementation	of	front-of-pack	labelling
•	 Eliminate	industrial	trans	fats	through	the	development	of	legislation	to	ban	their	use	
in the food chain
•	 Reduce	sugar	consumption	through	effective	taxation	on	sugar-sweetened	beverages
•	 Implement	subsidies	to	increase	the	intake	of	fruits	and	vegetables
•	 Replace	trans fats and saturated fats with unsaturated fats through reformulation, 
labelling, fiscal policies, or agricultural policies
•	 Limit	portion	and	package	size	to	reduce	energy	intake	and	the	risk	of	becoming	
overweight or obese
•	 Implement	nutrition	labelling	to reduce total energy intake (kcal), sugars, sodium, 
and fats
Physical inactivity
•	 Ensure	that	macro-level	urban	design	incorporates	the	core	elements	of	residential	
density, such as connected street networks that include sidewalks, easy access to a 
diversity of destinations, and access to public transport
•	 Provide	convenient	and	safe	access	to	quality	public	open	space	and	adequate	
infrastructure to support walking and cycling
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deciding what is covered and what is not, the central 
challenge is to achieve the right balance between 
preventive, health promotion, and treatment services, in a 
way that is equitable and does not entrench inequities 
within populations.162 Prioritisation and selection of 
health services are driven by national disease burden and 
priorities, which in turn should be determined by 
evidence of cost-effectiveness, affordability, and health 
impact. A country’s essential medicines list, for example, 
ought to be based on population needs, evidence of 
effectiveness, and cost.
Law and regulation are integral to making difficult 
choices, because they establish processes and institutions 
to guide transparent decision making. States use legal 
processes to express national health priorities, and legal 
frameworks define and delineate that which is possible 
for a state to achieve. In determining what is and is not 
covered, states use a variety of legal mechanisms and 
institutions, including the following four examples. First, 
independent statutory authorities are tasked with 
reviewing clinical and epidemiological evidence and 
providing advice to governments about the effectiveness 
and cost-effectiveness of treatments and technologies—
for example, the UK’s National Institute for Health and 
Care Excellence. Second, administrative agencies are 
tasked with determining which medications are placed 
on formularies, and the amount or extent of any 
government subsidy. Third, legislation can specify which 
services, or categories of services should be provided 
under a UHC scheme. Finally, courts and tribunals can 
make de-facto decisions on service prioritisation. In 
South Africa, the Constitutional Court required access to 
antiretroviral medication for pregnant women,60 while in 
Brazil the judiciary has ruled on numerous claims of 
denial of access to medicines. Conversely, Colombia’s 
Constitution Court required priorities to be decided 
through a participatory, evidence-based process (panel 4). 
Litigation can raise its own problems, including the 
concern that it could favour wealthy litigants and thus 
entrench health inequalities.163
Finally, good governance is an important role of the law 
in achieving UHC. An effective UHC programme 
requires a process of monitoring, evaluation, and 
accountability, including independent review, dispute 
resolution, and a compensatory process in the event of 
adverse outcomes, as well as other administrative, 
political, legal, and social remedies.164 Again, law plays a 
vital role. Because health sector corruption drains scarce 
resources, eliminating corruption is an essential 
component of good governance.
The World Bank and WHO have developed a UHC 
monitoring framework that focuses on three key 
components: quality, essential health services, and 
financial protection.165 In December, 2017, these 
two agencies launched the global monitoring report on 
tracking UHC.117 The report uses a set of indicators to 
monitor service coverage and financial protection. It 
indicated that about 800 million people around the world 
spend more than 10% of their household budget on 
health care, and almost 100 million people are pushed 
into extreme poverty each year because of out-of-pocket 
health expenses.
Monitoring and evaluation provide crucial information 
on health system performance, which assists countries 
in making further progress towards UHC.118 Data could 
assist governments in selecting services, making wise 
investments, and evaluating progress, particularly for 
marginalised populations or those with special disease 
burdens. UHC requires a legal framework that adequately 
protects patient privacy while retaining information 
integrity and security.
Law can also promote good governance in UHC adoption 
and implementation, including transparency and inclusive 
participation. Although public participation in law making 
varies from country to country, transparency and 
participation are widely agreed cornerstones of effective 
governance.166 For example, civil society participation in 
health policy can improve decision making and secure 
grassroots support for UHC. Robust public accountability 
and participation are more likely to result in reasonable 
and legitimate decisions, and fair, effective implementation. 
Such mechanisms are essential when deciding on the 
overall strategy, the specific pathways, and the appro-
priateness of central trade-offs, for UHC.118
Finally, a functional UHC programme requires a 
framework for dispute resolution, with explicit rules to 
guide those seeking relief. Different mechanisms for 
review and dispute resolution exist, including litigation 
and alternative dispute resolution. Considering the many 
public and private claims that arise under UHC, a country 
could establish a separate adjudication process for 
individual claims, similar to the Colombian tutela 
example (panel 5). Other models include a childhood 
vaccine compensation system to cover rare adverse events 
caused by immunisation, as is present in the USA.
Law gives tangible form to the SDGs’ goal of good 
health and wellbeing
Law provides mechanisms through which the vision and 
aspirations of the SDGs can be realised. Through this 
UHC case study, we have discussed multiple entry points 
by which law can influence UHC, from its legal 
foundations, to the establishment of fair and effective 
monitoring systems. The vital role of law and regulation 
is often overlooked; this case study makes visible the 
ways in which bad, or non-existent, laws might 
undermine UHC. Conversely, it shows where well-
designed and well-implemented laws can support its 
achievement, and in so doing, give tangible form to the 
SDG promise of good health and wellbeing for all.
Recommendations 1 and 2 relate to national and 
international regulatory frameworks to strengthen 
national health systems, consistent with the SDG target 
of UHC. Recommendation 1 calls on the UN and WHO, 
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along with international partners, to support the 
achievement of SDG 3·8 by setting standards on 
implementation and compliance. Recommendation 2 
gives greater detail at the national level: we urge 
governments to strengthen or create a legal framework to 
ensure rights-based UHC, and we set out key functions 
of such a framework.
Section 3: legal determinant 2
Governance challenges and the role of law
The second legal determinant states that law can be used 
to strengthen the governance of national and global 
health institutions. The field of global health is complex, 
comprising a web of institutions, norms, and processes at 
the global, national, and subnational levels, in which 
activities might overlap, come into conflict, or leave gaps. 
Institutional fragmentation undermines the effective 
functioning of the global health system. Our second legal 
determinant of health relates to institutions and 
governance.
Although governing is what states do, governance is a 
more diffuse concept, encompassing a broad range of 
actors, processes, and forces.167 Law is central to 
governance, but governance goes beyond law. We follow 
the Lancet-Oslo Commission’s definition of global 
governance: “The complex of formal and informal 
institutions, mechanisms, relationships, and processes 
between and among states, markets, citizens, and 
organisations, both intergovern mental and non-govern-
mental, through which collective interests on the global 
plane are articulated, rights and obligations are 
established, and differences are mediated.”168
The Lancet-Oslo Commission gave sustained attention 
to systemic weaknesses in global governance for health, 
emphasising that norms, policies, and practices arising 
from transnational interaction serve as political deter-
minants of health that cause and perpetuate health 
inequities.4 The Commission noted that global governance 
for health requires a global economic and political system 
that is rooted in commitments to global solidarity and 
shared responsibility.4 Here, we build on those findings 
by specifying areas where law can be used as a tool to 
strengthen governance for health. We identify three key 
governance challenges and propose ways in which law 
can strengthen and improve global governance for health.
Achieving good governance remains a work in progress. 
Failures of governance, including the WHO’s response to 
the west Africa Ebola epidemic, or national scandals 
relating to food poisoning, or tainted milk or medicines, 
highlight institutional and systemic weaknesses. Yet, 
institutions can also be remarkably effective, for instance 
in preventing or quickly containing outbreaks, in 
empowering marginalised and disadvantaged populations, 
or in catalysing funding for neglected health priorities. 
The law offers tools, some of which are still evolving, 
which can build upon these successes and help strengthen 
the institutional landscape.
Challenge 1: fragmented and overlapping mandates of 
actors and institutions
The mandates of national and global health actors 
frequently overlap, which can impede the effective use of 
law to set norms and standards, and to resolve disputes.
At the national level, multiple ministries can have 
profound and sometimes conflicting effects on health, 
resulting in policy incoherence. A country’s agriculture 
and health ministries, for example, often both have a 
mandate to regulate the safety and quality of the food 
supply. Ministerial mandates might overlap (eg, with 
regard to responsibility for food safety at various points 
in the supply chain) or might conflict. For example, 
agricultural policies could be inconsistent with health 
and nutrition policies: the Ministry of Health’s (public 
health) aim of reducing sugar consumption could 
conflict with the Ministry of Agriculture’s (economic) 
aim of increasing sugar production.169 A further example 
might be evident within countries, for example China, 
which supports a state tobacco industry in which 
economic growth and health might be in conflict.
Similar overlaps occur at the international level, in 
which non-health actors can have a profound effect on 
global health outcomes. However, the mandates, rules 
and decision-making processes of these entities rarely 
take population health into account. International 
organisations that deal with trade, investment, intellectual 
property, security, and the environment are among the 
non-health regimes that can have major impacts on 
human health (appendix).
Given the broad definition and remit of global health, 
multiple institutions can claim a mandate on particular 
issues. States, international organisations, and private 
funders, each deriving their mandate from a different 
legal source, could be involved jointly or separately in the 
same project or problem. For example, in relation to 
reproductive health, and maternal and child health, the 
activities of WHO, UNFPA, UNICEF, agencies like the 
United States Agency for International Development, 
and non-governmental organisations might overlap, 
conflict, or be hampered by poor coordination. Similarly, 
multiple institutions operate in the HIV and AIDS space, 
including WHO, UNAIDS, the Global Fund, and Unitaid 
(a WHO hosted partnership). Accomplishing results on 
complex problems requires organisations to act in a well 
coordinated manner—for example, WHO, FAO, and the 
World Organisation for Animal Health must work in 
conjunction to prevent the spread of antimicrobial 
resistant organisms.
In theory, the potential for overlap, gaps, inadequate 
coordination and fragmentation could be minimised by 
recourse to a sovereign decision-making authority or an 
authoritative dispute resolution body. The International 
Court of Justice (ICJ) is the UN’s judicial organ, with the 
power to determine whether certain activities are within 
the mandate of UN organs and specialised agencies. The 
ICJ decided in 1996 that WHO did not have a mandate to 
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deal with the legality of nuclear weapons.170 However, 
global health governance involves multiple institutions 
beyond UN organs and agencies. The ICJ has no 
jurisdiction over these institutions and cannot determine 
whether activities fall within their mandate. Even within 
the sphere of the UN, the ICJ’s role as an arbiter is quite 
limited in practice.
Fragmentation also exists in the international legal 
system governing global health. International law lacks a 
normative or institutional hierarchy,171 meaning that 
multiple venues could have jurisdiction over similar 
issues. This fragmentation affects the way in which law 
functions to set standards and resolve disputes. For 
example, the WTO, WHO, and the UN Human Rights 
Council (UNHRC) each have a mandate to set norms 
that affect access to pharmaceutical drugs. However, 
their mandates require the institutions to examine 
problems arising in trade, public health, and human 
rights through different legal lenses. This approach leads 
to conflicting outcomes: the WTO will continue to 
prioritise international trade and intellectual property, 
while WHO and the UNHRC will prioritise affordable 
access to medicines and the right to health. With limited 
avenues and no global sovereign entity, global health 
continues to rely on the traditional tools of international 
diplomacy to resolve conflicting decisions across 
international organisations—with mixed results.
In dispute resolution, parties may seek to use the 
fragmentation of international law to their advantage. 
States and other actors engage in so-called forum 
shopping (choosing the venue based on the outcome 
sought), leading to inconsistent standards.171–173 Tobacco 
giant Philip Morris reorganised its corporate structure in 
order to use the most favourable investment treaty to 
challenge Australia’s plain packaging legislation (a 2015 
arbitration panel found this to be an abuse of process).174 
Meanwhile, the tobacco industry apparently funded a few 
WTO member states in order to access the WTO dispute 
resolution system and challenge Australia’s plain 
packaging law.
Addressing the challenge of fragmented institutional mandates
Law can be an effective tool to harmonise mandates, 
clarify functions, and promote multiagency cooperation. 
Law can be used to designate the responsible agency to 
resolve a particular issue, or to create new entities to 
coordinate activities across multiple agencies. General 
legal principles can inform and direct all institutions to 
abide by and promote the rule of law, with particular 
attention to social justice. SDG 16 on the rule of law 
includes target 16·3: ‘‘promote the rule of law at the 
national and international levels and ensure equal access 
to justice for all.’’114
UNAIDS offers a prime example of an institution that 
spans multiple UN agencies operating to prevent and 
treat HIV and AIDS. Established by the UN Economic 
and Social Council in 1994, UNAIDS is a Joint Program 
bringing together 11 UN agencies with different mandates, 
to promote interagency dialogue and cooperation, while 
mobilising resources and political will.175 UNAIDS has a 
more modern governance system than other UN bodies, 
with civil society members represented on its governing 
board in a non-voting capacity.176
Because of the strong normative effect of non-binding 
instruments, soft rules can also fill gaps and clarify 
mandates. WHO’s PIP Framework (adopted in 2011) 
governs the ways in which countries are expected to share 
virus samples to facilitate research, while enhancing 
equitable sharing of the fruits of that research.39 As of 
2018, WHO is working with states parties of the Nagoya 
Protocol to the Convention on Biological Diversity (2010) 
to resolve a mission conflict between the PIP Framework 
and the Nagoya Protocol. The former is designed to foster 
global sharing of virus samples, while the latter purports 
to grant states sovereign ownership of viruses, and 
naturally, the right not to share. Finding synergies between 
these two international instruments to enable WHO to 
develop a legal resolution that fosters the global common 
good requires good faith negotiations between inter-
national institutions representing different interests and 
governance systems.
Since establishing a supreme dispute-resolution body is 
a remote, and perhaps undesirable possibility, several 
actors can work together to reduce fragmentation. WHO 
and WTO have had ongoing discussions about resolving 
conflicts in areas such as access to medicines and tobacco 
control. WHO’s IHR formally recognise the importance 
of international trade. In turn, the WTO has recognised 
FCTC guidelines as legitimate standards in WTO dispute 
resolution decisions.177 The WTO’s Agreement on the 
Application of Sanitary and Phytosanitary Measures 
explicitly recognises the sanitary and phytosanitary 
standards of the Codex Alimentarius Commission as the 
relevant food safety standard-setting entity.178 Under this 
commission, WHO and FAO work together. In these 
examples, and others, international regimes are beginning 
to recognise and act to harmonise decision-making 
processes, and, in so doing, improve the public’s health.
Challenge 2: weak monitoring, compliance, and 
enforcement
International law can be an important tool for global health 
because of its power to create norms that are binding on 
states parties. However, even though treaties are binding 
legal instruments, their implementation can be suboptimal 
because of weak enforcement and inadequate compliance. 
Typically, international law is built on a foundation of inter-
state cooperation and shared responsibility. The norms of 
international law guide behaviour, but often, treaty 
oversight bodies have few means by which to compel, or 
even incentivise, com pliance. In extreme circumstances, 
UN organs can authorise economic sanctions, but these 
tend to be limited to the arenas of global security, 
eg, counter terrorism, cybersecurity, and non-proliferation 
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of nuclear weapons.179 The WTO can also authorise 
sanctions through its dispute resolution process.180 The 
inability to enforce and ensure compliance with 
international law has stymied the international com-
munity’s ability to fully use human rights law to prevent or 
ameliorate gross inequalities.
In global health, the options to incentivise or coerce 
behaviour in the face of non-compliance are even more 
limited.181 The FCTC and IHR—the two major inter-
national legal instruments under the direct authority of 
WHO—have been plagued by incomplete state com-
pliance.39 This poor compliance has resulted, in part, 
from external and political forces, and partly from limited 
technical, legal, and financial capacity.
The IHR seeks to prevent the spread of public health 
threats from any source (including biological or even 
radio-nuclear), but primarily aims to prevent the spread 
of infectious diseases. The IHR covers areas such as state 
surveillance requirements and obligations to notify WHO 
regarding potential public health threats of international 
concern and establishes WHO procedures for when 
the organisation has been notified. Furthermore, states 
parties are required to have, or develop, eight minimum 
core public health capacities to prevent, detect, and 
respond to specified health hazards: legislation and 
policy, coordination, surveillance, response, preparedness, 
risk communication, human resources, and laboratory.182 
Each of these core capacities requires substantial 
resources and investment from national governments. 
These activities are largely unsupported by WHO or 
through other forms of international assistance.183 
Although the IHR encourage international assistance to 
build capacity in lower-income states, higher-income 
states—with notable exceptions, such as the US-led 
Global Health Security Agenda (GHSA)—have largely 
ignored the treaty’s norms of international financial and 
technical cooperation.
Weak monitoring, assessment, and follow-up capacity 
can also present a challenge to the effectiveness of 
international instruments like the IHR. Before 2016, 
countries were required to self-assess their IHR 
compliance and competencies. In 2016, WHO worked 
with the GHSA to introduce a new process and tool, the 
Joint External Evaluation (JEE).184,185 Under the JEE, 
independent experts work alongside national officials to 
ensure transparent reporting. However, JEE is voluntary 
and some countries remain reluctant to adopt it, in some 
cases because of concerns about national sovereignty. 
Furthermore, regarding the points at which JEE does 
identify gaps in IHR competencies, no comprehensive 
global mechanism exists to assist low-income countries 
to finance required reforms. As observed during the 
Ebola crisis, this absence of a global mechanism presents 
a potential threat to global security.39,99
Additionally, states could withhold cooperation for 
political or economic reasons. For example, the IHR 
require rapid state identification and reporting of novel 
infections to WHO. However, if states parties do report 
novel infections they could face travel and trade 
restrictions or loss of tourism and prestige. Consequently, 
states might be reluctant to comply in a timely manner 
with the IHR’s reporting obligations. States parties in 
west Africa were late in reporting Ebola in 2014. When an 
epidemic did engulf these countries, governments widely 
ignored WHO recommendations not to impose travel 
and trade restrictions. Airlines also unilaterally sus-
pended flights to the region.186
Addressing the challenge of weak treaty compliance
There are creative ways to foster state compliance, even if 
it is extraordinarily difficult to assure that compliance. 
Treaty oversight bodies need to work with states and 
other stakeholders to find innovative ways to promote 
treaty implementation. This is also true for soft rules, 
which are often amenable to similar compliance-
enhancing incentives and methods. The following are 
examples of tools that could facilitate compliance, and 
many already exist in most compliance-enhancing 
international instruments.
Setting targets and monitoring progress are important 
tools. Oversight bodies should set clear targets and 
benchmarks based on norms set in the treaty or soft rule. 
Having set clear, transparent targets, in collaboration with 
stakeholders, the oversight body should monitor progress 
through objective and transparent mechanisms and make 
its findings publicly available. For instance, WHO’s Global 
Action Plan for the Prevention and Control of Noncom-
municable Diseases 2013–20 is supported by a monitoring 
framework, which includes voluntary targets and 
indicators. Countries’ progress in taking actions to achieve 
the targets is now also being regularly monitored through 
the WHO Progress Monitor.187,188
Another tool is state reporting. Both hard law and soft 
rules could require or encourage states to self-report 
their progress. Fully transparent reporting is vital, and 
the oversight authority (such as WHO’s Director-
General) publicly holds states accountable for abiding, or 
failing to abide by the relevant norms. For example, the 
public should know if states fail to rapidly report novel 
infections as required under the IHR. Greater trans-
parency encourages states to abide by global norms.
Working under a mandate from the UNHRC, UN 
Special Rapporteurs are independent experts who 
examine, monitor, advise, and publicly report on human 
rights from a thematic or country-specific perspective.189 
As of 2018,  43 thematic and 13 country mandates are 
present. The Special Rapporteur on the Right to Health is 
Dainius Pūras. Other health-related thematic mandates, 
for which Special Rapporteurs exist, include access to 
safe drinking water and san itation, extreme poverty and 
human rights, and the right to food. 
Treaty monitoring bodies can also receive so-
called shadow reports, which supplement the reports 
provided by states. Shadow reports can come from 
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non-governmental organisations, UN organisations, 
and academic institutions, and can be presented to all 
the human rights treaty monitoring bodies, including 
CEDAW and the Committee on Economic, Social and 
Cultural Rights, as well as the UNHRC. Because states 
might not report fairly, completely, or truthfully, shadow 
reporting provides a mechanism for civil society organ-
isations to provide their own public reports on states’ 
compliance with their treaty obligations.
External evaluations can also be used as tools that could 
facilitate compliance. As mentioned previously, many 
states do not have the capacity or political incentives to 
properly assess their own compliance with global health 
norms. The majority of states have either not reported or 
under-reported their compliance with IHR core health 
system capacities. In the wake of Ebola, several global 
commissions criticised WHO for failing to ensure more 
independent assessments.186 The JEE was developed in 
response to these criticisms, but, as mentioned above, 
faces challenges for implementation.
Lower-income states often require financial and 
technical assistance to comply with treaty obligations. 
This assistance both incentivises and aids governments in 
fulfilling their responsibilities. The Global Health Security 
Agenda (a partnership between nations, inter national 
organisations and non-governmental organisations) 
provides financial and technical assistance in exchange 
for full cooperation with independent health system 
preparedness evaluations, which in turn strengthens 
compliance with the IHR.190
A further tool that can be used to assist compliance is 
transparency and public disclosure. State performance 
can often be hidden, or partially hidden from public 
scrutiny. Indeed, there is a subtle norm within certain 
international organisations not to publicly name or 
criticise member states. Yet, good governance requires 
openness and public accountability. Civil society and 
oversight bodies can push for compliance with 
international health norms by emphasising state actions.
As mentioned in section 1, WHO treaties have weak 
dispute resolution systems. These treaties could be 
amended to model more rigorous dispute resolution. 
Alternatively, WHO should work with states to emphasise 
the importance of routinely submitting to such resolution 
mechanisms for the common (public) global good.
The final tool that can be used to assist compliance is 
private law dispute resolution. As previously described, 
under the WHO’s PIP Framework, parties can be subject 
to private contracts that are binding, to strengthen 
compliance with the non-binding PIP Framework.
Understandably, many observers will continue to lament 
the absence of strong enforcement mechanisms in 
international law. Unfortunately, most international legal 
obligations are hard to enforce, for example, in relation to 
human rights, climate change, or arms control. However, 
the above examples describe ways in which the innovative 
use of legal and governance tools can enhance compliance 
with international rules, ultimately strengthening the 
governance of global health.
Challenge 3: new legal entities, old governance regimes
In the aftermath of World War II, WHO stood unrivalled 
in the global health space. As of 2019, the same space is 
occupied by more than 200 international agencies and 
initiatives.191 New institutions bring a host of benefits—
more funding, an enhanced voice for civil society, and 
innovative ideas—but also new challenges in leadership, 
oversight, and accountability. In many cases, old regimes 
have not fully adapted to the emergence of these new 
players, raising concerns relating to finding the 
appropriate level and means of participation by new 
institutions in governance processes such as those of 
WHO, and improving the internal governance arrange-
ments of both old and new institutions.
Traditional actors in global health (states and inter-
governmental organisations) are governed by established 
domestic and international legal frameworks. Frame-
works originally established many decades ago can fail to 
take account of new actors and values. Member states, 
for example, have almost exclusive governance powers 
under the WHO constitution. By contrast, valuable 
voices, such as those in civil society, are often not fully 
heard. Although non-state actors can informally 
contribute to the Organization’s work and attend 
governing body meetings, they are not permitted to 
engage in actual decision-making processes.192 This 
raises questions of equity, transparency, and account-
ability. At the same time, although civil society 
organisations often bring considerable practical and 
technical expertise, assessing their legitimacy or their 
sources of finance can be difficult.
As reported by the Lancet-Oslo Commission, global 
health is characterised by imbalances in political power, 
leading to inequities in health.4 Powerful, entrenched 
actors might influence international institutions to 
advance their private interests, rather than the health of 
the public. For example, civil society has criticised WTO 
for diminishing access to essential medicines in favour 
of private commercial interests in intellectual property 
(eg, patent protection for pharmaceuticals).193
WHO itself suffers from so-called capture by its 
powerful member states and non-state actors, who fund 
almost 80% of its annual operating budget.194 The Gates 
Foundation has considerable influence on WHO’s 
agenda. At the same time, WHO has been struggling to 
find an appropriate way to engage with the private sector. 
Health and human rights advocates have expressed 
concern about an overly close relationship between 
WHO and vested corporate interests.
Although WHO and other post-World War II inter-
governmental agencies often have clear governance 
arrangements, oversight of new players and new legal 
entities (eg, civil society organisations, foundations, and 
PPPs) presents a greater challenge. Large PPPs often 
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have limited transparency and accountability because of 
participation of private actors.195 At the national level, 
private entities such as corporations and charitable 
foundations are subject to government oversight, 
especially to protect private shareholders and the 
general public.196 However, no single state can fully 
control the activities of large, transnational corporations 
that operate in multiple countries and regions. States’ 
oversight of major non-profits such as the Gates 
Foundation is also inadequate.
This limited transparency can pose governance concerns: 
some PPPs have been criticised as vehicles for market 
penetration (increasing a product’s market share through 
strategies such as bundling, advertising, lower prices, or 
volume discounts), or as a means for private actors to wield 
influence over international law-making and policy-
making processes.197 In the fast-changing arena of global 
health, the potential efficiency of newer actors should not 
be traded against “good governance, transparency, partici-
pation and engagement; clear accountability for success 
and failure; coordination and coherence; and a new eye on 
priority setting to achieve ambitious global goals while 
balancing equity and efficiency”.105 Good governance 
should both facilitate efficiency, while still ensuring 
effective oversight and accountability.
Addressing the challenge of new and old governance regimes
To some extent, governance regimes are evolving in 
response to these new players. In 2016, WHO member 
states negotiated a Framework for Engagement with 
Non-State Actors,192 which includes non-governmental 
organisations, private sector entities, philanthropic 
foundations, and academic institutions. The Framework 
guides and strengthens the ways in which WHO 
interacts and works with these entities, seeking to 
ensure “transparency, openness, inclusiveness, account-
ability, integrity and mutual respect”, while “protecting 
its work from potential risks such as conflict of interest, 
reputational risks, and undue influence”.192 The Frame-
work could assist WHO to strike a better balance 
between active engagement with outside actors, and 
maintaining the integrity of its own governance 
arrangements. Yet, many in civil society continue to 
campaign for more participatory decision making.
Overcoming the problem of limited participation in 
WHO governance will require innovative thinking. The 
WHO’s Executive Board has granted a small number of 
non-governmental organisations, international business 
associations, and philanthropic foundations an official 
relations status on the basis that they “have a sustained 
and systematic engagement in the interest of 
the Organization…and contribute significantly to the 
advancement of public health”.192 This criteria has excluded 
smaller non-governmental organisations working in 
the health space, separating them from WHO. The 
Organization should find a way to better harness the 
creativity and energy of civil society organisations.
Innovative governance arrangements in newer entities 
could help improve inclusiveness and trans parency. For 
example, The Global Fund has implemented innovative 
governance for greater civil society participation, described 
as follows.7 The first implementation was non-govern-
mental organisation representation—including from 
developed and developing countries, as well as from 
communities living with the Fund’s targeted diseases—on 
its Board, alongside representatives of the private sector, 
national governments, and philanthropies. Additionally, 
local, multi-sector, multi-stakeholder committees, known 
as Country Coordinating Mechanisms (CCMs) were 
introduced to oversee grant implementation at the local 
level. CCMs must include members of communities 
living with the Fund’s target diseases and must document 
the involvement of marginalised or vulnerable populations 
in their work. The Global Fund has also adopted standards 
to manage conflicts of interest with CCMs.198 Dual-track 
financing, whereby the CCMs nominate both a govern-
mental and non-governmental principal recipient for 
financing was introduced;198 and finally, community 
systems strengthening through activities such as 
partnerships, capacity building, service delivery, as well as 
planning, monitoring, and evaluation.
The Global Polio Eradication Initiative is another 
example of a PPP that has adopted innovative governance 
arrangements to foster greater transparency. The 
Initiative—a partnership between WHO, Rotary Inter-
national, the US Centers for Disease Control and 
Prevention, UNICEF, and the Gates Foundation—is 
overs een by an Independent Monitoring Board of global 
experts. The Board evaluates the Initiative’s work against 
key milestones. If milestones are deemed to be at risk, 
off track, or missed, the Board reports to the partners, 
and makes its reports public.199
Independent and civil society voices are crucial for 
holding global health actors accountable. Arrangements 
such as these provide legal and governance mechanisms 
for those voices to be heard, leading to more robust 
processes, and ultimately, outcomes that achieve health 
with justice.
Legal reforms could greatly enhance the governance of 
global health
Law can shape the governance of global health in various 
ways. Law defines the mandates, powers, and structures 
of, and the interactions between, key players in global 
health. However, the potential to deliver health with 
justice is weakened by multiple governance challenges: 
fragmen tation and overlap, poor compliance and 
enforce ment, and disjunctions between actors with great 
influence over global health and the regimes intended to 
govern them. In this section, we have built on the work 
of the Lancet-Oslo Commission, specifically identifying 
ways in which law could strengthen good governance for 
global health. We have identified measures to harmonise 
institutional mandates, mechanisms for review of 
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decisions, forums for ensuring international policy 
coherence on health, and innovative compliance-
enhancing arrangements. In each of these ways, law can 
address vital governance challenges in global health. 
Specifically, recom mendation 3 proposes that the UN set 
good governance standards for UN specialised agencies 
and programmes, including WHO. This proposal is 
supported at the national level by recommendation 4, 
which states that governments should develop legal 
frameworks establishing principles of good governance 
throughout national health systems and policy making.
Section 4: legal determinant 3
Law can be used to implement fair, evidence-based 
health interventions, and can be a powerful tool for 
global health.3 Statutes and regulations can be used to 
implement interventions that lower the exposure to risk 
factors across entire populations. As a result, law has 
been integral to many of the great public health 
successes of the past century, including motor vehicle 
safety, tobacco control, infectious diseases control, a 
safer food supply, workplace safety, and childhood 
vaccinations.200 Many public health interventions require 
enactment and enforcement of laws and regulations, 
such as taxes on tobacco, alcohol, or sugar-sweetened 
beverages; marketing or sponsorship bans; and 
minimum age of purchase requirements. In other 
cases, laws facilitate effective health interventions, such 
as immunisation requirements for school entry or 
creation of safe injection sites for drug users.
However, law is only a tool. When used without 
sufficient evidence, or without regard for justice and 
human rights, statutes and regulations may be 
ineffective—or worse, could undermine health. Law 
could also perpetuate injustice, such as by establishing a 
multi-tier UHC health insurance system that provides 
real benefit to some people (eg, civil servants, formal 
sector employers) but only limited benefits to others 
(eg, informal sector workers). Our third legal determinant 
of health is the effective, fair, and evidence-based 
enactment and implementation of legal interventions.
In this section, we first offer a framework for evaluating 
health laws, and propose four characteristics of effective 
laws that advance health with justice. We then provide 
key examples of effective laws, across three risk 
factor domains: infectious diseases, non-communicable 
dis eases, and injuries. In each domain, we describe ways 
in which international and domestic laws interrelate and 
inform one another. Sharing of experiences and research 
regarding the effectiveness of public health laws among 
jurisdictions, and with inter national organisations, will 
be crucial to the global dissemination of just, evidence-
based legal inter ventions. Finally, we explain how laws 
that are not informed by evidence and human rights 
principles could undermine health, while entrenching 
inequality and discrimination.
Evaluating health laws: does this intervention advance 
health with justice?
The Commission concluded that across the spectrum of 
global health hazards, legal interventions will be most 
effective when they are based on sound science, and 
guided by the values of justice, transparency, and 
inclusion. The most just and effective public health laws 
share the following four core characteristics: they are 
evidence based, equity promoting, multisectoral, and 
supported by good governance (figure 4). Laws that 
share all these characteristics will best advance health 
with justice.
Health laws must be evidence-based
Sound scientific evidence is the most important 
characteristic of effective public health laws.201 Laws 
should be informed by  scientific evidence, rigorously 
answering the question: do they improve the health and 
safety of the population, while not posing undue burdens 
on individual rights? Although we emphasise the 
important role of innovation and well considered novel 
approaches in public health law and regulation, this 
should always be implemented in conjunction with well 
designed evidence gathering and rapid evaluation. In 
section 5, we suggest ways to expand and strengthen the 
evidence base for, and the legal capacity to, implement 
legal interventions.
Policy makers sometimes—perhaps often—must act 
on incomplete evidence or scientific uncertainty. A 
classic example of the need to act without complete 
information is when a major health hazard or emerging 
health risk demands an urgent response, and perhaps an 
innovative approach. For example, the Democratic 
Republic of Congo deployed investigational new vaccines 
and therapies in response to Ebola in 2018–19, even 
though regulatory agencies had not yet found the vaccine 
and drugs to be safe and effective.
The absence of full information to thwart legal 
innovations should not be allowed. If policy makers always 
had to wait for an exhaustive research study, many 
substantial threats to the public’s health would persist. 
Evidence might come from analogy to other areas of law, 
such as the effectiveness of taxes on reducing sugary 
beverages, based on effectiveness of taxes in reducing 
tobacco use. Similarly, evidence of effectiveness for portion 
controls on sugary beverages might come from studies 
Figure 4: Core characteristics of legal interventions that advance health with 
justice
Based on sound evidence 
Engage sectors beyond health Supported by good governance 
Equity-promoting 
Effective legal interventions 
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showing increased portion size, and its relationship to 
overweight or obesity. In such cases, policy makers need to 
make informed choices for law reform, in the absence of 
complete evidence.
While using the best available (albeit incomplete) 
evidence at the time, evaluating the law’s effect to ensure 
continuous quality improvement in health legislation is 
imperative. Even then, though, law makers might need to 
accept some uncertainty, such as where there is clear 
evidence that a suite of legal measures is effective at 
addressing a complex health threat (eg, obesity, or gun 
violence), but it is difficult to determine the specific 
contribution of any single intervention. For example, in 
tobacco control, a comprehensive approach using a host 
of demand and supply reduction measures has, in combi-
nation, substantially reduced smoking rates over time.
Health laws must promote equity
Poor and disadvantaged communities often have a 
disproportionate burden of morbidity and premature 
mortality, as well as the social and economic consequences 
of disease and injury. These populations include people 
with mental or physical disabilities; racial, ethnic, or 
sexual minorities; and women and children. Poor health 
outcomes, in turn, further entrench disadvantage. Poor 
and marginalised populations—whether living in 
low-income and middle-income countries, or in wealthier 
countries—often live, work, recreate, travel, and go to 
school in unsafe or unhealthy environments. They also 
benefit less from prevention services and have less access 
to high-quality treatment and rehabilitation services.202 
Interventions that target inequalities are thus funda-
mentally linked to those that address ill health.203
Achieving health with justice requires non-discrimi-
nation; equitable distribution of benefits and resources 
within and across communities, within countries, and 
globally; and protecting underserved com munities. At a 
national level, law makers should pay particular attention 
to the needs of the poorest, the most vulnerable, and 
those who are marginalised. At the global level, it is 
important to translate international norms to the national 
and local levels to reduce health disparities among and 
within states. If the world is to achieve the SDG’s pledge 
of “leaving no one behind”, public health laws must 
target areas of deep inequity.
Health laws must engage sectors beyond health
Laws far beyond the health sector influence the conditions 
for achieving population health and reducing inequalities. 
The criminal justice system, taxes and transfers, urban 
planning and development, trade, agriculture, housing, 
and the environment are incidental to, but deeply affect 
population health.10 If not conceived with due con-
sideration for health objectives, laws in these sectors 
could have powerful adverse effects on health. For 
example, agricultural subsidies for corn, sugar, or meat 
can exacerbate major health and environmental threats.
Conversely, multiple sectors have the potential to 
improve population health and justice. Urban planning, 
education, social services and other portfolios can have 
major health-enhancing features. Yet, public health 
researchers and officials often neglect agencies outside of 
health ministries. Achieving health with justice requires 
an all-of-government approach, supported by the head of 
government.
Health Impact Assessments (HIAs) measure the 
health effects of proposed initiatives in diverse sectors 
(criminal justice, education, housing, nutrition, edu-
cation, and revenue) using quantitative, qualitative, and 
participatory techniques, with particular regard for health 
equity. HIAs adopt an all-of-government or health-in-all-
policies (healthy policies) approach to governance. HIAs 
dynam ically improve health and wellbeing across sectors. 
Several countries and sub-national jurisdictions, such as 
Thailand, Slovakia, and several US states, have laws 
requiring HIAs for policies substantially affecting public 
health or for policies or programmes in certain sectors. 
Other laws empower public health authorities, or even 
the public, to request an HIA,204 as evidence shows that 
HIAs can have a substantial positive effect on public 
policy.205,206
In 2008, the WHO Commission on the Social 
Determinants of Health recognised the importance of 
reform in multiple sectors. Despite this, international 
institutions (including WHO itself) and governments 
have not devoted the attention and resources needed 
to address the social determinants of health. We argue 
that law can be highly effective in defining and 
operationalising government action. By creating and 
implementing social norms and redistributing resources, 
law can create the conditions for the public’s health. 
Examples of the power of law to affect the social 
determinants of health include social welfare and income 
support programmes; market regulations that enhance 
income and agency for workers (minimum wages, paid 
sick leave or family leave); protection of union and labour 
rights; redistribution policies, such as pre-tax limits on 
compensation levels, progressive taxation, and negative 
income taxes; nutrition policies, such as subsidising 
healthy foods and restricting unhealthy foods in school 
lunches; consumer protection; and occupational health 
and safety regulations.
Health laws must be supported by good governance
Finally, health with justice can only be delivered against a 
backdrop of good governance, sound regulatory principles, 
and the rule of law. These include transparency and 
openness; civil society or community engagement and 
inclusive participation; monitoring and evaluation 
systems; honesty, non-corruption, and stewardship; and 
accountability at all levels, from legislating, through 
implementation, to enforcement. We have addressed 
these concepts in detail elsewhere in this report, in 
sections 3 and 5.
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 Effective legal interventions
Despite past successes, law remains underutilised as a 
tool for population health.207 In this section, we discuss 
legal and regulatory interventions across three broad 
health domains: infectious diseases, non-communicable 
diseases, and injuries. These interventions have been 
effective because they share the characteristics previously 
discussed. For each, we provide key illustrations, com-
plementing the other examples and case studies found 
throughout this report. A comprehensive list of domains 
and interventions from around the world can be found in 
the report from WHO, International Development Law 
Organization, O’Neill Institute, Sydney University: 
Advancing the right to health—the vital role of law.86
In keeping with our global health lens, we also focus 
on the ways in which national and global health law 
intertwine, showing the potentially far-reaching effects of 
law. Legal interventions that successfully advance health 
with justice at the local and national levels have been 
adopted (and adapted) in other jurisdictions, as well as 
translated into international norms. At the same time, 
international norms have been codified in national and 
local laws. This interaction shows the multidimensional 
nature of creating and diffusing highly effective health 
laws from the global level to the local and national levels, 
and vice versa (figure 1).
Infectious diseases
During the 20th century, improvements in sanitation 
and hygiene, vector abatement, and surveillance ushered 
in substantial advances in infectious disease control.208 
Previously devastating infections are now treatable, even 
as the global health community wrestles with the 
frightening prospect of antimicrobial resistance. The 
advent of vaccination laws vastly reduced deadly 
childhood diseases such as measles, mumps, and rubella. 
Smallpox was a major killer before mass immunisation 
led to its eradication. Before the Salk vaccine, people 
feared the paralysing effects of polio. WHO, along with 
international partners, is now aiming to eliminate polio 
around the world.
Throughout modern history, law has played a major 
role in reducing infectious diseases through national 
public health laws and regulatory frameworks, inter-
national legal agreements, and governance reforms. As of 
2019, the international community faces new challenges 
and must undertake health system and animal husbandry 
reforms, while also incentivising development of new 
medicines to combat antimicrobial resistance.
National legal frameworks in the form of laws and 
regulations give public health agencies wide-ranging 
powers to control infectious diseases. These regulations 
include powers to identify individuals (testing) or 
populations (screening) who can potentially transmit 
infections; require health providers and others to notify 
public health agencies of cases of infectious disease; 
trace contacts of infected individuals or notify partners; 
vaccinate exposed persons, their contacts, and broader 
populations; directly observe individuals to ensure they 
take the full course of their medications such as directly 
observed therapy for tuberculosis; and separate people 
who are infected (isolation) or have been exposed 
Purpose of intervention Actions necessary for success of intervention
Legal interventions related to testing, screening, reporting, contact tracing, and partner 
notification can improve surveillance data, while protecting confidentiality and privacy
Improving essential data through early warning, 
identify individuals at risk, reduce transmission, 
monitor incidence, facilitate response
Improve public health infrastructure: labs, 
workforce, data systems
Legal interventions related to occupational health and safety, so-called wet markets, 
animal quarantines, and culls can decrease animal–human interchange
Protecting animal health, and preventing 
so-called species jumps to humans
Improve hygiene and infection control in animal 
farming, and meat and poultry markets
Legal interventions related to hand-washing, disinfection, respiratory hygiene, potable 
water, and sanitation can improve community hygiene
Reducing transmission in families and the 
community
Public education grounded in risk communication 
science, clean water and sanitation systems
Legal interventions related to disinfection, hand hygiene, personal protective 
equipment, and health-care worker vaccinations can help control hospital infections
Reducing transmission among patients, health 
workers, and families and communities
Training and monitoring in infection control, greater 
acceptance of vaccination by health professionals
Legal interventions related to the closing of public places, cancelling public events, and 
restricting mass transit can help decrease social mixing in the event of an outbreak
Slowing the spread of infection in public 
settings
Target closures to high-risk settings based on 
evidence
Legal interventions related to screening (entry and exit), reporting, health alerts, 
passenger data, travel advisories, hygiene (inspection, disinfection, and pest 
extermination) can help improve border controls
Preventing cross-border spread of infectious 
diseases
Adequate resources for surveillance, treatment, and 
response in affected areas and national borders
The law can prevent spread of infectious diseases through isolation and quarantine, 
and ensuring respect for human rights. Laws should ensure that in the event of an 
outbreak, any isolation or quarantine strategies, including so-called shelter in place 
policies, are safe and humane, evidence-based, and no more restrictive than necessary 
to protect public health
Separating the infected or exposed from the 
healthy
Safe and humane settings, assure necessities of life, 
logistics, modern laws with due process
Legal interventions related to vaccines and antivirals can help improve medical 
countermeasures
Implementing prophylaxis, and reducing 
infectiousness
Stable, viable supplies: incentives, public–private 
partnerships, tort reform, compensation
Legal interventions related to antibiotic use in humans and animals, and falsified or 
substandard medications can help in preventing drug-resistant infections
Reducing spread of drug-resistant infections in 
animals and humans and developing new 
antimicrobial medications
Appropriate medical prescribing, reduced use of 
antimicrobials in farmed animals, curbing the trade in 
falsified and substandard medications, incentivising 
research and development of new antimicrobials
Table: National public health laws to control infectious diseases
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(quarantine) from healthy populations. Law can also 
require rigorous community and hospital infection 
control, such as disinfection, hand hygiene, and personal 
protective equipment. It can limit animal–human 
interchange to prevent pathogens jumping from animals 
to humans (table). When public health officials exercise 
compulsory powers, they should provide due process or 
natural justice, such as a fair hearing. Procedural 
safeguards are often necessary to prevent health officials 
from acting in an arbitrary or discriminatory manner.
In addition to the IHR and PIP Framework, which 
relate to human pandemic illness, countries should 
prepare for, and evaluate preparedness for, zoonotic 
diseases (animal diseases that can be transmitted to 
humans). Even diseases that infect only animals can 
damage economies by curtailing meat exports, or driving 
up domestic food prices. As of April, 2017, only 
six countries worldwide had undergone two external 
evaluations of their ability to withstand a global 
pandemic. One evaluation is for human diseases (the 
JEE, in cooperation with WHO) and the other relates to 
animal diseases (in cooperation with the World 
Organization for Animal Health).209,210
Law can also be used to help limit the spread of 
organisms that are resistant to antimicrobial medications. 
For example, regulation can operate to better ensure 
appropriate prescribing of antimicrobials. Law can also be 
used to ban the prophylactic use of antibiotics in animal 
populations or to promote growth, thus reducing the 
reservoir of drug resistant organisms in farmed animals. 
Similarly, regulations can require surveillance of drug 
resistant infections in both human and animal populations.
Law plays a particularly important role in limiting the 
manufacture of, and trade in, falsified and substandard 
medicines. When patients take antimicrobials that have 
sub-optimal doses of active pharmaceutical ingredients, 
they can develop drug resistant infections. Countries 
should update legislation to provide clarity on what 
qualifies as falsified and substandard medicines according 
to the definitions that the WHA approved in 2017,211 
strengthen criminal penalties to deter manufacture and 
sale of these products, ensure adequate registration and 
quality surveillance systems, and sufficiently resource 
public health regulatory and customs agencies for 
increased surveillance and enforcement. Legislation 
could require that pharmacists are trained in detecting 
falsified and substandard medicines. The WHA should 
adopt a code of practice on falsified and substandard 
medicines that sets standards on surveillance and inter-
national reporting and provides guidelines for and 
coordinates regulation and law enforcement.212
Because infectious diseases do not respect national 
borders, global health law and governance are just as 
important as national legislation. WHO has adopted two 
major legal instruments to safeguard global health 
security, but both face major problems, as does WHO 
governance itself.
The 2014–15 Ebola virus epidemic in west Africa 
revealed “deep inadequacies in the national and inter-
national institutions responsible for protecting the public 
from the far-reaching human, social, economic, and 
political consequences of infectious disease outbreaks.”99 
A review of four global commissions in the wake of the 
epidemic drew together recommendations and suggested 
reforms for future global health pandemic preparedness.186 
Many proposed reforms involved law and regulation, 
including surveillance, disease notification, infection 
control, and strengthening national health systems. Good 
governance for health was another major aspect of the 
required reforms, both at the national and global levels—
for example, transparency, monitoring, risk com-
munication, community engagement, and accountability.
Crucial to this last function is strengthening and 
scaling up WHO’s IHR and PIP Framework, and 
building capacity at WHO itself.39 Implementation of the 
IHR during the Ebola epidemic was deeply flawed: WHO 
delayed its declaration of a Public Health Emergency of 
International Concern (PHEIC) for over 4 months after 
the first international spread.213 Declaration of a PHEIC 
under the IHR carries normative weight under inter-
national law, and allows WHO to alert and engage the 
international community.214 At the same time, only 30% 
of states parties had reported meeting the IHR require-
ments to develop core health system capacities,215 and 
states widely ignored WHO travel recommendations. 
During the Ebola epidemic, the PIP Framework was not 
even applicable, as its narrow scope is limited to 
pandemic influenza strains.
The post-Ebola commission reports urged research 
and development of vaccines and anti-microbial 
medications to be better funded and expedited. Yet, 
regulatory frameworks such as intellectual property, so-
called ownership of viruses, inconsistent regulatory 
approval pathways, legal liability for pharmaceutical 
companies, and divergent clinical trial standards can 
hinder rapid development of medical technologies to 
respond to public health emergencies. These regulatory 
frameworks need to be reformed, or made more flexible, 
to support the development, procurement, approval, and 
deployment of effective therapeutic countermeasures. 
Legal obstacles to the effective deployment of counter-
measures should be addressed and resolved in advance 
of future pandemics.
The law can also offer a protective function, helping to 
ensure that patients and human participants in research 
are treated with dignity and respect, while safeguarding 
them against unethical research and unsafe products. 
Liability reform can incentivise manufacturers to more 
rapidly develop and deploy products. Additionally, the 
formation of multi-disciplinary partnerships that include 
patients, health care providers, experts, industry partners, 
ethicists, lawyers, and others would promote a clearer 
understanding of regulatory rules and ethical practices, 
as well as better sharing of research information.
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Despite considerable progress, the burden of infectious 
diseases remains unacceptably high, particularly in low-
income and middle-income countries, and among poor 
and rural populations.3 Each year, millions of people die 
from diseases such as HIV and AIDS, tuberculosis, 
malaria, hepatitis, influenza, and neglected tropical 
diseases (although WHO is making substantial progress 
in controlling negative tropical diseases).119 The un-
precedented movement of people and goods around the 
globe is amplifying the spread of infectious diseases, as 
is climate change.216,217 In settings where health systems 
are weak, populations are all the more vulnerable to 
emerging or re-emerging infectious diseases. Since 2000, 
the world has experienced major outbreaks of novel 
infections such as Severe Acute Respiratory Syndrome, 
Middle East Respiratory Syndrome, new strains of 
pandemic Influenza (H1N1), Ebola, and ongoing Zika 
virus transmission.186 Outbreaks of cholera, plague, and 
yellow fever have caused considerable illness and death.
Infectious disease laws are crucially important, but 
must respect human rights, promote equity, and reflect 
international norms such as the Siracusa Principles.
Non-communicable diseases
WHO estimates that non-communicable diseases cause 
40 million deaths annually, amounting to 70% of all deaths 
globally.218 People die too young from these diseases, with 
negative consequences on productivity and socioeconomic 
development. In 2015, 16·9 million deaths were estimated 
to occur before age 70 years and 9·2 million before age 
60 years. Moreover, the huge toll of death and disability 
from non-communicable diseases does not affect all 
populations equally; 31 million (or three quarters of the 
total) of global non-communicable disease deaths occur in 
low-income and middle-income countries. The main non-
communicable diseases—cardiovascular diseases, cancer, 
chronic respiratory diseases, and diabetes mellitus—share 
four main behavioural risk factors: tobacco use, physical 
inactivity, the harmful use of alcohol, and unhealthy 
diets.160 Evidence shows that social and economic 
circumstances can significantly increase the risk of non-
communicable diseases.219
An increasingly strong evidence base exists regarding 
how population-level interventions can be used to 
prevent and control non-communicable diseases. WHO’s 
Global Action Plan for the prevention and control of non-
communicable diseases 2013–20, including the updated 
appendix 3, represents the most important normative 
instrument on non-communicable diseases at the global 
level.160 Many of its policy recommendations, some of 
which are so-called best buys for public health (highly 
cost-effective, evidence-based interventions), include the 
use of law and regulation (panel 6). Building on the 
strong evidence of success in Denmark, New York City 
and other settings, WHO now recommends that 
countries use legislation to eliminate industrial trans fats 
in the food supply.
Tobacco control is important in containing the spread of 
non-communicable diseases. WHO’s non-communicable 
diseases Global Action Plan incorporates the FCTC’s 
provisions in its recommended actions. Updated 
appendix 3 calls on states parties to “strengthen the 
effective implementation of the WHO FCTC and its 
protocols”, including by establishing “national mech-
anisms for coordination of the WHO FCTC implem-
entation as part of national strategy with specific mandate, 
responsibilities and resources”.160 The action plan also 
invites member states that are not parties to the FCTC to 
“consider implementing the measures set out in the 
WHO FCTC and its protocols, as the foundational 
instrument in global tobacco control”.160
The FCTC provides a prime example of the inter-
relationship between international and domestic law, 
providing a precedent for future global health govern-
ance. The WHA in 1995 urged member states that had 
already successfully implemented all or most of a 
comprehensive strategy for tobacco control to provide 
assistance to WHO.220 This aid would allow WHO to 
provide advice and support to other member states 
seeking to improve their tobacco control strategies. The 
following year, the WHA voted to begin work on 
developing a framework convention. A decade later, the 
FCTC entered into force.221
The FCTC has had a substantial effect on global tobacco 
control, with its norms widely implemented at national 
and local levels. Particularly in high-income countries, a 
so-called suite of national and local laws and regulations 
has resulted in large declines in tobacco use. A com-
bination of legal interventions all operate to reduce 
smoking in youth and adults, including lowering the 
legal age for buying tobacco products, marketing bans or 
restrictions, bans on smoking in public places, high 
taxation, and graphic packet warnings. For example, 111 
of 181 FCTC states parties require pictorial warnings on 
cigarette packages, as recommended under Article 11.222 
Governments are now implementing major so-called 
endgame strategies, such as gradually increasing the 
legal smoking age, and vast reductions in the nicotine 
levels in cigarettes, which addict virtually all smokers.223
However, the FCTC faces substantial compliance 
challenges, particularly in low-income and middle-
income countries. For instance, Article 14 encourages 
countries to put in place tobacco cessation infrastructure 
but does not provide the resources to allow low-income 
and middle-income countries to do so. As of 2013, only 
a minority of countries had in place the infrastructure 
necessary to offer cessation support to tobacco users.224 
Furthermore, compliance and enforcement challenges 
are only made more difficult in the presence of 
aggressive opposition from vested commercial 
interests.225 Ongoing monitoring, and strategies to 
strengthen the capacity of states to comply with their 
FCTC obligations, are two important ways to bolster the 
effect of this instrument. 
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Dietary salt reduction provides another good 
illustration of countries incorporating WHO guidance 
on non-communicable disease prevention, fitting global 
norms into their social, political, and regulatory contexts. 
High salt intake is estimated to be associated with nearly 
half of the disease burden ascribed to hypertension, a 
major contributor to global morbidity and mortality.226–228 
The physiological requirement for salt is less than 1 gram 
per day,229 and WHO recommends less than 5 grams 
per day for adults.230 Yet, in 2010, the global mean salt 
intake was twice this level, or 10 grams per person 
per day.231 WHO’s Global Action Plan has set a target of a 
30% reduction of population-level salt intake by 2025.232
Population salt reduction is among WHO’s so-called 
best-buys to reduce chronic disease—an intervention that 
could lead to substantial health benefits as well as cost 
savings.233,234 In the USA, it has been estimated that a 
regulatory intervention designed to achieve a reduction in 
salt intake of 3 grams per day would save 194 000 to 
392 000 quality-adjusted life-years and US$10–24 billion 
in health-care costs annually, and would be more cost-
effective than using medications to lower blood pressure 
in all people with hypertension.235 From a population 
perspective, the most effective and equitable means of 
reducing salt consumption is to reduce the salt content of 
manufactured foods.236,237 In many countries, processed 
foods substantially contribute to salt intake,238 regardless 
of any action individuals might take to reduce the salt 
they add to food.
Countries are adopting population-level salt reduction 
strategies to achieve WHO’s 30% reduction target by 2025. 
Many of these focus on reductions at the manufacturing 
level (reformulation), complemented by public information 
campaigns and nutrition labelling. The strategies also use 
diverse regulatory forms. In 2006, the UK became the first 
country to set salt targets for food composition. Using a 
voluntary approach, but with strong government 
leadership and oversight, UK manufacturers agreed to 
progressive reduction targets for around 80 categories of 
processed foods. Their reformulation efforts were 
supported by consumer education and improved food 
labelling. The approach was highly successful, resulting in 
a 15% decrease in salt intake across the population.239 
South Africa was the first country to set legislatively 
mandated salt reduction requirements across a wide range 
of processed foods. In March 2013, the South African 
Minister of Health issued the Regulations Relating to the 
Reduction of Sodium in Certain Foodstuffs and Related 
Matters.240 The requirements took effect on June 30, 2016, 
with more stringent maximum levels coming into force 
on June 30, 2019.240 Argentina has used a combination of 
voluntary and mandatory salt reduction techniques. 
Initially, the Ministry of Health and large food companies 
signed a voluntary agreement in 2011 to gradually and 
progressively reduce sodium in processed foods.241 
Voluntary targets were set according to the category of 
food, with reductions ranging between 5–18% over a 2-year 
period, and a government campaign supporting and 
encouraging behaviour change. In 2013, to build on the 
success achieved through the voluntary scheme, Argentina 
enacted a national law regulating the sodium content of 
processed foods. As of 2019, 83 countries have salt 
reduction strategies in place or planned, including 
35 countries with voluntary targets and nine with 
mandatory, legislated targets. Almost all countries use a 
multifaceted regulatory approach, with 70 counties 
implementing, or planning to implement more than one 
type of strategy, and 33 countries incorporating legislative 
initiatives such as taxes, maximum limits, or warning 
labels.242 Programmes are now being implemented in 
countries across all WHO regions and across countries 
with a broad range of income levels.242 An example of these 
changes is described in the case study of the regulation of 
sugar-sweetened beverages (panel 7).
Physical inactivity is the fourth leading risk factor for 
global mortality and was associated with an estimated 
55·3 million deaths globally in 2008.255,256 A European 
prospective investigation of over 334 000 men and 
women found that twice as many deaths could be 
attributed to lack of physical activity, compared with the 
number of deaths attributable to obesity. Even a modest 
increase in physical activity could have significant health 
benefits: a brisk 20 minute walk each day could be 
enough to reduce an individual’s risk of early death.257 
WHO recom mendations go further, recommending that 
adults undertake 150 minutes of moderate-intensity 
physical activity, or 75 minutes of vigorous-intensity 
physical activity, throughout the week.258 Building on 
these findings and recommendations, an emerging body 
of evidence on legal and regulatory interventions is 
aimed at increasing physical activity.
Features of the built environment, including the so-
called walkability of a city, are strongly associated with 
the prevalence of obesity. A gender equity dimension is 
also present, as women tend to be further disadvantaged 
in their opportunities for physical activity where cities 
are not walkable.259  This is another area in which laws 
and regulations that affect population health might lie 
well outside the usual reach of health ministries, thus 
requiring intersectoral cooperation. In a 2009 review of 
the evidence, WHO found that modifying the built 
environment, policies that reduce barriers to physical 
activity (such as walking, biking, and recreation), 
transport policies, and increased space for recreational 
activity were all effective interventions.260
Examples of effective laws and regulations to increase 
physical activity include urban planning, land use 
management and zoning, transport policy (including 
taxes on car use, availability and accessibility of public 
transport, and bicycle and walking paths), and road and 
traffic control.261 Local governments can play an important 
role because land use and zoning frequently fall under 
their remit. Local governments can implement building, 
zoning, and development regulations that encourage 
The Lancet Commissions
1888 www.thelancet.com   Vol 393   May 4, 2019
more physically active lifestyles: streets that are 
welcoming and safe for pedestrians and cyclists, facilities 
for public recreation (parks and playgrounds), and traffic 
calming measures.15
The common theme among legal and regulatory 
interventions to prevent non-communicable diseases is 
that they promote small changes, across entire 
populations, for a mass impact. By simply changing a 
default option (eg, reducing salt in processed food, 
forbidding smoking in certain areas, or making public 
transport easier than car use), law has the power to 
facilitate profound changes in behaviour. Good laws can 
make healthier and safer behaviours the easier or normal 
choice. In conjunction with health promotion and 
awareness campaigns, countries can use law to support 
and encourage communities to resolve the problems 
arising from the shared risk factors of non-communicable 
diseases.
Panel 7: Regulation of sugar-sweetened beverages
Sugar-sweetened beverages (SSBs), generally defined as liquids 
with added sugars (soft drinks, sports beverages, energy drinks, 
sweetened waters) are a known contributor to a variety of 
non-communicable diseases such as obesity, type 2 diabetes, 
heart disease, kidney disease, non-alcoholic liver disease, tooth 
decay and cavities, and gout.243 In response to the non-
communicable disease epidemic, countries have begun to 
regulate SSBs, primarily through excise taxes, which add a per 
ounce fee to the SSB sales price, although traditional sales taxes 
have sometimes been employed.244,245 The trend toward taxation 
has increased substantially over the past decade, and particularly 
during the past 5 years. As of 2019, more than a dozen countries, 
including France, the UK, Norway, Portugal, Chile, Saudi Arabia, 
South Africa, Thailand, and Mexico, along with numerous 
localities, have adopted sugar taxes of varying scope and size.246
Two of the most studied tax cases were in Mexico and Berkeley, 
California. Mexico was among the first countries to implement 
a substantial tax on SSBs, in 2014, levying a 10% excise tax on 
all SSBs except milk. Researchers found an immediate 
reduction in SSB consumption during the following years, with 
sales of SSBs falling by 5·3% in 2014 and 9·7% in 2015, while 
sales of untaxed beverages increased in 2014 and fell by 
only 1% in 2015.247 In Berkeley, which adopted a 1 cent 
per ounce tax on SSBs, researchers found that SSB sales 
decreased by 9·6% while untaxed beverage sales increased by 
3·5%, driven primarily by a 15·6% increase in sales of bottled 
water.248 Importantly, the tax did not seem to meaningfully 
affect overall consumer shopping habits, as average grocery 
bills did not increase, and Berkeley store revenue did not 
decrease compared with control cities. Multiple studies (in 
addition to those in Mexico and Berkeley) found that SSB taxes 
lead to moderate reductions in consumption, which could 
support positive downstream health outcomes.249
WHO supports adoption of SSB taxes as a strategy to help 
combat non-communicable diseases, particularly obesity and 
diabetes, citing evidence that an SSB tax that increases consumer 
prices by 20% can lead to an approximate 20% reduction in 
consumption.249 Crucially, researchers have cautioned that SSB 
taxes must be relatively high to reduce consumption; at lower 
levels retailers could elect to absorb the cost of the tax in order to 
retain customer business, particularly if customers are readily 
able to purchase comparable goods from a nearby retailer in a 
location without such a tax.250
Supporters of SSB taxes often argue that improved population 
health resulting from SSB taxes will eventually reduce 
health-care costs. WHO cites estimates that, over 10 years, a tax 
on sugary drinks of 1 cent per ounce in the USA would result in 
more than US$17 billion in health-care cost savings.249 
Supporters argue that the revenue generated by SSB taxes can 
offset health-care expenses. For example, WHO cites estimates 
that an SSB tax of ¥1 (US$0·16) per litre in China would generate 
an estimated ¥73·6 billion (US$11·8 billion) in revenue.249
As policy makers have become more interested in taxation and 
other regulation of SSBs, so too has the beverage industry, 
adopting creative techniques to forestall new regulation. For 
example, in response to local efforts to implement SSB taxes 
within California (the largest state in the USA, with over 
39 million residents), the beverage industry engaged in an 
aggressive and ultimately successful strategy to preempt local 
taxation authority. In California, the generally liberal state 
government would normally be unlikely to adopt a state wide 
ban on new soda taxes. However, in 2018, the beverage 
industry deployed a two-pronged effort to curb local SSB taxing 
authority, first, by financing a ballot initiative in support of a 
sweeping preemptive tax law251,252 that would have been 
devastating to localities, and later, by agreeing to withdraw the 
proposed initiative if a more narrow food and beverage tax ban 
bill passed, a move that was characterised by some legislators 
as “blackmail” and “being held hostage”.253
The industry’s forceful techniques were effective. In June, 2018, 
the California legislature passed a bill preempting any new local 
food or beverage taxes for 12 years,254 joining Michigan and 
Arizona in adopting state wide bans on new soda taxes. Several 
other states in the USA have considered such bills, and the 
industry appears likely to continue to lobby in support of their 
passage in the USA and globally.
The California example is emblematic of the challenges facing 
policy makers and health advocates. Although research shows 
that SSB taxes are an effective legal tool to help combat the 
non-communicable disease epidemic, the industry has 
mobilised to defeat any important new regulation. With 
industry willing to spend heavily in support of its objectives, 
public health advocates must be prepared for a more difficult 
path toward adoption of future SSB taxes.
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Injuries
WHO estimates that more than 5 million people 
(equivalent to 9% of global mortality) die each year as a 
result of injuries, and many more endure temporary or 
permanent disability, along with great social and 
economic hardship.262 Leading causes of injuries include 
road traffic crashes, drowning, poisoning, falls, burns, 
and violence.262 Again, the burden falls disproportionately 
on the poor, and more than 90% of injury-related deaths 
occur in low-income and middle-income countries. 
Unsafe workplaces or dwellings expose people to high 
levels of injury risk: prominent incidents include the 
2012 Tazreen Fashion factory fire on the outskirts of 
Dhaka, Bangladesh, and the 2017 Grenfell Tower fire in 
London, UK. In both episodes, fire safety laws were 
substandard, poorly enforced, or both. In lower-income 
countries, countless women sustain debilitating injuries 
or death from unsafe cooking stoves. Around the world, 
injuries from the mining and extractive industries 
disproportionately affect men, and young men bear a 
disproportionate burden of motor vehicle injuries. Yet, a 
strong evidence base exists for legal interventions in 
injury prevention, with road safety being the most 
prominent example.
The UN General Assembly declared 2011–20 as the 
Decade of Action for Global Road Safety,263 and road 
safety is integrated into SDGs 3 and 11. Each year, 
1·24 million people die as a result of road traffic injuries, 
and a further 20 million to 50 million sustain non-fatal 
injuries.263 Road traffic injuries are the leading cause of 
death among people aged 15–29 years.264,265 Evidence 
shows that legislating on five key behavioural risk 
factors—speeding, drink driving, helmet use, seat belt 
use, and child restraint use—could significantly reduce 
this toll.266 The regulation of environmental and design 
factors, such as safer vehicles and roads, has also proved 
highly effective in preventing road crashes. Such 
interventions include energy-absorbing crumple zones 
on cars, passive restraints, visible roads with clear lane 
markings, traffic separation (eg, oncoming vehicles or 
bicyclists), and traffic calming (eg, roundabouts and 
speed bumps). However, few countries have system-
atically implemented laws that target behavioural risk 
factors and design features, or laws that implement best 
practices. In particular, low-income and middle-income 
countries often have substandard laws, and poor 
compliance and enforcement.267
Global health institutions can establish norms that 
promote the uptake of such laws. Efforts to define 
technical standards for safety and to conduct policy 
surveillance of national road safety laws can be effective in 
helping to spread better laws. For example, seatbelts are a 
proven way to reduce road traffic injuries and have been 
mandatory in northern Europe and the USA since the 
1970s.268,269 In 2004, the WHA adopted resolution 
WHA57.10, recommending that member states implement 
mandatory seatbelt laws. The following year, the UN 
General Assembly adopted its own resolution, A/60/5, 
similarly calling for mandatory seatbelt legislation. Since 
then, there has been a significant increase in the number 
of states that have legislated for national mandatory 
seatbelt use.270 Botswana, Cuba, and Kyrgyzstan had a 
notable drop in road fatalities after mandating seatbelt use 
for all vehicle occupants.
Wearing helmets can substantially reduce road traffic 
injuries, and laws mandating helmets for motorcycle 
drivers and passengers are making an impact around the 
world. The UK and many US states have had such laws in 
place since the late 1960s and early 1970s; however, many 
states in the USA have since repealed their helmet laws, 
which has significantly increased head injuries. Helmet 
laws have been proven to be highly effective, reducing the 
risk of head injuries by 69% and the risk of death by 37%.271 
In 1997, Taiwan introduced legislation making it 
compulsory to wear a motorcycle helmet. The government 
supported this legislation with, on one hand, a public 
information campaign, and on the other, strict fines for 
both riders and passengers.272 The results have been 
powerful: between 1991 and 2008, motorcycle-related 
deaths almost halved (from 7322 to 3646), despite an 
increase in both motorcycle use and crashes during the 
same period. In 2007, Vietnam introduced a similar law,273 
supported by large fines for non-compliance. The Ministry 
of Health in Vietnam and WHO reported that road traffic 
head injuries and deaths had decreased by 16% and 18%, 
respectively, 3 years after the law was introduced.274
When laws do not advance health with justice
When used effectively, law can be the foundation for 
sustainable, transformational social change. However, 
when used inappropriately, law can cause grievous 
harm—sanctioning discrimination and inequality, 
imposing barriers to access, creating intentional 
obfuscation, and increasing complexity. As we have 
reiterated throughout this report, law is only a tool, and its 
effectiveness depends on how this tool is used. 
Emphasising the risks that arise when laws do not have 
the characteristics set out above is important.
The criminal justice system has had a particularly 
tenuous relationship with public health. Criminal laws 
can provide a powerful incentive for behaviour change 
that improves public health, as in the case of road safety. 
However, too often, the criminal law is used in ways that 
cause harm to health and to dignity. The history of laws 
relating to mental health, substance abuse, sexual and 
reproductive health, sexually transmitted infections, and 
poverty are often particularly harmful.
Even with an ostensible public health objective, laws 
can institutionalise inequality, discriminate against 
already vulnerable populations, and remove opportunities 
for stigmatised populations to access testing and 
treatment. We see this most often where criminal laws 
are enacted to promote a moral norm, rather than to 
punish a harmful act. For example, numerous 
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international commissions have called for the de-
criminalisation of HIV exposure or transmission.275 The 
overly broad criminalisation of HIV non-disclosure, 
exposure, or transmission are not only contrary to 
established public health evidence, but have also been 
shown to negatively affect health outcomes.275,276 In many 
countries it is a crime for a person with HIV infection to 
have sex without disclosing his or her HIV status. In 
these settings, such laws are inequitably enforced, fail to 
meet any tangible public health objective —ie, reduce 
rates of HIV transmission277—and additionally, embed 
stigma and punish people for engaging in common 
behaviours such as sexual activity. The result is that 
individuals are driven underground, preventing them 
from accessing treatment, and potentially placing the 
broader community at risk.275
Similarly, criminal laws have also posed barriers to the 
treatment and rehabilitation of people who use drugs 
(panel 8).
Criminalisation can lead to people avoiding health (and 
potentially other needed) services for fear of arrest, and 
because of concerns about discrimination. Consequently, 
their health and wellbeing are harmed.
Another pertinent example involves people with mental 
disabilities incarcerated in the criminal justice system, 
rather than treated in a therapeutic environment. Studies 
of the US prison system show that “about 20 per cent of 
inmates have a serious mental illness, 30 to 60 per cent 
have substance abuse problems and, when including 
broad-based mental illnesses, the percentages increase 
significantly.”287 Most inmates placed in seclusion have a 
mental health disorder. Beyond lack of any therapeutic 
intent, incarcerating people with a mental health disorder 
results in further marginalisation and discrimination of 
an already vulnerable group (panel 9).
The criminal justice system can be especially unfair to 
women, particularly with regards to sex work and 
reproductive health. Laws criminalising sex work are 
globally ubiquitous. Sex workers are a highly 
marginalised group, and the illegality of their work often 
results in scant protection against abuse, violence, and 
financial extortion.300 The criminalisation of sex work 
virtually eliminates the negotiating power of people 
engaged in sex work. Criminalisation makes it harder for 
sex workers to negotiate safe sex with their clients, and it 
increases the risk of violence, because sex workers are 
deterred from reporting violence to police. Some 
jurisdictions, such as New Zealand, have legalised sex 
work, but both legalisation and decriminalisation are 
controversial and politically difficult.
In many jurisdictions, reproductive choice and health, 
including access to safe contraception and abortion, are 
threatened. Despite WHO guidance, many countries 
have criminalised abortion and restricted family plan-
ning, and in some countries, women are imprisoned for 
involuntary miscarriage.301 A 2016 study found that 
“abortion rates are not substantially different across 
groups of countries classified according to the grounds 
under which abortion is legally allowed.”302 However, the 
study did find “the level of unmet need for contraception 
is higher in countries with the most restrictive abortion 
laws than in countries with the most liberal laws, and 
this contributes to the incidence of abortion in countries 
with restrictive laws.”302
Laws that restrict or penalise reproductive health 
programmes and family planning not only cause stigma, 
but can also undermine public health messages. Several 
Latin American countries restrict reproductive rights. 
These restrictions caused major concern during the Zika 
epidemic, given fears about neurological disorders and 
neonatal malformations.303 Countries in the Americas 
have observed an increase in babies born with micro-
cephaly, with a clear association between microcephaly 
Panel 8: Effects of the criminalisation of drug use on health and justice worldwide
Control of the cultivation, trafficking, and use of illicit drugs is an issue of global concern. 
The international legal drug control system is comprised of three treaties: the Single 
Convention on Narcotic Drugs of 1961, the Convention on Psychotropic Substances of 
1971, and the UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988. Countries have a two-pronged obligation: to ensure adequate 
availability of drugs for medical and scientific purposes, while also preventing illicit 
production, trafficking, and use of such drugs.278 Although the drug conventions require 
governments to take steps to reduce supply and demand for controlled drugs, these 
efforts must be balanced with countries’ human rights obligations,279 including their 
citizens’ rights to health, dignity, and freedom from arbitrary detention.
The UN Office on Drugs and Crime has stated that the UN drug conventions do not 
require penalisation of drug use or drug possession for personal use,280,281 and the system is 
grounded in a health framework explicitly stating that the “health and welfare of 
mankind” is its overarching concern.282 Despite this, countries across the globe use 
criminal law measures to try and address the reduction of demand prong of their 
obligations—including 33 countries that maintain the death penalty for drug-related 
offences.283 In many countries, sentences for minor drug dealing are longer than sentences 
for serious acts of violence such as murder, rape, or armed robbery,284 and people 
imprisoned on drug-related charges make up a substantial proportion of prison 
populations worldwide.282 In many countries, punitive drug control efforts have resulted 
in serious human rights abuse, including torture and ill treatment by police, mass 
incarceration, extrajudicial killings, arbitrary detention, and denial of essential medicines 
and basic health services.282
The criminalisation of drug use has facilitated the spread of blood-borne viruses, 
particularly HIV, among drug users. Some of the most severe drug-related harms are 
associated with injecting drug use. Outside of sub-Saharan Africa, up to 30% of all new 
HIV infections occur among people who inject drugs with unsafe injecting practices.285 
In fact, HIV prevalence in countries that rely on punitive approaches is substantially 
higher (37–42% vs less than 5%) than countries that use public health approaches to drug 
use.275 Furthermore, criminalisation has also been used to limit access to treatment 
options. Drug control efforts often have a disproportionate effect on vulnerable groups 
and marginalised communities, including indigenous populations, the poor, and racial or 
ethnic minorities.286 In some countries, including the USA, treatment for hepatitis C has 
been restricted on the basis of a person’s active injecting status. Criminalisation has also 
resulted in reduced access to disease prevention interventions, and proliferation of 
high-risk drug use behaviours in the absence of accessible harm reduction technologies.
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and exposure of the mother to Zika virus during 
pregnancy.304 In 2016, WHO recommended that women 
in countries where Zika virus infection is a threat should 
delay pregnancy for several months to several years.305 
However, at the same time, several affected countries 
have strict barriers to accessing abortion, including laws 
that criminalise abortion for any purpose.306 Women are 
consequently placed in an untenable position and can 
face a violation of their human rights. Such laws 
endanger the health of women, especially those who seek 
unsafe abortions because of the lack of access to legal 
abortion services.
Laws in other realms can also adversely affect the 
public’s health. Many countries ban or restrict access to 
health services for non-nationals—particularly, but not 
only, undocumented immigrants. The law can also 
undermine the health of migrants in other ways. For 
example, immigration laws often require deportation of 
non-citizens infected with tuberculosis, which drives the 
population underground (panel 10).
Panel 9: Law as a tool to support improvement of mental health disorders
WHO defines mental health as “a state of well-being in which 
every individual realises his or her own potential, can cope with 
the normal stresses of life, can work productively and fruitfully, 
and is able to make a contribution to her or his community”.288 
The WHO and Institute for Health Metrics and Evaluation 
category of mental health and substance use disorders 
encompasses several conditions including depression, anxiety, 
bipolar disorder, eating disorders, schizophrenia, intellectual 
developmental disability, and alcohol and drug use disorders.
Globally, the burden of mental health disease is substantial. 
Approximately 15–20% of the world’s population have one or 
more mental or substance use disorders;289 in 2016, 
approximately 1·1 billion individuals had a mental or substance 
use disorder. Some argue that the true burden of mental health 
and substance use disorder is even higher because of factors such 
as difficulties in accurate measurement and reporting, along with 
challenges in categorisation of overlapping conditions.290
Mental health is neglected in most countries, particularly in 
relation to physical health conditions. Individuals with mental 
health disorders face pervasive stigma and discrimination, 
resulting in considerable disparities between the services 
available for physical and mental health, with decreased 
availability, accessibility, and quality of mental health services.290
Although countries vary widely in access to mental health 
services, even the best performing systems have yet to meet the 
need, leaving a wide treatment gap between the need for 
treatment and actual service delivery. Estimates range from 76% 
to 85% of people with mental disorders not receiving treatment 
in low-income and middle-income countries, compared with 
50% of comparable individuals in high-income countries.291
WHO has identified the development of mental health policies 
and laws that promote human rights as crucial to the 
protection of people with mental health disorders, observing 
that such policies and laws are inadequate in most countries.292 
WHO’s Mental Health Action Plan 2013–20 set a target that 
50% of countries should have developed or updated their 
mental health laws in line with international and regional 
human rights instruments by 2020.293
Although successful mental health policy involves myriad 
components, a foundational issue is access to affordable, 
quality mental health services, which requires laws supporting 
such access along with adequate funding for services. 
Historically, countries devoted their scarce mental health 
resources almost exclusively to high-cost inpatient services for 
relatively few acute cases, which has contributed to the 
treatment gap. As evidence has shown the effectiveness of 
community-based outpatient treatment and integration of 
mental and physical health services, countries are slowly 
transitioning their laws and policies accordingly.
A notable example is the UK’s Improving Access to Psychological 
Therapies (IAPT) programme. Initiated in 2008, the IAPT 
programme provides evidence-based outpatient services to 
people with anxiety or depressive diagnoses. The programme 
has several unique features, including mandatory use of 
standardised evidence-based protocols with intensive clinical 
supervision and, crucially, providing the services free of charge 
at the point of care.294 The UK invested £400 million in the 
programme from 2011 to 2015, and data indicate that about 
950 000 people per year access IAPT for an initial assessment, 
of whom more than 537 000 receive therapy.295 This increase in 
access has helped narrow the treatment gap by improving 
treatment rates for adults with anxiety or depression from 
24% in 2007 to 37% in 2014.294, 296
Another example of a law designed to improve mental health is 
India’s Mental Healthcare Act of 2017, a broad bill that seeks 
explicitly to comply with the UN Convention on the Rights of 
Persons with Disabilities. India has traditionally underfunded its 
mental health services, spending only 0·06% of its total health 
expenditures on outpatient mental health care,297 and has a 
severe shortage of mental health providers, even when 
compared with other low-income and middle-income 
countries.298,299 Among the new law’s provisions is a 
requirement that insurers cover mental and physical health 
services in parity, which supporters hope will help combat the 
stigma surrounding treatment and lead to improved mental 
health outcomes.
The ongoing stigma surrounding mental health conditions and 
continued shortfalls in funding mean that change will come 
slowly, but the actions of countries such as the UK and India 
show that targeted laws can help speed progress toward 
improved mental health outcomes, particularly when coupled 
with adequate resources.
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People who fear deportation are unlikely to seek testing 
and treatment, placing infected individuals and the wider 
public at risk. Moreover, by interrupting continuity of care, 
deportation can jeopardise tuberculosis treatment for 
those who have already started it, which risks resistance 
developing to first-line tuberculosis medications.310
Healthy people in healthy communities
A substantial body of evidence and learned experience 
shows that legal interventions can advance global health 
with justice. Around the world, law has been used to 
reduce health risks, examples of which include vector 
control and immunisation for infectious diseases, tobacco 
control, food reformulation, healthy built environments 
for non-communicable diseases, vehicle and road design, 
and increased road safety measures.
But the lessons of evidence and practice also run in the 
opposite direction. Too often, governments have used 
law for improper purposes, or with little consideration 
for the values of health with justice. In such cases, law 
can raise risks and create stigma. Inappropriate use of 
the criminal law has been deeply harmful in multiple 
spheres. For these reasons, policy makers should monitor 
and evaluate the effects of law on health and on justice. 
Legal determinant 3 encapsulates the need for ongoing 
evaluation of public health laws, ensuring that laws and 
Panel 10: The effect of international law on the health of refugees—the case of tuberculosis
Nowadays, the world is facing the highest levels of 
displacement on record.307 With an unprecedented 68·5 million 
people around the world forced from their homes—of whom, 
nearly 25·4 million are refugees and 10 million are stateless 
people—the origins and consequences of the displacement 
crisis remain some of the most formidable challenges of our 
modern time.307 Attempting to address the myriad challenges 
that face refugees and asylum seekers across the world, the 
international community, by way of international law and 
treaties, has sought to foster norms  on how countries treat 
refugees. The core instruments of international refugee law—
the 1951 Convention relating to the Status of Refugees, and the 
1967 Protocol308—provide protection for refugees by 
prohibiting refoulment of refugees, or forcible returning of 
refugees to places where they fear for their lives or freedom.309
Although the law has taken important steps to protect the 
wellbeing of refugees, profound gaps persist and negatively 
affect the rights and experiences of refugees, particularly with 
respect to health. Yet even more troublingly, laws and policies 
themselves can hinder health outcomes and contravene well 
established public health principles. This twin dynamic of 
unmet need and avoidable harm is exemplified in national laws 
and policies surrounding refugees and tuberculosis.310
From the start of the journey, through to arrival at the country 
of asylum, refugees and others who are subject to forced 
migration are susceptible to contracting tuberculosis. This 
vulnerability begins with refugees’ experiences in their home 
country, where health-care infrastructure might be lacking or 
have broken down because of war. For example, before the 2011 
crisis began, Syria had a relatively low burden of tuberculosis.311 
Although data regarding tuberculosis in Syria remains elusive, 
reports show a rapid rise of the disease in the country, which is 
still believed to only be a fraction of the actual burden.311,312
After refugees leave their home country, the journey 
exacerbates their susceptibility to tuberculosis. Economic, 
social, and legal barriers increase the likelihood that tuberculosis 
will spread along the way and block access to care for those who 
contract it. These barriers, in turn, can lead to increases in the 
prevalence of tuberculosis in countries of asylum. Lebanon has 
been a country of asylum for Syrian refugees from the start of 
the conflict in 2011.313 In the first year of receiving Syrian 
refugees, Lebanon saw a 27% increase in tuberculosis cases.311
Reflecting this dynamic, countries enact national laws and 
policies regarding migrants and tuberculosis. For instance, 
some countries will not provide essential medical services to 
migrants with tuberculosis, some have legal requirements that 
individuals with tuberculosis undergo treatment as a condition 
of attaining legal status, and many detain and deport 
individuals who have or develop tuberculosis, frequently 
without providing necessary treatment.310 In the USA, active 
tuberculosis is still one of the communicable diseases that 
trigger inadmissibility under the Immigration and Nationality 
Act, though a waiver may be possible.314 These national 
restrictions based on tuberculosis claim public health as a 
justification, but directly contravene established public health 
principles and violate international law.
The WHO emphasises that screening of migrants, including 
refugees, for active or latent tuberculosis “should always be 
done with the intention to provide appropriate medical care, 
and never to exclude or preclude entry”.315 Because tuberculosis 
is preventable, treatable, and curable, public health principles 
guide the international community towards identifying and 
treating every individual with active tuberculosis, regardless of 
location, immigration status, or socioeconomic status.310 This 
approach builds on the experience of countries’ HIV and AIDS 
responses and the International Health Regulations, which call 
for any measure to prevent the spread of an infectious disease 
to use the least restrictive means possible.316
With respect to international law, countries have a right to 
exercise their sovereignty in imposing immigration 
restrictions.317 However, international law requires that states 
only undertake measures that are consistent with human rights 
and other international obligations. These obligations include 
non-discrimination on the basis of other status, which includes 
health status. If states do indeed opt to limit rights, states must 
show that the limitations are necessary to achieve a legitimate 
aim, that the means achieve the stated aim, and that they are 
the least restrictive means.318
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their implementation are evidence-based, fair, inter-
sectoral, and transparent. Laws that promote human 
rights, particularly the right to health, can be 
transformative; however, those that violate human rights 
can be deeply harmful.
Despite the firm foundation of the right to health in 
international law, the persistence of unconscionable 
health inequities and the lack of accountability to health 
commitments have led to calls for a new treaty on the 
right to health. The Framework Convention on Global 
Health (FCGH), an idea first suggested a decade ago, is a 
major proposal for a treaty based on the right to health.319 
The FCGH has since been supported by a growing 
number of civil society organisations, as well as national 
and global health leaders,320,321 with this movement now 
crystallised through the FCGH Alliance. The FCGH 
would reinforce norms of equity, justice, and human 
rights; create mechanisms for inclusive participation, 
cross-sector cooperation, and accountability; and delineate 
national and global responsibilities for sustainable 
financing.322 Rather than a piecemeal approach to discrete 
global health challenges, the FCGH would function as an 
overarching, rights-based framework under which all the 
vital components of the right to health could be realised, 
with additional protocols where needed to fill gaps. The 
FCGH would respond to the SDGs call for governments 
and international institutions to “leave no one behind.”
When research tells us that an intervention works, 
and when governments operate on the basis of sound 
scientific evidence and the rule of law, it becomes 
possible to create the conditions in which people can 
achieve health with dignity and human rights. Healthy 
populations and healthy communities start with the 
enactment and implementation of effective and just 
public health laws. Recommendation 4 urges govern-
ments to form country-appropriate mechanisms to 
advise on legal interventions that will impact the 
public’s health and safety. These might take the form of 
national health law commissions, task forces, or other 
structures, with the aim of developing a systematic 
plan to identify and propose effective legislation. As 
part of this process, we also recommend that govern-
ments adopt legislation requiring HIAs for policies, 
programmes, and projects that might seriously 
affect health.
At the international level, recommendation 4 proposes 
that WHO use its constitutional law-making powers to 
adopt further international legal instruments to 
safeguard the public’s health and safety. This approach 
would build on the successes of existing instruments, 
while also addressing deficiencies, and aim to understand 
and improve underserved areas such as mental health.
Section 5: legal determinant 4
Our final legal determinant of health underpins all the 
others: building and strengthening legal capacities for 
health. Robust legal architecture and resources for 
enacting, implementing, and monitoring public health 
legislation can bring to fruition all the legal determinants 
of health. Law and health should be mutually reinforcing, 
but the two fields often do not work synergistically, 
whether in research, practice, or philosophical 
orientation. In this section we make the case for, and set 
out the key features of, the legal capacities required to 
achieve health with justice.
Why build capacity?
Strong legal capacity for health will be a key determinant 
of progress towards global health and sustainable 
development. Yet, too often, countries lack the basic legal 
infrastructure or the capacity to build it. The WHO 
report, Advancing the right to health: the vital role of 
law,86 put forward several reasons why legal capacity 
building is essential.
First, the report states that over time, laws have become 
outdated, fragmented, ambiguous, or incoherent. 
Therefore, health officials might lack the mandate and 
legal powers to implement new, evidence-based 
inter ventions. Outdated laws and existing interventions 
might stigmatise or penalise vulnerable individuals and 
communities, driving epidemics underground. Secondly, 
new and emerging health hazards might require new 
legislative frameworks. Public health laws are often 
introduced reactively, and then stay on the books for 
decades. In the face of emerging threats—whether novel 
pandemics, or new paradigms such as non-communicable 
diseases—these laws might not be fit for purpose. 
Conversely, an ambitious goal like achieving UHC calls 
for forward planning and proactive regulation. The WHO 
capacity building report also stated that governments 
might lack the legislative and regulatory tools to discharge 
their public health and human rights responsibilities 
effectively. Public health officials need a wide-ranging set 
of powers to carry out their responsibilities to safeguard 
the population. At the same time, the law must protect 
the civil and political rights of individuals, as well as their 
social, economic, and cultural rights, including non-
discrimination and equal protection under the law. 
Protecting such rights is particularly relevant to achieving 
the SDGs, in which health, development, and human 
rights are closely intertwined.
In settings where  regulatory and governance capacity is 
lacking, laws intended to protect the public’s health might 
be poorly drafted or ineffectively implemented. In the 
absence of a sound legal infra structure, the law might 
even undermine health goals.
How do we define legal capacity?
The term capacity building (or capacity development) 
originally comes from the lexicon of sustainable 
development.323 Capacity can include “infrastructure, 
institutions, human knowledge and skills, and collective 
attributes such as social relationships, leadership and 
management.”324 The UN Economic and Social Council 
For more on the FCGH Alliance 
see https://www.fcghalliance.org
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defines capacity development as “the process by which 
individuals, organizations, institutions and societies 
develop abilities to perform functions, solve problems 
and set and achieve objectives.”325
Just as public health requires governments to invest in 
health systems, it also requires investment in regulatory 
capacity and effective legal environments.86 Legal capacity 
for health refers to three interlinked dimensions: effective 
legal environments (which include the infrastructure for 
drafting, implementing, and enforcing laws that promote 
health with justice, as well as fairly resolving grievances 
that arise); a strong and growing evidence base, built on 
the rigorous monitoring and evaluation of existing laws; 
and an empowered, transdisciplinary health law 
workforce. The latter includes connected networks of well 
trained professionals—legal and non-legal—who share 
information and strategies, and who provide technical 
legal assistance.16 Building capacity means attending to 
each of these dimensions (figure 5).
An effective legal environment: a process, not an 
endpoint
Enacting a good health law is only the first step towards 
building an effective legal environment. Laws that are 
defined as on the books must be supported by effective 
processes for their drafting (including public partici-
pation), implementation, enforcement, monitoring, 
eval uation, and ultimately their revision or repeal 
where necessary (figure 6). Ongoing evaluation and 
continuous quality improvement lead to legislation and 
regulations that demonstrably improve the public’s 
health and safety.
Drafting and enacting public health law
The most visible aspect of an effective legal environment 
for health is so-called law on the books—the group of 
enacted laws and regulations that makes up public health 
law. Traditionally, the focus of public health law was on the 
management of unsanitary environmental conditions 
(eg, drains, water, food, and housing), and the control of 
infectious diseases.17 Nowadays we recognise that public 
health law encompasses a far wider range of topics. 
Specific public health laws include “laws that are intended 
as health interventions, laws that define the powers, duties 
and boundaries of health agencies and systems, and laws 
that have an impact on health but were not enacted 
primarily with population health in mind”.5 Examples for 
each of these categories are provided (panel 11).
From pandemic responses to the prevention of non-
communicable diseases, law on the books is a crucial 
determinant of what is achievable: empowering and 
obligating agencies to safeguard the public’s health, but 
also protecting individual rights by placing limits on 
government and private action.
Governments first need capacity to write and enact 
laws and regulations. Such drafting should ensure that 
laws are comprehensible and systematic; adhere to 
principles of good governance and sound regulation, 
such as being developed through transparent processes 
with public participation; are evidence-based; are 
transparent and clearly communicated to the public, 
setting out health officials’ powers and responsibilities, 
as well as their limits; are consistent with, and supportive 
of human rights; and promote equity. Many of these 
features are addressed in sections of this report.
Effective legal environments, like effective health 
environments, require transparency and accountability. 
Effective legal environments give affected populations 
and civil society organisations meaningful opportunities 
to participate in the decision-making process. Translating 
the goals and processes of health laws from the 
immediate context of policy makers and legal or health 
practitioners, to the wider public and the organisations 
that represent their interests, is crucial. This idea goes far 
beyond education or health promotion: rather, it means 
that affected communities should be genuine partners 
in, rather than targets of, health policy.
Figure 5: The overlapping dimensions of legal capacity building for health
Figure 6: Features of an effective legal environment
Effective legal environment
Empowered health law
workforce
Strong evidence base
Drafting and enacting law; 
public participation
Implementation, 
enforcement, monitoring
Evaluation
Revision (repeal if necessary) Law on the books
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The global response to HIV and AIDS provides the 
most powerful illustration of community mobilisation. 
In the face of stigma, discrimination, and neglect, 
advocates raised social and political awareness, which 
ultimately generated the political will to take action. They 
demanded high quality research into the prevention and 
treatment of HIV infection. When interventions were 
developed, they advocated for the right to affordable 
access throughout the world. The response to HIV and 
AIDS is, of course, an ongoing struggle, and is only 
one major health hazard among the many that urgently 
require social mobilisation.
In areas where civil society voices are not yet sufficiently 
empowered—for instance, for non-communicable dis-
eases,326 injuries, or mental health—governments should 
actively seek public involvement in policy making, using 
public announcements, open forums, and public com-
ment sessions. Consumers and health advocates should 
be invited to attend important meetings as partners 
alongside public officials, health professionals, and 
scientists. These governance mechanisms can incentivise 
public participation and help “dispel potential concerns of 
suspicion or mystification that might surround the 
development of public health laws”.327
Public participation and open forums also enable civil 
society to understand the purpose of health law and 
engage more effectively in the policy process. In turn, 
this can support adherence to the norms and standards 
established by health laws. For example, in Denmark, 
public health groups worked with the government, 
industry bodies, and civil society organisations, to raise 
public awareness of the cardiovascular risks of 
consuming artificial trans fats.328,329 This type of public 
engagement meant that when regulation limiting these 
harmful fats was introduced in 2003, it already had a 
high level of public confidence and support, and strong 
industry compliance—ultimately leading to a successful 
public health legal intervention.
Public participation can also mean opening the door to 
powerful vested interests. New York City’s regulation 
Panel 11: Public health laws
Laws intended as health interventions
•	 Standards:	food	safety;	consumer	protection;	air	quality;	
drinking water; drugs, cosmetics and medical devices; 
pesticides; occupational health and safety; road safety; 
hygiene and sanitation; vector control
•	 Regulation	and	licensing	of	tradespersons	and	professionals:	
health workers; social workers; hair and nail stylists; tattoo 
artists
•	 Regulation	and	inspection	of	premises:	hospitals	and	
nursing homes; bars and restaurants; food markets; 
docks; swimming pools; tattooing and tanning 
establishments
•	 Pest	and	animal	control:	vector	abatement	
(eg, mosquitoes, fleas, and rodents); dangerous or exotic 
animals
•	 Infectious	disease	response:	vaccinations;	testing	and	
screening; isolation and quarantine; contact tracing and 
partner notification; directly observed therapy
•	 Tobacco	control:	age	limits,	smoking	bans	in	public	places;	
taxation; advertising and marketing bans and restrictions; 
packet labelling (or warnings) and plain packaging; bans on 
cigarette flavouring; nicotine reduction
•	 Alcohol	control:	age	limits;	restrictions	on	marketing	and	
advertising, package warning labels; prohibiting driving 
while intoxicated
•	 Mental	health	laws:	guardianship	and	civil	commitment;	
mandatory or community treatment; rights protections
•	 Promoting	healthy	diets: nutrition labelling on food 
products and restaurant menus; regulation of junk food 
advertising aimed at children; regulating food ingredients 
(eg, limits on trans fatty acids, added sugars or sodium); 
portion size limits; taxes on unhealthy foods (eg, sugar-
sweetened beverages)
Laws that define the powers, duties, and boundaries of 
health agencies and systems
•	 Laws	establishing	and	governing	public	health	agencies,	
including mission, powers, limits
•	 Laws	establishing	and	governing	health-care	agencies,	
including quality assurance, eligibility for services, essential 
medicines list, reimbursement for services
•	 Laws	protecting	patients’	and	service	users’	rights	and	
privileges
•	 Privacy	laws	governing	data	held	by	health	agencies	and	
health-care providers, including data protection and 
confidentiality
Laws that have an effect on health, but were not enacted 
primarily with population health in mind
•	 Planning	and	zoning	laws:	walking	and	biking	paths;	parks,	
playgrounds, and recreation; pedestrian zones and 
congestion taxes; limiting fast food outlets and encouraging 
supermarkets
•	 Firearms	regulation:	weapons	bans	(eg,	automatic	discharge	
firearms); smart firearms (eg, discharge only with owner’s 
fingerprints); safe gun storage; firearms training; 
background checks prior to purchasing
•	 Social,	welfare,	and	housing	services	and	programmes:	child	
protection and benefits; community centres (for the elderly 
or vulnerable) and support groups (for drug or alcohol 
dependency); pensions and disability benefits; income 
supports; nutrition programmes; public and subsidised 
housing
•	 General	taxation:	progressive	tax	structures;	negative	
income taxes; deductions for health care, child care, and 
public transportation expenses; eliminating tax havens or 
loopholes; fair and efficient tax collection
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limiting the portion size of sugary drinks (known 
popularly as the soda ban) received a great deal of 
community opposition. However, research subsequently 
showed that much of this opposition was led by 
organisations supported by the sweetened beverage 
industry.330 The American Beverage Association (with 
Coca-Cola and PepsiCo as members) spent millions of 
dollars swaying public opinion against the soda ban, and 
ultimately succeeded in having the courts strike down the 
measure. Elsewhere, the food industry has spent lavishly 
to influence legislative processes on issues ranging from 
menu labelling to taxes on sweetened beverages.331
Furthermore, as sales of unhealthy foods in higher-
income countries have begun to lag, food companies are 
expanding their markets in developing countries by 
targeting community networks. An exposé in The New 
York Times,332 describes the use of direct marketing by 
multinational Nestlé to sell sugary foods to poor people 
in Brazil, under the guise of nutrition and community 
empowerment. These grassroots efforts take place while 
food and beverage conglomerates enjoy an enormous 
amount of political and economic power in Brazil.
Policy makers must be alert to the risk that genuine 
community voices are likely to be weaker, less organised, 
and less well-funded than commercial players with 
substantial interests to defend. As such, governments 
should empower civil society organisations to meaningfully 
participate in the development of health laws. Health 
advocates also need to anticipate industry opposition and 
build broad-based community coalitions for health.333
Implementation: inspections, monitoring, and enforcement
Effective legal environments are supported by systems of 
monitoring, inspections, and tools for enhancing 
compliance with public health laws and regulations. A 
range of different professions—including public health, 
food and drug, and environmental health officers; 
medical and nursing practitioners; scientists; and even 
police in certain contexts17 —will have responsibility for 
monitoring and enforcing public health laws. These 
professionals exercise statutory powers as health officials, 
officers, or inspectors. For the purposes of enforcement, 
these powers usually include a range of responsibilities, 
described as follows: inspect and search premises or 
goods—eg, to ensure safe workplace environments, 
purity of food and drugs, or sanitary conditions of farms 
or restaurants;327 issue orders to cease and desist unsafe 
conditions or activities, such as pest or animal abatement; 
issue formal notices of failure to comply; levy and collect 
fines; confiscate unsound goods; shut down unsafe 
businesses or premises; sanction professionals for poor 
quality or safety lapses, including the loss of a licence, 
permit, or accreditation needed to legally operate; publicly 
disclose instances in which there has been a failure to 
adhere to public health standards, such as by issuing 
prominent notices on restaurants of their sanitation and 
hygiene rating; and finally, engage in dispute resolution, 
when there is a legitimate disagreement between 
regulators and the regulated party.327
Where disputes arise, the court system or other means 
of redress must be empowered to impartially adjudicate 
disputes, ensuring fair application of the regulations, 
and allowing regulated professionals or industries to 
contest decisions.
Research and evaluation
Ongoing monitoring and evaluation of the effects of laws 
and regulations are crucial steps in the process of 
ensuring effective legal environments for health, but are 
often overlooked. Because law has the power to affect 
diverse populations in different ways, it is crucial that 
policy makers rely on evidence, whenever possible, to 
distinguish between laws that work, laws that do not 
work, and laws that cause harm. Yet, nowhere else in the 
realm of public health are interventions used to treat so 
many people with so little evaluation of the effects.201 A 
few exception areas, including alcohol and tobacco 
control, have showed the importance of evaluation in 
developing and spreading highly effective legal solutions. 
In the following section, we focus on a second dimension 
of legal capacity for health: a strong evidence base.
A strong evidence base, informed by the values of 
justice and equity
Health laws and regulations should be informed by a 
robust body of evidence regarding their effectiveness in 
reducing risks of injury and disease. In this section, we 
make the case for strengthening the evidence base in 
relation to the design and use of health law research. At 
the same time, we acknowledge the important role of 
values in health policy innovation. As we have noted 
throughout this report, public health is not simply the 
application of technical solutions to health problems. 
Rather, it is unabashedly infused with the values of social 
justice and grounded in the language and practice of 
human rights. Although we recognise that the law-
making process is embedded in politics, we urge policy 
makers to critically evaluate existing evidence, support 
ongoing health law research, and prioritise the right to 
health and other human rights.
Health laws must be based on robust evidence
Since the turn of the 21st century, public health law as a 
field of scholarship has undergone a renaissance: its 
philosophical orientations, conceptual frameworks, and 
core debates have been well articulated.15 Building on 
this, researchers and policy makers are now recognising 
the growing need for empirical research. Empirical 
research can relate to any of the stages in figure 6—from 
the design of laws, to their monitoring and enforcement—
and aims to answer the questions: which laws or practices 
are associated with better health outcomes? Which laws 
or practices are associated with worse health outcomes? 
Which laws impose undue burdens, particularly on 
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disadvantaged populations? How can these laws or 
practices be improved, for population health and the 
protection of human rights?
Law is rarely amenable to what scientists regard as the 
so-called gold standard of evaluation, which is the 
randomised clinical trial. Nevertheless, the impact of law 
can be studied scientifically, the study of which leading 
scholars describe as legal epidemiology.334 Legal epid-
emiology aims to study law as a variable that can affect 
health outcomes. For example, it might rigorously 
examine whether a law is correlated with a particular 
health outcome, or compare outcomes in jurisdictions 
that have implemented similar or different laws—noting 
that contextual factors will mean that success in one 
jurisdiction will not necessarily predict success in a 
neighbouring jurisdiction. Comparison of health effects 
before and after implementation of a law is also a useful 
research tool. Health law research can also survey those 
who implement laws, and those affected by them, to 
ascertain their effects on the ground.
Empirical health law research employs scientific, 
quantitative methods to assess the effect of laws and to 
improve their design. Such empirical research methods 
include evaluating the policy-making process, so-called 
mapping particular categories of laws or regulations, 
examining how laws are implemented and enforced in 
practice, intervention studies, and close analysis of the 
legal mechanisms of particular interventions.334 Beyond 
strengthening the evidence base, this type of research 
can have far-reaching social and political effects. Research 
findings can strengthen political and public support for 
the enactment of particular health laws (by giving an 
evidence-based rationale for their implementation) and, 
at a deeper level, can also help strengthen the 
philosophical and practical linkages between law, health, 
development, and related disciplines.
A persistent reason for public opposition to health 
laws lies in the claim that they are paternalistic: an 
intrusion by the so-called nanny state onto individuals’ 
freedom to choose what to eat or how to behave. 
Opponents argue that certain public health laws force 
individuals to act in ways they would not otherwise 
choose—such as compelling them to wear a motorcycle 
helmet or raising the price of sugary drinks. Health 
advocates can use normative reasoning to address claims 
of paternalism—arguing, for example, that these laws 
increase wellbeing and reduce health-care costs. 
However, objective evidence of positive behaviour 
changes that improve health can be a more powerful 
counter to such so-called nanny state arguments.
Well designed studies often require access to large 
datasets, medium-to-long-term funding and perhaps most 
importantly, a workforce of interdisciplinary researchers.335 
Universities, which have played an important role in the 
expansion of global health as a discipline,6 can help to 
build such a workforce by offering health training to legal 
graduates, and legal training to health professionals. As a 
global health community, we need to set, and drive 
forward, a clear and ambitious research agenda. We need 
to build consensus on the key questions that require 
answers and the laws in most urgent need of evaluation, 
and to prioritise resources accordingly.336 Given that 
society invests substantial political and economic capital 
in enacting and enforcing public health laws, devoting 
resources to enable high-quality research into their effects 
would be worth the investment.
But evidence is not the only consideration
Even as we advocate for high-quality empirical research 
on the relationship between law and health, we recognise 
that evidence is only one important aspect of a well 
regulated society. Policy makers often must act on the 
basis of incomplete scientific information, taking social 
values into account. In some cases, the call for full 
objective evidence before enacting any public health 
intervention can stifle innovation. If a new law represents 
a sharp turn from accepted practice, the case for reform 
will often require building an evidence base over time.
In settings where law makers have good grounds for 
believing that legislation will have positive effects, and 
have a plan for ongoing evaluation, they should have the 
leeway to introduce novel ideas. For example, following 
the first case of HIV transmission via drug-injecting 
equipment in 1985, Australia quickly introduced a Needle 
and Syringe Programme (NSP). The NSP provided 
sterile drug injection equipment and facilities for the 
safe disposal of used equipment. The programme also 
became a first point of contact between injecting drug 
users and health services, providing education, 
information, and onward referrals to drug treatment, 
medical care, and legal and social services.337
Evaluations of NSPs in Australia found them to be “the 
single most important and cost-effective strategy in 
reducing drug-related harms among [persons who inject 
drugs]”,338 and the programme has been endorsed by 
WHO, UNAIDS, and the UN Office on Drugs and Crime. 
Yet initially, experts and policy makers faced intense 
opposition. The evidence was not watertight, but policy 
makers had to act decisively to stem a potential epidemic. 
In doing so, they were guided by human rights principles 
and the need to protect a susceptible community. Once 
adopted, programmes such as NSPs can and should be 
subject to rigorous empirical examination. As of 2019, we 
have robust evidence that NSPs help prevent the 
transmission of blood-borne diseases and save lives. As 
observed with so many public health successes, the lack 
of complete evidence did not act as a barrier to innovation. 
Therefore, governments should establish infrastructure 
to enable early, rapid, and systematic evaluation of 
innovative policy ideas.339
An empowered, transdisciplinary health law workforce 
Finally, effective legal environments are only possible 
with a knowledgeable and capable health law workforce. 
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As the linkages between global health and the law 
become stronger, the need for an empowered, 
transdisciplinary health law workforce will become 
more pronounced. Recognition of the potential for 
legislative and regulatory interventions to improve 
population health is growing; however, this is not 
matched by the availability of skilled professionals who 
can implement and evaluate such interventions.340 
Although difficult to quantify numerically, in our 
assessment, the deficit is marked. We identify three 
aspects central to building the necessary workforce 
capacity: building disciplinary bridges, building 
knowledge and skills, and building networks.
Building disciplinary bridges
Researchers and practitioners in law and in health have 
traditionally worked in quite distinct ways. In the 
medical profession, as in the wider public, 
understanding or recognition of the power of law to 
drive behavioural and social change is lacking. Health 
professionals might even have a negative view of the 
legal profession, perceiving lawyers as adversaries 
bringing malpractice litigation.340 For their part, lawyers 
can be protective of their turf and unwilling to 
acknowledge the limits of their subject-matter expertise. 
This silo mentality leads to missed opportunities for 
teaching, research, practice, and problem-solving. 
Colleges and universities are uniquely positioned to 
address this problem, but these institutions alone are 
insufficient to foster the necessary health law ecosystem. 
Building the empirical evidence base for effective health 
laws first requires building disciplinary bridges: mutual 
understanding, collaboration, common terminologies, 
and an appreciation of how different skill sets can be 
applied to public health problems. It also requires 
genuine interdisciplinary (or even trans disciplinary)16 
research, drawing on the expertise of legal scholars, 
epidemiologists, clinical scientists, policy analysts, 
behaviour change experts, and anthropologists, amongst 
others, working together.
Building knowledge and skills
The interdisciplinary or transdisciplinary nature of health 
law presents unique challenges for teaching and training. 
Nevertheless, equipping law graduates with health 
knowledge and epidemiological skills, and health 
graduates with an understanding of the role of law and 
governance in creating healthy environments, is crucial 
for building capacity. Both health graduates and law 
graduates should be introduced to the basics of inter-
national human rights law. Education in public health, 
law, and policy should include the range of skills needed 
in a transdisciplinary public health law practice, including 
policy development, basic principles of law and legal 
procedure, advocacy, ethics, implementation and enforce-
ment, and legal epidemiology.16,201 Schools of medicine, 
nursing, public health, and law can teach a broad 
curriculum encompassing a variety of trans disciplinary 
skills. These schools can also collaborate to offer joint 
degrees, such as a Juris Doctor with Master of Public 
Health or Juris Doctor with Doctor of Medicine.
Academic institutions have the opportunity to 
successfully deliver training and teach skills to help 
resolve specific health challenges—for instance for non-
communicable diseases, access to medicines, and 
injuries. Solutions to all of these complex health 
problems require a variety of scientific and legal skills. 
Progress in these areas can be achieved only if health 
advocates have access to the training and resources 
needed for deep under standing not only of the health 
hazard, but also of the legal rules and mechanisms that 
govern the particular field. Understanding the field of 
non-communicable diseases and the law requires a 
strong understanding of multiple other areas, including 
consumer law, marketing law, food law, tax law, and 
environment and planning law.341 Similarly, the law 
surrounding access to medicines requires understanding 
the linkages between trade law, intellectual property law, 
and health.340 Health advocates push for affordable access 
to medical technologies, but to be truly effective they 
need the acumen to understand the legal rules governing 
the pricing and regulation of vaccines and medicines.342
Health diplomacy is another crucial legal capacity. 
Whether at the national, regional, or global level, legal 
and health professionals must develop the skills and gain 
the experience needed to bridge often bitter ideological 
and political divisions to forge effective norms and 
standards. Health diplomacy requires the ability to 
genuinely listen to the concerns of stakeholders, while 
identifying common ground and finding fair and 
innovative ways to coax the parties toward consensus. 
WHO explains that global health diplomacy “brings 
together the disciplines of public health, international 
affairs, management, law, and economics, and focuses 
on negotiations that shape and manage the global policy 
environment for health”.343 Effective health diplomacy 
can operate at the national level (eg, negotiations over 
new legislation or regulations, especially where health 
considerations need to be integrated in non-health 
legislation) and at the trans national level (eg, negotiations 
over new health treaties, global action plans, or codes of 
practice). The complex negotiations over the FCTC, the 
IHR, or the PIP Framework all provide good examples of 
the need for skilful health diplomacy. Academic insti-
tutions can partner with governments and international 
organisations to fill these gaps in knowledge and skills. 
For instance, academic institutions could help train the 
workforce charged with implementing health laws and 
international agreements.
Building networks
Trained health law professionals must also have the 
opportunity to share knowledge, strategies, and expertise. 
This approach is of particular relevance in relation to 
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new and emerging areas of law, and in resource-
constrained environments. Many low-income and 
middle-income countries do not have a cadre of trained 
health law professionals, and health lawyers are also 
scarce in many high-income countries. In such cases, 
networks of experienced health lawyers could collaborate 
with local health professionals, lawyers, and policy 
makers to strengthen local capacities.
Training in health law could strengthen the contri-
bution of a variety of professions or groups to advancing 
health with justice. These include officials of international 
organisations such as WHO, the WTO, and the World 
Bank; officials in regional organisations such as WHO 
regional offices, regional alliances such as the Association 
of Southeast Asian Nations, the Organization of 
American States, or the European Union; policy makers 
and public officials in health or justice ministries who 
have responsibility for developing, implementing, or 
enforcing health laws and regulations; officials in other 
ministries, whose work could have an impact on public 
health (eg, agriculture, trade, urban planning, foreign 
affairs);86 front-line government workers who might be 
involved in enforcing health laws (eg, customs or taxation 
officials);344 personnel responsible for funding decisions, 
programmes, and policy making within health-related 
entities, such as non-governmental organisations, 
philanthropies and PPPs; lawyers who work closely with 
health agencies or programmes;336 and lawyers tasked 
with defending new health laws from legal challenges.
Network-building and collaboration have been 
especially important in cases where health advocates face 
powerful, organised resistance from vested interests. The 
FCTC explicitly calls for legal capacity building and 
knowledge sharing in litigating tobacco control cases, 
such as defending strong tobacco control laws or suing 
tobacco companies for deception or unfair marketing. 
These calls have been realised through the efforts of 
professional groups (eg, the so-called lawyer’s circle for 
tobacco control, which connects legal expertise in high-
income countries with that in low-income and middle-
income countries), civil society (eg, the Framework 
Convention Alliance, made up of 500 member groups 
worldwide), and philanthropies (eg, the Bloomberg 
International Legal Consortium, which provides 
resources for legal capacities in tobacco control). Earlier 
we mentioned food industry opposition to new laws 
facilitating healthier population diets. Ensuring that the 
food industry does not undermine efforts to protect 
public health could be another area in which cross-
jurisdictional networking would be particularly valuable. 
As multinational organisations expand their markets, a 
trained cadre of well-connected health lawyers can help 
guide health legislation, regulations, and litigation to 
ensure the public’s health and safety.
Public interest law organisations can act as centres of 
excellence, sharing their knowledge and expertise gained 
from grassroots experience. In South Africa, Section 27 
combines legal action with research and advocacy in its 
pursuit of human rights and social justice. Building on 
past success in mobilising legal and community action 
around HIV and AIDS, as of 2019, Section 27 focuses on 
access to health care, the right to food, and good 
governance. In India, the Lawyers’ Collective works at the 
intersection of health, human rights, and the law; fighting 
for access to medicines; and the rights of women, the 
lesbian, gay, bisexual, transgender and intersex com-
munity, and those living with HIV and AIDS.
In the USA, the Network for Public Health Law lawyers 
connects public health practitioners; local, tribal, state and 
federal officials; policy makers; public health advocates 
and organisations; and provides training and technical 
assistance.345 Its areas of legal expertise include overdose 
prevention, health data sharing, injury prevention, 
maternal and child health, and environmental health. In 
the USA, medical–legal partnerships bring together 
health, public health, and legal expertise for the benefit of 
patients, but also bring about systemic changes and 
improve population health.346 Medical–legal partnerships 
guide patients through the complex terrain of the health-
care system, enabling them to claim their rights and gain 
access to the services they need.
Strong capacity for an effective legal environment
Throughout this report, we have identified multiple ways 
in which the law can be a powerful instrument for the 
public’s health and justice, focusing on effective, 
coordinated, and strategic uses of law. Building legal 
capacity is the common denominator. Governments, 
international organisations, funders, non-governmental 
organisations, academic organisations, and other health 
institutions can take concrete, practical action to support 
states as they build legal capacity. Such measures fall under 
three interlinked dimensions: effective legal environments, 
which should be supported by a strong evidence base, and 
an empowered, transdisciplinary health law workforce.
Although all of our recommendations relate to capacity-
building, we have made four targeted recom mendations to 
a variety of institutional actors. In recommendation 5, we 
call on WHO to partner with governments, foundations, 
and civil society, to expand the evidence-base for public 
health laws (including research and information sharing), 
and support strategies to enact and implement national 
and global health laws that are effective and sustainable. 
Recom mendation 6 is for governments to build national 
capacities to enact and effectively implement public health 
laws. This relates to leadership, planning, funding, and 
professional training. Finally, in recommendation 7, the 
Commission offers to partner with The Lancet to create a 
standing commission on global health and the law, 
building on the momentum of this Commission.
Section 6: recommendations
In the following seven recommendations (summarised in 
panel 12), we propose a public health law action agenda 
For more on Section 27 see 
http://section27.org.za/
For more on the Lawyers’ 
Collective see https://www.
lawyerscollective.org/
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consisting of legal instruments, legal capacities, and 
institutional reforms as tools for achieving global health 
with justice. Our programme of action is based on 
principles of human rights and good governance, founded 
on the right to health. Overarching the specific aims in 
each recommendation, we intend these recom mendations 
to help foster conversations among policy makers and 
health workers, researchers, public health authorities, 
civil society, and others who work in global health.
Legal determinant 1
Recommendation 1 states that the UN, WHO, and 
international partners should set standards to support 
the implementation of, and objectively evaluate 
compliance with, SDG 3.8 (UHC), as well as the 
upcoming UN political declaration on UHC in 2019.
WHO should develop a joint external evaluation 
(modelled on the IHR’s JEE) of country compliance with 
SDG 3.8 and the UHC political declaration. Under the 
JEE, national and peer country stakeholders and external 
experts would evaluate UHC laws, regulations, and 
programmes against rights-based benchmarks, make such 
evaluations publicly available, and issue recommendations.
WHO or the UN should establish an international legal 
framework to ensure that high-income countries and 
other development partners provide the funding and 
expertise necessary for all countries to implement UHC, 
in line with their right to health obligations.157
Recommendation 2 states that governments should 
strengthen or create a legal framework, such as a 
constitutional or statutory right to health, to ensure 
rights-based UHC on the basis of principles of equity 
and non-discrimination, including affordability, financial 
protection, transparency, accountability, participation, 
privacy, and sustainable financing.
Governments should promote sustainable financing 
and financial protection by allocating an adequate share 
of GDP to implement UHC. They should ensure quality 
through accreditation systems for public and private 
sector health facilities, pharmacies, and professionals; 
inspection of health facilities; and drug and medical 
device approvals based on safety and efficacy. They should 
also prevent health sector corruption and misappropriation 
of resources by establishing strong public financial 
management systems and anticorruption mechanisms, 
and avoiding conflicts of interest.
Panel 12: Commission recommendations for the legal determinants of health
Legal determinant 1: using law to translate vision into 
action on sustainable development
Recommendation 1: the UN, WHO, and 
international partners should set standards to support the 
implementation of, and objectively evaluate compliance with 
SDG 3.8 Universal Health Coverage (UHC), as well as the 
upcoming UN political declaration on UHC in 2019
Who must take actionable steps: the UN, WHO, and 
international partners
Recommendation 2: governments should strengthen or create 
a legal framework, such as a constitutional or statutory right to 
health, to ensure rights-based UHC on the basis of principles of 
equity and non-discrimination, including affordability, financial 
protection, transparency, accountability, participation, privacy, 
and sustainable financing
Who must take actionable steps: national governments
Legal determinant 2: using law to strengthen the 
governance of national and global health institutions
Recommendation 3: the UN, WHO, and international partners 
should use their respective powers and influence to safeguard 
the public’s health and safety through the creation or adoption 
of good governance standards, embracing the highest 
principles of equity, inclusive participation, transparency, and 
accountability
Who must take actionable steps: UN, WHO, and international 
partners
Recommendation 4: governments should develop legal 
frameworks that establish principles of good governance 
throughout national health systems and policy making, form a 
country-appropriate mechanism to advise on legal 
interventions with high health impact, and adopt legislation 
requiring health impact assessments for policies, programmes, 
and projects that might seriously affect health
Who must take actionable steps: national governments
Legal determinant 3: using law to implement fair, 
evidence-based health interventions
Recommendation 5: WHO should increase its legal capacity to 
enable it to spearhead development of a global evidence base for 
public health laws and to support the enactment and 
implementation of national and global health laws that are 
effective and sustainable
Who must take actionable steps: WHO, national governments, 
foundations, and civil society
Legal determinant 4: building legal capacity for health
Recommendation 6: governments should build national 
capacities to enact and effectively implement public health laws
Who must take actionable steps: national governments
Recommendation 7: WHO and The Lancet should partner with 
legal and health experts to create an independent standing 
commission on global health and the law that would advance 
the health-related SDGs by proposing evidence-based legal 
interventions for addressing major global health challenges, 
reforms of the global health architecture and international law, 
and strategies to build and strengthen global and national 
health law capacities
Who must take actionable steps: The Lancet and WHO
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Legal determinant 2
Recommendation 3 advises that the UN, WHO, and 
international partners should use their respective 
powers and influence to safeguard the public’s health 
and safety through the creation or adoption of good 
governance standards, embracing the highest principles 
of equity, inclusive participation, transparency, and 
accountability.
The UN General Assembly should adopt a set of good 
governance standards, reflecting best practices in 
governing complex public institutions for UN specialised 
agencies such as WHO, civil society organisations, and 
others. These standards should ensure the operations of 
the institutions are consistent with the highest principles 
of equity and transparency. WHO should additionally 
establish an independent unit tasked with ensuring 
effective implementation of such governance standards.
As a normative agency with law-making powers, 
WHO should use these powers to adopt international 
legal instruments to safeguard the public’s health and 
safety, prioritising health threats in low-income and 
middle-income countries and developing compliance 
mechanisms. They should explore a global treaty 
focused on the right to health, equity, and accountability, 
such as the proposed FCGH.
Recommendation 4 suggests that governments should 
develop legal frameworks that establish principles of good 
governance throughout national health systems and 
policy making, form a country-appropriate mechanism to 
advise on legal interventions with high health impact, and 
adopt legislation requiring health impact assessments for 
policies, programmes, and projects that might seriously 
affect health.
Governments should develop national laws and 
regulations that safeguard inclusive participation in 
health-related decision making, from community to 
national levels, which require transparency. They should 
also establish mechanisms that ensure accountability, 
guarantee equitable distribution of health services, and 
require multi-sector action on health equity.
Governments should form a national health law 
commission, task force, or other structure to develop a 
systematic plan to identify and propose legislation with 
high impact on the public’s health and safety. The 
commission or other mechanism should base its 
recommendations on the best available evidence, focus 
on equity, propose repealing or reforming existing laws 
that undermine the right to health, and address the 
broader socioeconomic determinants of health.
Governments should develop HIAs through inclusive 
participation, with compliance, and reinforced by indep-
 endent oversight. These should analyse the anticipated 
impacts of health and non-health sector policies on 
health before implementation, should be regularly 
monitored, and where possible, should be enhanced 
with real-time assessments. HIAs should actively 
promote the public’s health and guide decision makers’ 
choices about available options to prevent injury and 
diseases.
Legal determinant 3
Recommendation 5 suggests that WHO should increase 
its legal capacity to enable it to spearhead development of 
a global evidence-base for public health laws and to 
support the enactment and implementation of national 
and global health laws that are effective and sustainable.
The WHA should provide WHO with the resources 
and political backing to develop WHO’s capacity to 
support member states in developing public health laws 
on the basis of evidence, equity, and human rights.
The WHO should increase its legal capacities to include 
a robust global network of well-trained experts, linking 
existing repositories and databases of national health 
legislation, and developing platforms and information 
systems. These changes would enable health lawyers, 
medical professionals, policy makers, and advocates to 
share information and strategies on laws and litigation, 
as well as increasing legal skill sets within the WHO 
Secretariat at headquarters, and at regional and country 
levels.
Legal determinant 4
Recommendation 6 states that governments should build 
national capacities to enact and effectively implement 
public health laws.
Ministries of health and justice should lead an inter-
ministerial, multi-stakeholder process, which includes 
civil society, to develop a strategic plan to build health law 
capacities, working to strengthen or create institutions to 
lead and coordinate health law research and development, 
identifying priority areas for public health laws.
Governments and foundations should support research 
to build a high-quality empirical foundation for evidence-
based, rights-based, equity-based laws that provide health 
coverage and safeguard the public’s health and safety, 
expanding research on existing public health laws and 
developing open access databases to share public health 
law research.
Recommendation 7 suggests that WHO and The Lancet 
should partner with legal and health experts to create an 
independent standing commission on global health and 
the law that would advance the health-related SDGs by 
proposing evidence-based legal interventions for 
addressing major global health challenges, reforms of 
global health architecture and international law, and 
strategies to build and strengthen global and national 
health law capacities.
As an example, this standing commission could 
recommend a comprehensive and legal reform agenda 
for global health security that would examine issues such 
as potential improvements to the IHRs, incentives for 
bringing countries into full compliance with IHR 
obligations and the JEE process, better coordination 
of laws relating to animal and human health, greater 
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harmonisation of regulatory standards to accelerate 
development of vaccines and other countermeasures, and 
improvements to benefit-sharing frameworks. This 
potential legal reform agenda could feed into the work of 
the newly established Global Preparedness Monitoring 
Board, which will monitor progress, identify gaps, and 
advocate for efforts needed for global preparedness for 
outbreaks and other health emer gencies, and help ensure 
it fully considers legal issues and possibilities.
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